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ABSTRACT
Siderophores are small, high-affinity ferric iron chelators released by many
microorganisms and some plants to solubilize iron. They are of great interest due to
their clinical use to treat iron overload in humans, and also in relation to the
development of novel antibiotics that target the biosynthetic and uptake pathways for
iron in pathogens. Pathogens such as Bacillus anthracis excrete more than one type
of siderophore. This is linked to increased pathogenicity. The Gram-positive soil
bacterium Streptomyces coelicolor A3(2) excretes three siderophores:
desferrioxamine B, desferrioxamine E and coelichelin. These displace iron from
insoluble ferric hydroxides, and the resulting ferric complexes are transported into
the cell via siderophore-binding proteins (lipoprotein receptors) associated with
ATP-binding cassette (ABC) transporters. Previous studies showed that some of the
genes in the biosynthetic clusters of the desferrioxamines (des) and coelichelin (cch)
were required for efficient uptake of ferrioxamine E and ferri-coelichelin
respectively and a third ABC transporter gene cluster (cdt), not associated with
siderophore biosynthesis genes, was implicated in the import of ferrioxamine B.
In this study, the lipoprotein receptors encoded within the des, cch and cdt clusters -
DesE, CchF and CdtB – were recombinantly overproduced in E. coli and purified by
immobilized metal affinity chromatography. Also, ferri-coelichelin was purified
from cultures of S. coelicolor. The binding of the ferric complexes of the three
cognate siderophores, as well as the xenosiderophores ferrichrome and ferri-
albomycin, to the lipoprotein receptors was monitored by intrinsic fluorescence
quenching. Dissociation constants of receptor-siderophore complexes were found to
be in the nanomolar range, and a revised model of cognate siderophore transport in
S. coelicolor was proposed. In collaboration with researchers at St. Andrews
University, an X-ray crystal structure was solved for apo-DesE and DesE bound to
ferrioxamine B, which demonstrated the similarity of DesE to other bacterial
siderophore-binding proteins and the negligible conformational change on substrate
binding. Ferrioxamine B also exhibited an unusual configuration not observed
before in X-ray crystals of this ferri-siderophore. Also, a forcefield was constructed
to model the structure and distortions ferric-tris-hydroxamate complexes, which
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could be used in the future to investigate the molecular basis of the tight and specific
binding of ferri-siderophores to siderophore-binding proteins.
xxii
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1Chapter 1: Introduction
1.1 : Iron in living systems
Iron is essential for almost all life, being the active constituent of many redox
enzymes such as haem-containing proteins, catalases, peroxidases and iron-sulfur
proteins1, essential for processes such as respiration and DNA biosynthesis. Some
lactic acid bacteria are an exception: manganese and cobalt are used instead of iron2.
Despite the fact that iron is one of the most abundant elements in the Earth’s crust,
many microorganisms and plants have difficulty obtaining enough iron in non-
acidic, oxygenated environments as it is usually found in the trivalent form Fe3+,
which forms hydrated hydroxides (such as rust) that are insoluble and notoriously
stable1. By contrast, the Fe2+ ion is soluble but is invariably oxidised via the Fenton
reaction by hydrogen peroxide in aerobic conditions3:
Fe2+ + H2O2 → Fe3+ + OH. + OH-
In neutral or alkaline environments, the concentration of free Fe3+ ions in solution
can be as low as 10-18 mol L-1 at neutral pH1; this is far below the physiological
concentration needed for microorganisms to survive.
The scarcity of iron in animals is also a fundamental issue for pathogenic bacteria.
In mammalian hosts, iron is tightly bound to proteins such as haemoglobin, the iron
transport protein transferrin, defence protein lactoferrin and the iron storage protein
ferritin. The strict homeostasis of iron leads to a free concentration4 of about 10-24
mol L-1, hence there are great evolutionary pressures put on pathogenic bacteria to
obtain this metal.
1.2 : Iron acquisition by microorganisms
To obtain enough iron to survive and proliferate, both prokaryotes and eukaryotes
have developed mechanisms to obtain iron from the extracellular environment.
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There are two main ways this is achieved: the direct binding and extraction of iron
from extracellular proteins, and the indirect extraction of iron from other
extracellular sources.
1.2.1 : Direct binding and extraction from proteins
Pathogenic Gram-negative bacteria such as Neisseria and Haemophilus have outer
membrane transporters that bind to the host’s transferrin and lactoferrin3,5. As these
proteins are too large to pass through the bacterial outer membrane, the iron carried
by these proteins has to be extracted, probably by the separation of the domains
containing the iron-binding sites. The free Fe(III) ion in the periplasm is captured by
ferric ion binding proteins (FBP)6, and the iron contained within is shuttled to the
cytoplasm via adenine triphosphate (ATP)-binding cassette (ABC) protein
transporters3.
Some bacteria also bind to haem-containing proteins such as haemoglobin,
myoglobin and the haem-sequestration proteins haemopexin and albumin. Instead of
ferric ion being transported, the haem group is extracted from the haem protein and
transported into the cell7. The Gram-positive bacterium Staphylococcus aureus
contains a haem uptake system consisting of three cell-surface lipoprotein receptors
that bind to different haem proteins, which in turn are substrates for an ABC
transporter system, which extracts and transports only the haem groups into the
cytoplasm8. Free haem is reactive and cytotoxic, hence it is degraded to release the
ferrous or ferric iron7.
1.2.2 : Indirect extraction of iron from extracellular sources
Microbes can increase the concentration of extracellular soluble iron by releasing
small molecules that scavenge ferric ion from ferric hydroxides and iron transport
proteins. The resulting ferric complexes are actively transported into cells via
specific transporters, or are reduced extracellularly to release the iron from the ferric
complex. These small molecule iron scavengers are known as siderophores (Greek:
“iron carrier”) and is by far the most widespread means used to obtain iron amongst
the kingdoms of life9.
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By analogy, some organisms can scavenge haem from haem proteins via small
proteins called haemophores10; but only the haem is transported into the cells as the
haemophore-haem complex is too large for absorption. Analogous processes are
used to transport free haem groups as with ferric-siderophore complexes into cells.
The weakness of haemophores is that they are of course restricted to haem-
containing iron sources, whereas siderophores can sequester iron from almost all iron
sources9.
Synthetase
Siderophores
Fe3+
A. Prokaryotes and eukaryotes
B. Eukaryotes only
e -
Fe2+
Figure 1-1: Siderophore-mediated iron acquisition.
Under iron deficiency, iron dependent repressors derepress to allow transcription of genes
involved in siderophore biosynthesis and uptake. Synthetases manufacture siderophores
(purple crescents) that are exported to the extracellular medium where they bind to ferric iron
(red). A. Once the cell encounters the Fe-siderophore complexes, in most organisms they are
recognised by high-affinity membrane-associated receptors that transport the complete Fe-
siderophore complex into the cell to release the iron contained. B. Eukaryotes, such as fungi,
possess extracellular reductases that can release iron from the siderophore by reduction of the
iron centre. The Fe(II) ion can be transported into the cell via specific Fe(II) importers.
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1.3 : Siderophores
1.3.1 : Introduction
Siderophores are low molecular weight, high affinity iron chelators which are
produced by many microorganisms and some higher plants to scavenge iron from
precipitates and iron-containing proteins. They are produced in response to
intracellular iron limitation and excreted. They bind mainly to ferric iron, and the
resulting ferric-siderophore complexes are shuttled back into cells via active
transport mechanisms.
Siderophores are amongst the highest affinity Fe(III) chelators known; ferric
enterobactin has a dissociation constant4 of 10-52 mol L-1. Their prodigious affinity
for metals is not restricted to ferric iron: they have strong affinities for other cations
such as Al(III), Ga(III) and Pu(IV)11. For this reason they have attracted the interest
of medical scientists for iron sequestration in man, but many are toxic or are unstable
in the body. The siderophore desferrioxamine B (as the mesylate salt Desferal®),
produced by many members of the bacterial genus Streptomyces12, has gained
widespread use as treatment for iron overload in humans. Desferal has been a
success in treating iron poisoning resulting from overdoses and thalasaemias, despite
being mildly toxic and the requirement for several hours of intravenous
administration13.
1.3.2 : Nomenclature
There is much confusion in the naming of siderophores and their ferric (or other
metal) complexes. For enterobactin, the ferric complex is referred to as ferric-
enterobactin. The ferric complex of desferrioxamine B is known as ferrioxamine B
(the des implies the absence of iron). This analogy is extended to the other
desferrioxamines. The deferrated form of ferrichrome is known as desferri-
ferrichrome, whilst its gallium(III) complex is commonly referred to as gallichrome.
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1.3.3 : The structures of siderophores
The molecular mass of siderophores varies from 600 to 1600 Da. They are
biosynthesised by both prokaryotes and eukaryotes either using non ribosomal
peptide synthetases (NRPS)14 or NRPS-independent siderophore synthetases (NIS)15.
Extracellular ferric iron binds to the ligating atoms of the siderophore to form stable
(in most cases, hexadentate) complexes.
Fe(III) prefers strong Lewis bases as ligands. These are usually neutral or anionic
oxygen electron pair donors9. The ligating groups within siderophores are usually
hydroxamate, catecholate (phenolate), or α-hydroxy carboxylates such as citrate
(Table 1-1)16 . Citric acid itself can act as a siderophore; bacteria such as
Escherichia coli have specific uptake systems for ferric dicitrate17.
Due to the extreme rarity of soluble iron in many environments, microbes need to
take advantage of any iron source encountered. Many bacteria produce no more than
two types of siderophore, but can utilize many different ferric-siderophores as
sources of iron. For example, E. coli produce only the siderophores enterobactin and
aerobactin, but can utilize the xenosiderophores ferrichrome and ferric coprogen as
sources of iron as well as ferric-aerobactin, ferric-enterobactin and ferric dicitrate11.
The remarkable diversity in the structures of siderophores may be due to some
organisms developing siderophores whose ferric complexes cannot be taken up by
other bacteria18, or cannot be recognised by the immune system in the case of
pathogenic bacteria19.
1.4 : Siderophore-mediated iron acquisition
1.4.1 : The regulation of the biosynthesis of siderophores
Microbes need to tightly regulate production of biosynthetic enzymes and transport
systems to allow efficient siderophore biosynthesis and secretion, as well as ferric-
siderophore uptake and iron release9.
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Table 1-1: The structures of representative siderophores, and examples of organisms that
produce them in response to iron deficiency.
The ferric iron binding groups in each molecule are highlighted in red.
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The first step in siderophore-mediated iron acquisition is the manufacture of
siderophores. Bacterial siderophore utilization and iron homeostasis is usually
mediated at the transcriptional level by the ferric uptake repressor Fur in Gram-
negative bacteria and low guanine-cytosine (GC) content Gram-positive bacteria,
whilst in high-GC content Gram-positive bacteria this role is taken by proteins
related to the diphtheria toxin repressor DtxR9. These repressors are regulated by the
concentration of Fe2+ in the cytosol: when Fe2+ is bound to one of these proteins, the
protein has a strong affinity for a palindromic sequence of DNA bases and
transcription of the downstream DNA is repressed. When Fe2+ dissociates from its
complex with the repressor, in turn, the repressor disassociates from the DNA,
allowing transcription of the genes20. Searching genomes for the palindromic
repressor binding sequence can allow identification of genes downstream which may
have a role in the maintenance of iron homeostasis.
1.4.2 : The secretion of siderophores
Siderophore secretion systems have been identified in only a few microbes so far3.
A recently characterized pathway in Mycobacterium tuberculosis involves one
protein, IrtA, as a complete ATP-binding cassette (ABC) transporter involved in the
export of carboxymycobactin21.
1.4.3 : Uptake of ferric-siderophore complexes in bacteria
Once the ferric siderophore complex has formed in the extracellular milieu, the ferric
ion remains solubilized until a microbe encounters the complex. The ferri-
siderophore complexes are too large to be transported by diffusion or via porins.
Eukaryotes such as fungi are able to reduce the ferri-siderophore complex to release
Fe(II), which can be readily absorbed, because some possess extracellular ferric
reductases. In the case of prokaryotes, the ferri-siderophore complex is actively
transported into the cytoplasm, where the complex can be reduced or degraded to
release the iron (Figure 1-2).
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In Gram-negative bacteria, which have an outer membrane and an inner
(periplasmic) membrane, the Fe-siderophore complex is taken up via outer
membrane receptors (OMRs) and ABC transporter systems, respectively. In Gram-
positive bacteria, with only an outer membrane, ABC transporter systems analogous
to those in the periplasmic membrane of Gram-negative bacteria import the
complex3.
Gram-negative bacteria Gram-positive bacteria
ATP ADP + Pi
TonB
Periplasm
Cytoplasm
OMR
SBP
ABC
transporter
ATP ADP + Pi
Cytoplasm
ABC
transporter
lipoprotein
receptor
Figure 1-2: General mechanisms of ferri-siderophore uptake in Gram-negative and Gram
positive bacteria.
(Left) In Gram-negative bacteria, the ferri-siderophores (orange circles) are taken up by high
affinity β-barrel membrane proteins known as outer membrane receptors (OMRs). Active
transport is powered by changes in the conformation of the TonB protein. Once in the
periplasm, the ferri-siderophore binds to periplasmic binding proteins or siderophore-binding
proteins (SBPs), part of ABC transporter systems (permease domains in green, ATPase
domains in blue) which transport the ferri-siderophore to the cytoplasm. (Right) Gram-
postitive bacteria have only one membrane through which the complex has to pass to enter the
cytoplasm. This is mediated by “lipoprotein receptors”, tethered analogues to the SBPs, which
feed the substrate to analogous ABC transporter systems.
1.4.4 : Outer membrane ferric-siderophore transport in Gram-negative
bacteria
The import of ferric siderophores across the outer membrane of Gram-negative
bacteria is mediated by OMRs, large β-barrel proteins which span the membrane.
The loops between the β-strands of the barrels that are exposed to the extracellular
environment are involved in Fe-siderophore recognition (Figure 1-3). X-ray
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crystallographic structures have been solved for the E. coli OMRs FepA22 (ferric
enterobactin receptor) and FhuA23 (ferric hydroxamate uptake receptor). They have
a very high affinity for their substrates, Fe-enterobactin having a dissociation
constant of 20 nM from FepA9.
Figure 1-3: Outer membrane transporter E. coli FhuA in complex with TonB.
The α-helices, β-sheets and loops of FhuA are coloured red, yellow and green respectively, and
TonB is coloured purple. The extracellular loops at the top are responsible for ferri-
siderophore binding. PDB code: 2GRX.
The active transport of the Fe-siderophore complex via the OMRs is driven by the
changes in conformation of the TonB-ExbB-ExbD complex24, where TonB interacts
with the OMRs whilst ExbB and ExbD reside on the periplasmic membrane. The
conformational change is driven by the proton motive force difference between the
periplasm and the cytoplasm24.
1.4.5 : Periplasmic membrane ferric siderophore transport in Gram-negative
bacteria
Once the Fe-siderophore is in the periplasmic space, it is transported to the
cytoplasm via ATP-binding cassette (ABC) transporters. These consist of
periplasmic binding proteins (PBP) or siderophore-binding proteins (SBP), a pair of
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permeases (which span the width of the membrane and form a heterodimer) and a
pair of ATPases on the cytoplasmic side – the site of hydrolysis of ATP that drive
the translocation of the ferri-siderophore25.
One of the best characterized ABC transporter systems is the E. coli BtuCDF
system26, which is responsible for the transport of vitamin B12 into the cytoplasm.
Vitamin B12 is an essential vitamin (a cobalt-corrin complex) that shares many
similarities to ferric siderophore complexes in terms of size and shape. The fold of
the PBP BtuF is very similar to those of SBPs such as the E. coli ferric hydroxamate
transporter FhuD (Figure 1-4). Thus, this system is a good model to elucidate the
mechanisms of ferric siderophore uptake.
BtuF is a bilobal, “kidney-shaped” protein, consisting of two antiparallel β-sheet
regions connected by a rigid backbone of severalα-helices. Opposite this backbone
is a cavity whose shape is defined by the residues on the extracellular loops of both
antiparallel β-sheet regions. An X-ray crystal structure of BtuF in complex with its
substrate vitamin B12 showed little conformational change compared to the apo
protein form27. A similar shape and rigidity of the complex is seen in all SBP
proteins26,28 crystallized to date, in particular the E. coli proteins FepB (ferric-
enterobactin receptor) and FhuD. This is not the case for all periplasmic binding
proteins of ABC transporters - the most notable example being maltose binding
protein (MBP)29, whose fold is dramatically altered on substrate binding.
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Figure 1-4: X-ray crystallographic structures of the E. coli proteins BtuF and FhuD with their
substrates bound.
Left: BtuF with vitamin B12 bound (PDB code: 1N4A). Right: FhuD with ferric coprogen bound
(PDB code: 1ESZ)
The E. coli SBP FhuD30 showed markedly lower affinity for its substrates than the
corresponding OMRs, having 10- to 100-fold lower affinity for ferrichrome than
FhuA31. This is unsurprising as the accumulation of the substrate into the periplasm
has already been performed by the OMRs, hence there is little evolutionary pressure
to increase the SBP’s affinity for siderophores. Ferri-enterobactin has a dissociation
constant of 30 nM from the E. coli SBP FepB32; this is comparable to the OMR
FepA.
1.4.6 : PBP interaction with the permease-ATPase domains
A crystal structure has been solved for BtuF in complex with the BtuC2D2 permease-
ATPase dimer (Figure 1-5), but without the substrate. This structure may represent
the complex after vitamin B12 has been transported26. It showed the PBP interacting
with the permease dimer BtuC2 via the substrate binding pocket, which also may
provide evidence that the vitamin itself may be involved in recognition by the
permease domains. Closer analysis of the structure showed the PBP was pulled
apart slightly on binding to the permease (via aspartate residues conserved in many
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siderophore PBPs) compared to the apo and ligand bound forms of BtuF. This is
likely to be the mechanism of siderophore release from BtuF into the BtuC2 pore.
Comparisons to a crystal structure of the BtuC2D2 permease-ATPase dimer33 showed
differences in the arrangement of transmembrane domains of the permease dimer,
demonstrating the conformational changes involved in vitamin B12 transport.
1.4.7 : Ferri-siderophore uptake in Gram-positive bacteria
Gram-positive bacteria have only one outer membrane (surrounded by a thick
peptodiglycan layer) which Fe-siderophores have to pass through to get to the
cytoplasm. This is mediated by ABC transporters which are analogous to the ABC
transporters of Gram-negative bacteria, except that the SBPs are tethered to the outer
membrane by an N-terminal lipid, and are consequently known as “lipoprotein
receptors”. The X-ray crystal structure of FeuA (Figure 1-6), a ferric-bacillibactin
SBP of Bacillus subtilis34,35, confirmed the similarity of these proteins to Gram-
negative SBPs. These tethered SBPs are also seen in Gram-negative organisms: for
example the enterobactin SBP CeuA36,37 of Campylobacter jejuni. Despite the
tether, they are assumed to interact with the permease-ATPase parts of their ABC
transporters in a similar way to untethered periplasmic SBPs.
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BtuF
BtuC2
BtuD2
Figure 1-5: The X-ray crystallographic structure of BtuF in complex with BtuC-BtuD dimer.
The periplasmic binding protein BtuF (red) interacts on the substrate binding side with the
permease dimer BtuC (blue and green) embedded in the cytoplasmic membrane. The dimer of
BtuD ATPases, found on the cytoplasmic side, is coloured yellow and purple. The absence of
the substrate vitamin B12 from this structure led to the conclusion that this was a post-
translocation intermediate (PDB code: 2QI9).
These receptors have higher specificities towards their Fe-siderophore substrates
than SBPs of Gram-negative bacteria. Dissociation constants for Gram-positive
SBPs are about 2 orders or magnitude smaller than for Gram-negative SBPs, close to
those of the OMRs in Gram-negative bacteria. For example, the S. aureus
lipoprotein receptor FhuD2 has dissociation constants of 20 nM and 50 nM from
ferrichrome and ferrioxamine B respectively38 (compared with E. coli FhuD30, whose
dissociation constants are 600 nM and 35 μM respectively).
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Figure 1-6: Crystal structure of FeuA, a ferric-bacillibactin lipoprotein receptor of Bacillus
subtilis (PDB code: 2PHZ).
1.4.8 : Iron release from ferric siderophores
The mechanism of iron release from the ferric-siderophore complex is likely to
involve reduction for siderophores such as hydroxamate and α-hydroxy carboxylate
siderophores9, as Fe(II) has little affinity for these siderophore ligands. This
reduction is predicted to be carried out by flavoproteins, because the reduction of the
Fe-siderophore complex at physiological pH is within the range of reducing agents
such as flavin adenine dinucleotide (FAD)9. Although many enzymes with ferri-
siderophore reductase activity have been identified, only a few have significant
specificity for siderophore substrates, suggesting that reductive iron release has not
led to the development of highly specialized enzymes9.
A family of potential reductases have been identified which may have significant
specificity for certain ferric-siderophores: these are known as siderophore interacting
proteins (SIPs)9. One example is ViuB of Vibrio cholerae, which is essential for the
utilization of the catecholate siderophore ferric vibriobactin39, and a crystal structure
of a related SIP40 from Shewanella putrefaciens has FAD bound in a cleft (Figure
1-7). This may be the site of Fe-putrebactin reduction. An unrelated iron-sulfur
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protein in E. coli (FhuF) has been shown to have specificity to ferric hydroxamates
such as ferrichrome41. It is speculated that the role of the iron-sulfur cluster is to
mediate electron transfer to the Fe-siderophore to reduce it.
Ferric-enterobactin and ferric-bacillibactin, in contrast, have very low redox
potentials and much lower dissociation constants from Fe3+ (ferrioxamine E has a
dissociation constant for ferric iron of 10-32 mol L-1 compared to 10-52 mol L-1 for
ferric enterobactin11). Thus, enzyme-catalyzed hydrolysis of the backbone is the
proposed iron release mechanism in E. coli and Bacillus subtilis for ferric-
enterobactin and ferric-bacillibactin respectively34,42.
Figure 1-7: X-ray crystallographic structure of the putative SIP from Shewanella putrefaciens.
The FAD group bound in a cleft of the protein is highlighted in blue (PDB code: 2GPJ).
1.5 : The importance of understanding siderophore-mediated iron
uptake in bacteria
Siderophores have recently attracted interest as potential drug delivery agents, due to
the high specificity and efficiency of their uptake systems43. Albomycin (Figure
1-8), a siderophore-antibiotic conjugate produced by the bacterium Streptomyces
griseus, is effective against E. coli and S. aureus because its uptake uses the same
siderophore transport system as the fungal siderophore ferrichrome23,44.
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Understanding the specificity of these transport systems could lead to the design of
new “Trojan horse” antibiotics which masquerade as siderophores43.
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Figure 1-8: Albomycinδ1. The antibiotic portion of the molecule is highlighted in red.
The production of siderophores is also a critical factor for pathogenic organisms to
establish infections in the body9. For example, the Gram-positive anthrax pathogen
Bacillus anthracis produces two siderophores, bacillibactin and petrobactin, to
scavenge ferric iron. Whilst bacillibactin has been shown to bind to the immune
system protein siderocalin45 (see Figure 1-9), rendering it ineffective as a means of
scavenging iron from the host, petrobactin was proposed to evade siderocalin and
has been shown to be important for virulence in mice46.
Figure 1-9: Crystal structure of ferri-enterobactin bound to the immune system protein
siderocalin.
Enterobactin is an analogue to the Bacillus anthracis siderophore bacillibactin. Figure from 19
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The inhibition of the production of stealth siderophores such as petrobactin could
lead to the development of novel antibiotics that target microbial iron acquisition
pathways. Genes involved in petrobactin production have been identified, and
currently its biosynthetic pathway is being elucidated by gene knockout
experiments47 and biochemical experiments with purified recombinant proteins48.
Another approach to inhibit siderophore-mediated iron acquisition is to design
inhibitors to block the uptake of ferric-petrobactin. The uptake pathway for ferric-
petrobactin has been recently elucidated through binding studies involving the
purified recombinant siderophore-binding lipoprotein receptors of the closely-related
pathogen Bacillus cereus49. Two lipoprotein receptors have been shown to bind
ferric-petrobactin and its photoproducts. Other lipoprotein receptors have been
found to bind the xenosiderophores ferric enterobactin, ferric-schizokinen,
ferrioxamine B and ferrichrome49.
1.6 : Iron metabolism in the model Gram-positive organism
Streptomyces coelicolor A3(2)
1.6.1 : Introduction
Streptomyces coelicolor A3(2) (Figure 1-10) belong to the Streptomycetes – a group
of soil-dwelling filamentous Gram-positive bacteria that have a complex life cycle
and are responsible for producing many antibiotics as secondary metabolites.
Streptomycetes belong to the Actinobacteria, an order of GC-rich Gram-positive
bacteria which include the pathogens Mycobacterium tuberculosis and
Corynebacterium diphtheriae. S. coelicolor is not pathogenic however (it is found in
many soils and produces geosmins50, which are responsible for the odour of soil). Its
biology is relatively well characterized, and its genome was published in 200251.
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Figure 1-10: Colonies of Streptomyces coelicolor A3(2) growing on solid media.
The blue spots are water droplets containing the pigmented antibiotic actinorhodin.
Photograph from the John Innes Centre, Norwich, UK.
Like some pathogenic microorganisms, S. coelicolor produces more than one
siderophore (M. tuberculosis produces both mycobactin and carboxymycobactin21).
In particular, S. coelicolor produces three siderophores of the hydroxamate type
(Figure 1-11): desferrioxamine B, desferrioxamine E and coelichelin52,53 under iron-
limiting conditions. Many streptomycetes produce desferrioxamines and many more
types of bacteria can utilize their ferric complexes as iron sources. This led to the
proposal that coelichelin may be produced by the relatively slow-growing S.
coelicolor (and the related S. ambofaciens ATCC28377) to guarantee a ferric iron
supply in the competitive soil environment18.
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Figure 1-11: Siderophores produced by Streptomyces coelicolor.
Left: Desferrioxamine B, marketed as its mesylate salt Desferal®. Middle: Desferrioxamine E;
Right: Coelichelin
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1.6.2 : Biosynthesis and uptake of siderophores in Streptomyces coelicolor A3(2)
1.6.2.1 : The desferrioxamines
The des cluster of genes in S. coelicolor (Figure 1-12) is responsible for the
production of both desferrioxamines E and B54. A role of each of the genes
desABCD in their biosynthesis have been proposed54. DesD belongs to the group of
NRPS-independent siderophore (NIS) synthetases involved in siderophore
production15,55. Immediately upstream of desA is a DmdR (divalent metal-dependent
regulatory protein) binding site and its function has been experimentally elucidated,
which suggest that the expression of the genes is controlled by intracellular ferrous
iron levels56.
= Iron-boxes for DmdRor IdeR
= Siderophore uptake genes
= Siderophore utilization genes
= Siderophore biosynthetic genes
Figure 1-12: The organisation of the des cluster of S. coelicolor
Despite the structural similarities between the desferrioxamines B and E, they have
distinct properties – desferrioxamine E has a 100-fold greater affinity for Fe(III) than
desferrioxamine B11, and the latter is the only one that is used clinically to treat iron
overload12.
Whilst desABCD is involved in the biosynthesis of desferrioxamines, there were also
two genes upstream of desA, namely desE and desF, which also appear to be
transcriptonally controlled by Fe(II) levels inside the cell based on the presence of a
DmdR binding site upstream of desE. These genes were predicted to encode a
lipoprotein receptor (siderophore-binding protein) component of an ABC transporter
and a SIP likely to be involved in the reduction of ferric siderophores, respectively
(Table 1-2)53. The permease and ATPase domains of the DesE-associated ABC
transporter are not encoded by genes in the gene cluster, suggesting DesE would
have to interact with other (unidentified) permeases to transport ferri-siderophores.
desEdesF
desA
desB
desC
desD
5000(bps)
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Table 1-2: Proposed functions of proteins encoded by the des cluster53.
Protein Homologue (% identity) Proposed function
DesA Ddc A. baumannii (37%) L-Lysine decarboxylase
DesB AlcA B. bronchiseptica (47%) 1,5-Diaminopentane monooxygenase
DesC AlcB B. bronchiseptica (46%) Acyl-CoA dependent acyl transferase
DesD AlcC B. bronchiseptica (51%) Type C siderophore synthetase
DesE FhuD B. subtiltis (24%) Ferric-siderophore lipoprotein receptor
DesF ViuB V. cholerae (30%) Siderophore-interacting hydrolase
1.6.2.2 : Coelichelin
Coelichelin production is directed by the cch cluster of genes52, and is also found in
S. ambofaciens (Figure 1-13). The largest gene by far in this cluster is the cchH
gene, encoding a trimodular NRPS.
Figure 1-13: The organisation of the coelichelin biosynthetic cluster in S. coelicolor.
The unusual feature of the CchH NRPS are that it lacks a C-terminal thioesterase
domain which is usually involved in the release of the assembled peptide from the
synthetase, and that it produces a tetrapeptide rather than the predicted tripeptide57.
A novel mechanism for coelichelin biosynthesis was formulated, where the non-
proteinogenic amino acid N-formylhydroxyornithine was loaded twice onto the same
module of the NPRS to make the tetrapeptide, and the enzyme encoded by the cchJ
gene (similar to E. coli enterobactin esterase – see Table 1-3) was implicated in
releasing the tetrapeptide from the enzyme52. The genes cchCDEF, which encode an
ABC transporter, are flanked by DmdR iron boxes. cchF encodes a lipoprotein
receptor, cchC and cchD encodes the permeases, and cchE encodes an ATPase.
cchAcchB
cchC
cchD
cchE
cchF
cchG
cchH cchI cchJK
= Iron-boxes for DmdR or IdeR
= Siderophore uptake genes
= Siderophore utilization genes
= Genes of unknown function
= Siderophore export genes
= Siderophore biosynthetic genes
5000 10000 15000 20000(bps)
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1.6.3 : The effect of mutations in the des and cch gene clusters on siderophore
uptake
To investigate the effect of deletion of the des and cch gene clusters in S. coelicolor
on siderophore uptake53, the gene clusters were separately replaced by apramycin
and viomycin resistance cassettes respectively using the PCR-targeting REDIRECT
technology50. Siderophore non-producing mutants that had both genes desD and
cchH replaced were also made. The cluster deletion mutants lacked the DesE and
CchF lipoprotein receptors, while the desD and cchH mutants still encoded these
receptors. The various mutants were grown on iron-deficient colloidal silica plates
(which lacked xenosiderophores), and the growth halos around filter paper discs
supplemented with different siderophores were observed.
Table 1-3: Proposed functions of proteins encoded by the cch cluster53
Protein Homologue (% identity) Proposed function
CchA FxbA M. smegmatis (49%) Formyl transferase
CchB PsbA Pseudomonas sp. B10
(39%)
L-Ornithine-N5-monooxygenase
CchC FepD Yersinia spp. (39%) Permease component of ABC
importer
CchD FepG Yersinia spp. (35%) Permease component of ABC
importer
CchE FepC Y. enterocolitica (54%) ATPase component of ABC importer
CchF FhuD B. subtiltis (26%) Ferric-siderophore lipoprotein
receptor
CchG ExiT M. smegmatis (50%) ATPase/permease of exporter
CchH FxbC M. smegmatis (42%) Coelichelin NRPS
CchI StrV S. glaucescens (33%) ATPase/permease of exporter
CchJ Fes E. coli (30%) Thioesterase
CchK MbtH M .tuberculosis (70%) Essential for biosynthesis58
The des cluster mutant was unable to grow well when supplemented with
ferrioxamine E and ferrichrome, whilst the cch cluster mutant could not grow when
supplemented with ferri-coelichelin. Surprisingly, all of the mutants, including ones
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where both des and cch clusters were deleted, were able to grow well with
ferrioxamine B, coprogen and aerobactin supplementation. This suggested the
presence of another transport system, independent of the des and cch clusters, which
were involved in ferrioxamine B uptake and utilization.
1.6.4 : Identification of another ABC transporter involved in ferrioxamine B
transport
Bunet et al.59 identified another gene cluster cdtABC that could be involved in
siderophore transport (Figure 1-14). A putative DmdR binding site was identified
upstream of cdtC53, and the cdtB gene encoding a protein similar to siderophore
binding proteins (Table 1-4).
Figure 1-14: The organisation of the cdtABC cluster in S. coelicolor which plays a role in
salmycin uptake and possibly ferrioxamine B uptake.
To determine whether this gene cluster had a role in siderophore transport, the
cdtABC cluster was replaced using the REDIRECT technology60 with an apramycin
resistance cassette, and the resulting mutant was grown in the presence of ferri-
salmycin44, a siderophore-antibiotic conjugate analogous to ferrioxamine B (Figure
1-15). It was found that the mutant was not sensitive to ferri-salmycin, whilst the
wild-type S. coelicolor was, and that this was not due to the presence of the
apramycin-resistance gene used to replace cdtABC. Competition experiments with
ferrioxamine B found that this siderophore reduced the sensitivity of the wild-type S.
coelicolor to salmycin on solid media, although uptake experiments with radioactive
55Fe-ferrioxamine B suggested there was no difference in uptake of this siderophore
between the wild-type and the mutant.
= Iron-boxes for DmdR or IdeR
= Siderophore uptake genes
cdtA cdtB cdtC
2500(bps)
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Table 1-4: Proposed functions of proteins encoded by the cdt cluster of genes59.
Protein Homologue (% identity) Proposed function
CdtA E. coli FepG (33%)
E. coli FepD (33%)
Permease dimer/component of ABC
importer
CdtB E. coli FepB (24%) Ferric-siderophore lipoprotein
receptor
CdtC E. coli FepC (41%) ATPase component of ABC importer
These results suggested that the antibiotic salmycin is taken up by S. coelicolor via
the cdtABC transporter system. This system can also take up ferrioxamine B,
although ferrioxamine B could be taken up via an alternative route – possibly via
DesE, which is involved in ferrioxamine E uptake.
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Figure 1-15: The structure of salmycin A compared to desferrioxamine B
1.6.5 : Other genes which may be involved in siderophore uptake
Gene clusters were also found that had similarity to the E. coli enterobactin ABC
transporter system FepBCDG. SCO1785-1787 had similarities to the ATPase FepC,
permease FepG and the permease FepD, whilst SCO2272 had similarities to the SBP
FepB, FepD and FepC respectively. Also the genes SCO0996 and SCO7218 had
similarities to SBPs, and were adjacent to ABC transporter system genes.
1.6.6 : The proposed roles of the DesE, CchF and CdtB lipoprotein receptors in
siderophore uptake
From the gene knock-out experiments, the following model was proposed53: After
excretion of the siderophores and formation of the corresponding ferric complexes,
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the lipoprotein receptor DesE was proposed to bind to ferrioxamine E, and possibly
ferrioxamine B, but not to ferri-coelichelin. The transport of the ferri-siderophore
complex is mediated by as yet unknown ABC transporter permease and ATPase.
The ABC transport system CchCDEF, with receptor CchF, transports only ferri-
coelichelin, whilst the CdtABC system, containing the receptor CdtB, could
transport ferrioxamine B, but not ferrioxamine E or ferri-coelichelin. Also, the
hydroxamate siderophore ferrichrome was proposed to bind only to DesE, but not
CchF and CdtB. The proposed biosynthesis and uptake of cognate siderophores of S.
coelicolor is illustrated in Figure 1-16.
1.6.7 : Methods for investigating the role of the lipoprotein receptors
To elucidate the routes of ferri-siderophore transport in S. coelicolor A3(2), one has
to study the lipoprotein receptors which govern ferri-siderophore entry. To test the
interaction of siderophore-binding proteins with ferri-siderophores, the main
approach used by others have been to recombinantly express and purify the proteins
in the bacterial host E. coli, and then to monitor the decrease of intrinsic fluorescence
of the proteins on titration with small amounts of ferri-siderophores30,38,49,61. The
sensitivity of the fluorescence technique has been used to calculate dissociation
constants in the nanomolar range, and required only small amounts of protein and
ferri-siderophores.
If there is binding of a siderophore-binding protein to a ferri-siderophore, it is likely
that the ferri-siderophore is taken up into the cell via its corresponding ABC
transporter components, whilst if there is little or no binding, one can deduce that the
siderophore-binding protein is not involved in the uptake of that ferri-siderophore.
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Figure 1-16: Model of the biosynthesis, export and uptake of coelichelin, desferrioxamine E and
desferrioxamine B by Streptomyces coelicolor A3(2).
Abbreviations for intermediates in coelichelin and desferrioxamine biosynthesis are as follows:
hDAP: N-hydroxy-1,5-diaminopentane; haDAP: N-hydroxy-N-acetyl-1,5-diaminopentane;
hsDAP: N-hydroxy-N-succinyl-1,5-diaminopentane; L-hOrn; L-N5-hydroxyornithine; L-N5-
hydroxy-N5-formylornithine. An arrow indicating the possibility that DesE is also involved in
ferrioxamine B binding is not shown. Figure from 53.
1.6.8 : Properties of the three putative lipoprotein receptors DesE, CchF and
CdtB
The protein sequence of DesE, CchF and CdtB proteins share similarities to other
siderophore binding proteins from Gram-positive and Gram-negative bacteria
(Figure 1-17). A multiple alignment of DesE, CchF and CdtB proteins with E. coli
FhuD and B. subtilis FeuA showed several regions of great similarity, but these
correspond to structural elements (α-helices and β-sheets) that are important as the
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scaffold of the FhuD and FeuA proteins. These residues do not participate in ligand
binding. Also, there were several glutamate and aspartate residues not inα-helices
or β-sheets that were conserved - in FhuD and FeuA these correspond to the
permease-binding face of these proteins, which may be important for interactions26.
DesE -MSHASATHP TRRGILAAGG ALGLGAVLAA CGDGDGKSDG AGDGSGGAAK SGPWSFKDDR
CchF MLLRTTRTKP WRRLAAALSA AALGVGLLAG CGSDSDDPAD EAGGGTPAAA GAFPVTVEHA
CdtB ---------- MRRLLLTAAA TTAAALTLAA CGTTEPAADK AEKKASEAI- ----TLKDGK
FeuA ---------- -MKKISLTLL ILLLALTAAA CGSKNESTAS KASGTASEK- -----KKIEY
FhuD ---------- MSGLPLISRR RLLTAMALSP LLWQMNTAHA AAIDP----- ----------
DesE GTTVKLDKVP ANIVAFTG-V AAALFDYGVE VKGVFGPTTT KDGKPD---- ----VQAGDL
CchF FGTTKIDKAP ERVVSVGYTD DQTVLAFGIK PVGMVDQYPN PAGQSPDINT QWPWVKDKWG
CdtB GTEVKLDGPA TKVVATEWNV VESLVSLGVD PVGVADVKGY KTWDSA---- ----VPLKNE
FeuA LDKTYEVTVP TDKIAITG-S VESMEDAKLL DVHPQGAISF SGKFPD---- ----MFKDIT
FhuD ---------- NRIVALEWLP VELLLALGIV PYGVADTINY RLWVSE---- ----PPLPDS
DesE DVDKVTVLGN EWGKLNVEKY ASLAPEVLIT TTFDTAGTLW SVPEESKDKV AKLAPSVAIS
CchF DTKPEVVMKN GDTGPNFEKI AALRPDLIVA VYSEID---- ---QAAYDKL SKIAPTVGRT
CdtB PKD----IG- TRGEPSMDTV ASLAPDLIVA TTDLAP---- ----AAVKQL REVAPVIEVK
FeuA DKAEP--TG- EKMEPNIEKI LEMKPDVILA STKFPE---- ----KTLQKI STAGTTIPVS
FhuD VID----VG- LRTEPNLELL TEMKPSFMVW SAGYGP---- ----SPE-ML ARIAPGRGFN
DesE VFDR--QLTQ PLQRMWELAE SLGADMKAKK VTDAKAAFDK AAARLRAAAK AKPEIRVLAG
CchF KGEKEPFSAP WQDNALHIAK ALGKAEEGEK MVADIQGKLD AAKQAHPEFA DKTAVVLSWY
CdtB SADGTGQIDR MLENVDLIAE ATGTTDRAKS LREGFETKVA EGKKALADAG MAGKDIAFAD
FhuD FSDGKQPLAM ARKSLTEMAD LLNLQSAAET HLAQYEDFIR SMKPRFVKRG AR--PLLLTT
FeuA HISS-----N WKENMMLLAQ LTGKEKKAKK IIADYEQDLK EIKTKINDKA KDSKALVIRI
DesE ----SASPDL FYVSGTNLSV DLEYFKALGV NFVEPSEDAK KATGGWFESL SWENVDKYPA
CchF K------DSV APFTSTDVRG --RLVTGIGF KYETEIDKVA GGDFYTTLSP ERVDLVDVDR
CdtB GYVASNQVSI RPYTATSLIG EVNEAVGLKN AWTVKGDEAY GLGATDVEGL TKLPEDTQFA
FeuA R------QGN IYIYPEQVYF NSTLYGDLGL KAPNEVKAAK AQELSSLEKL SEMNPDHIFV
FhuD ---LIDPRHM LVFGPNSLFQ EILDEYGIPN AWQGETN-FW GSTAVSIDRL AAYKDVDVLC
DesE DVIIMDDRAS TIQPADITEG -TWKQLPAVK AGQVIARSPE PILSYDKCTP LLDNLAE--A
CchF VFVINDKAD- ---QDALKKF ELFTNLDAVK NGKVSYLLDS EGPAVGAAIS QGTLLSMPYA
CdtB YIGNDDDPSA TPFTGELAKN PVWKSLPFVK AG-DVHRLDD GIWMFGGPGS MEAYIDA--V
FeuA QFSDDENADK PDALKDLEKN PIWKSLKAVK EDHVYVNSVD PLAQGGTAWS KVRFLKA--A
FhuD FDHDNSKD-- ---MDALMAT PLWQAMPFVR AG-RFQRVP- AVWFYGATLS AMHFVRV--L
DesE IENAKKVG-
CchF VDELVKSAG
CdtB VGALTK---
FeuA AEKLTQN--
FhuD DNAIGGKA-
Figure 1-17: Multiple alignments of DesE, CchF and CdtB with the siderophore-binding
proteins E. coli FhuD and B. subtilis FeuA. Key: Magenta: conserved residues throughout the
five proteins. Green: conserved residues from three or more proteins. Cyan: Similar residues
to the green residues. The alignment was performed by ClustalX using Gonnet scoring.
The DesE, CchF and CdtB proteins were found in the S. coelicolor membrane-
associated proteome62 by analysis of membrane protein extracts in liquid culture
using two-dimensional gel electrophoresis (Figure 1-18), and matrix-assisted laser-
desorption ionization time-of-flight (MALDI-TOF) peptide mass fingerprinting of
the resulting protein spots. All three proteins ran on the gel at similar molecular
masses and isoelectric points around pI 4 – 5, as predicted by their protein sequences
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(Table 1-5). This data is consistent with the proposed role of these proteins as
membrane-associated receptors.
Figure 1-18: Two dimensional gel electrophoresis of the membrane-associated proteome of S.
coelicolor.
The spots 6, 12 and 18 (indicated by arrows) were identified by peptide mass fingerprinting as
the proteins CchF, DesE and CdtB respectively. Figure from 62.
Also, all three proteins have been identified as putative substrates of the twin-
arginine translocase (TAT) protein exporter of S. coelicolor63. This suggests that
these proteins are produced and folded in the cytoplasm of S. coelicolor, and
exported in a fully folded form to the outer membrane. TAT substrates are identified
by their hydrophobic N-terminal signal sequences (Table 1-6) with the distinctive
RR (twin arginine motif)64. To test whether DesE, CchF and CdtB were TAT
substrates, the membrane-associated proteome of S. coelicolor ΔtatC (defective in
TAT substrate export) was compared to the wild-type strain. Only DesE was clearly
absent from the ΔtatC membrane proteome, and its TAT signal sequence was able to
direct the export of the agarose-consuming enzyme agarase on solid media when a
chimeric gene was integrated into the wild-type S. coelicolor chromosome63.
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Table 1-5: The molecular masses and pIs of the three lipoprotein receptors predicted from their
protein sequences (prior to N- terminal cleavage and lipidation)
Protein Molecular weight (Da) pI
DesE 36641.8 4.94
CchF 37374.6 4.73
CdtB 34093.9 4.44
Analysis of the sequences of DesE, CchF and CdtB indicate the presence of the
prokaryote lipidation site PS5125765 (also known as a lipobox). This suggests the
proteins are likely to be lipidated at the N-terminal cysteine after translocation to the
outer membrane by the Lgt protein of S. coelicolor and N-terminal cleavage
catalysed by the Lsp protein65(which may also acylate the free amino group of the
cysteine) (Figure 1-19).
Table 1-6: The first 35 residues of the S. coelicolor DesE, CchF and CdtB proteins.
The twin-arginine translocase (TAT) consensus sequence R-R-x-Φ-Φ (where x is any amino
acid and Φ is a hydrophobic residue) is highlighted in cyan, while the PS51257 Prosite
prokaryotic membrane lipid attachment site (originally called PS0013) is highlighted in green.
The lipid is attached to the cysteine residue at the C-terminus of the highlighted sequence.
Protein First 35 residues of the protein sequence
DesE MSHASATHPTRRGILAAGGALGLGAVLAACGDGDG
CchF MLLRTTRTKPWRRLAAALSAAALGVGLLAGCGSDS
CdtB MRRLLLTAAATTAAALTLAACGTTEPAADKAEKKA
PhD. Thesis: Prakash Patel Chapter 1: Introduction
29
Figure 1-19: The proposed mechanism of lipidation of the lipoprotein receptors in Gram-
positive bacteria.
(i) The protein (red) with hydrophobic signal sequence (blue) is secreted by the TAT pathway to
the cytoplasmic membrane; (ii) The Lgt protein then lipidates the N-terminal cysteine of the
protein at the end of the signal peptide (black line); (iii) the signal peptide is cleaved by Lsp,
leaving the mature protein (red) with an N-terminal lipid (black).
1.7 : Structural aspects of SBP-siderophore binding
In S. coelicolor, the DesE receptor was predicted to bind ferrioxamines B and E, and
ferrichrome, whilst CdtB was predicted to bind ferrioxamine B only. CchF was
predicted to bind only ferri-coelichelin. It is difficult to predict which siderophores a
receptor may bind to from its sequence alone; one can only infer the protein may
bind to siderophores. For example, CdtB was annotated as a ferrichrome-binding
protein due to its similarity to E. coli FhuD, although the available experimental
evidence suggests otherwise. What features do siderophore-binding proteins have to
make them so specific for various ferri-siderophores?
The recognition of ferric siderophores by OMRs, SBPs and lipoprotein receptors is
highly dependent on the coordination environment of the ferric iron11. E. coli can
take up the tris-hydroxamate siderophores ferrichrome, ferrichrysin and ferricrocin
(whose peptide backbones differ, but the coordinate environment of ferric iron is
similar), but cannot use ferrichrome A. This is due to the periphery groups attached
to the hydroxamate groups in ferrichrome A (Figure 1-20), which affects its binding
to the E. coli OMR FhuA66.
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The chirality of ferri-siderophores around the iron centre, in particular, the
handedness of the propeller when the Fe-siderophore is viewed from the C3 axis
(Figure 1-21), has also been marked out as an important factor for Fe-siderophore
uptake67. Inhibition of ferric coprogen uptake in the fungus Neurospora crassa was
greater with Δ-trans isomers of chromic coprogen than with Δ-cis isomers, implying
that Δ-trans coprogen is recognised by its receptors better than Δ-cis coprogen67.
The ferric complex of coprogen crystallized as the Δ-trans isomer68 .
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Figure 1-20: Desferri-siderophores of the ferrichrome family.
Left: Desferri-ferrichrome (X=H, X’=H), desferri-ferrichrysin (X=CH2OH, X’=CH2OH) and
desferri-ferricrocin (X=CH2OH, X’=H). Right: Desferri-ferrichrome A. The iron-ligating
regions are highlighted in red. E. coli cannot use ferrichrome A as an iron source due to the
presence of the groups highlighted in blue.
On the other hand, the crystal structure of E. coli FhuD with the siderophores
ferrioxamine B, ferric-coprogen and ferri-albomycin bound showcased various
coordination environments of ferric hydroxamates on binding to the SBP, with the
complexes exhibiting either the Δ or Λ configuration. This may be due to the
relaxed substrate specifity of this protein, by virtue of having to shuttle siderophores
collected by both the FhuA (ferrichrome)69 and FhuE (coprogen) OMRs70.
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Figure 1-21:  The Λ and Δ configurations of Fe(acetohydroxamic acid)3, a simple ferri-
hydroxamate
To attempt to understand siderophore-SBP binding fully, one must be able to
produce a model of the SBP bound to their putative substrates, usually via X-ray
diffraction of a crystal of the complex. This is a time-consuming exercise, as many
proteins do not crystallize readily. Once a crystal structure is found, one can analyse
the hydrogen bonds and van der Waals’ contacts of the siderophore to the protein.
1.8 : Molecular modelling of ferric-tris-hydroxamates to predict the
strength of siderophore-SBP binding
Once the structure of a receptor/ferri-siderophore complex has been determined, one
may want to predict the affinity of the protein for other ferri-siderophores by
molecular modelling. As the coordination environment of the iron is crucial for its
recognition by the SBP, the molecular model must be able to reproduce the bond
lengths, angles, torsion angles etc. of ferri-siderophore complexes. The problem
with many molecular modelling programs is that they cannot model the high
coordination numbers of transition metal complexes, and the hexacoordinate Fe(III)
siderophore complexes are assumed to be perfectly octahedral, which is not the case
(Figure 1-22).
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Figure 1-22: A model of the simple ferric-tris-hydroxamate, Fe(acetohydroxamate)3.
The arrangement of the oxygen atoms around the Fe centre in the X-ray crystal structure71 is
not octahedral (Oh symmetry), but very close to C3 symmetry. This complex is representative of
ferric hydroxamate ligands bound to Fe(III).
Also, a model should be able to accurately reflect the lability of the coordination
environment of iron with its siderophore ligands, due to the low ligand field strength.
Ferrioxamine B formed a racemic mixture of Λ-cis and Δ-cis (fac) isomers when
crystallized on its own72, but bound to E. coli FhuD it adopts the Λ-C-trans-cis
configuration28. To investigate protein-siderophore binding computationally, the
transition of siderophores from fac isomers to other isomers has to be modelled
effectively. This involves the careful modelling of the energy of trigonal distortion
of the complexes, because this is the most probable way that isomers interconvert.
The software package DOMMIMOE73, developed at the University of Warwick, is
an incorporation of the ligand field theory of transition metal complexes into the
Molecular Operating Environment (MOE)74, a commercial molecular mechanics
package. It is an attractive tool for developing a suitable parameterization for ferric-
tris-hydroxamate siderophores.
1.9 : Aims of the project
The main aim of this project was to characterize DesE, CchF and CdtB, the three
lipoprotein receptors of Streptomyces coelicolor A3(2), and assess their binding with
the cognate siderophores ferrioxamine B, ferrioxamine E and ferri-coelichelin, as
well as the xenosiderophores ferrichrome, albomycin and ferric enterobactin. The
PhD. Thesis: Prakash Patel Chapter 1: Introduction
33
siderophore ferri-coelichelin is not commercially available. Thus it was planned to
purify it by RP-HPLC from large-scale cultures of S. coelicolor grown in iron
deficient medium. It was aimed to overproduce the DesE, CchF and CdtB proteins
in E. coli and to purify them by affinity chromatography. The change in the intrinsic
fluorescence of the proteins was to be used to monitor ferri-siderophore binding and
to calculate dissociation constants. Another aim was to determine the structure of
DesE protein with one of its substrates, ferrioxamine B, bound to gain further
insights into the molecular basis of ferric siderophore recognition.
It was also planned to construct a molecular model which accurately reproduces the
structural characteristics of ferric-tris-hydroxamate siderophores, in particular bond
angles, lengths and trigonal twists of the complexes, using statistical optimization
techniques to parameterize the program DOMMIMOE. This model could be used to
predict and assess the binding of DesE to non-cognate ferric-tris-hydroxamate
siderophores.
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Chapter 2: Isolation and purification of ferri-
coelichelin
2.1 : Introduction
Ferri-coelichelin was not commercially available, so it was isolated from cultures of
Streptomyces coelicolor. Less than 500 μg of ferri-coelichelin was produced, using
three RP-HPLC steps, involving the purification of the desferri- and gallium
complexes of coelichelin52. As coelichelin is a siderophore, it is only produced in
significant quantities if grown under iron-deficient conditions. A medium based on
the iron-deficient medium used by Müller and Raymond12 was used to grow
Streptomyces species for siderophore production.
2.1.1 : Ferri-coelichelin production comparison of S. coelicolor M145, S.
ambofaciens ATCC 23877 and S. longisporus ruber
S. coelicolor M145 and S. ambofaciens ATCC23877 have been shown to produce
desferri-coelichelin in a previous study53. Both contain a similar cch cluster that
directs its biosynthesis. S. longisporus ruber is responsible for producing the red
antibiotic streptorubin A, which has a very similar structure to streptorubin B
produced by S. coelicolor. It had been shown in unpublished work that S.
longisporus ruber also produces coelichelin. All these strains were analysed for
production of ferri-coelichelin after growth in iron-deficient medium for four days.
The concentrated supernatants supplemented with FeCl3 were analysed by LC-MS
using the method of Barona-Gómez et al.53
2.1.2 : Results
The extracted ion chromatograms at m/z 619 contained a large peak at 3 – 4 minutes
for all the culture supernatants (Figure 2-1). Analysis of the mass spectrum between
3 and 4 minutes revealed a large peak with m/z 619 which had the characteristic
isotope pattern of an iron-containing species (Figure 2-2). This corresponded to a
large peak at 3.1 minutes in the UV chromatogram at 435 nm (Figure 2-3), the
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maximum absorbance wavelength for the charge transfer transition of ferric
hydroxamates.
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Figure 2-1: LC-MS analysis of Streptomyces culture supernatants: extracted ion chromatograms
at m/z 619 from 0 – 14 minutes of HPLC run.
Figure 2-2: Mass spectrum from the S. longisporus ruber supernatant between 3.41 – 3.62
minutes from m/z 595 – 635.
The large signal at m/z 619 has a distinctive isotope pattern corresponding to an iron-containing
compound, in this case ferri-coelichelin.
The retention time of 3-4 minutes was similar that reported in two previous
studies52,53, leading to the conclusion ferri-coelichelin was being detected, hence S.
longisporus ruber did indeed produce the siderophore coelichelin (or a compound
whose ferric complex has the same mass and retention time). On comparison of the
UV chromatograms (Figure 2-3), the largest peak corresponding to ferri-coelichelin
was observed in the S. coelicolor M145 supernatant; hence this strain was used to
produce ferri-coelichelin for further studies.
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M145_2_01_7394.d: UV Chromatogram, 435 nm
Sambofaciens_5_01_7397.d: UV Chromatogram, 435 nm
SCongicidus_6_01_7398.d: UV Chromatogram, 435 nm
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Figure 2-3: LC-MS analysis of Streptomyces culture supernatants: Absorbance at 435 nm
UV chromatograms (monitoring absorbance at 435 nm) from HPLC-MS analysis of the FeCl3-
supplemented supernatants of cultures of S. coelicolor M145, S. ambofaciens ATCC23877 and S.
longisporus ruber. Ferri-coelichelin eluted from the HPLC column at 3.2 minutes and is
indicated by the arrows.
2.2 : Large-scale purification of ferri-coelichelin
2.2.1 : Growth of S. coelicolor cultures
Ferri-coelichelin was produced on a large scale by growing 2 L cultures of S.
coelicolor M145 and S. coelicolor W2 bacteria. The W2 strain has the desD gene,
which is essential for desferrioxamine B and E biosynthesis, replaced by an
apramycin resistance cassette, hence the only siderophore it produced was
coelichelin.
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2.2.2 : RP-HPLC separation of ferri-coelichelin from other siderophores
The HPLC method used to separate ferri-coelichelin from the other ferri-
siderophores differed to the published procedure52 in that a semi-preparative C-18
column was used instead of the Supelco Discovery H5-F5 column. A method was
developed using a gradient of the mobile phases H2O (0.1% TFA) and MeCN (0.1%
TFA), with ferri-coelichelin eluting with mobile phases 93% H2O and 7% MeCN.
The eluate was monitored by absorption of light at 435 nm, and a yellow-orange
elute was collected (Figure 2-4). The presence of ferri-coelichelin was confirmed by
positive ion mode ESI-TOF-MS, Large peaks with m/z 619 and 641, indicative of
the protonated and sodiated forms of ferri-coelichelin, were observed. The fractions
containing ferri-coelichelin were combined and lyophilized.
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Figure 2-4: HPLC chromatogram of the separation of ferri-coelichelin from concentrated
culture supernatants of S. coelicolor M145 overlaid with the H2O (0.1% TFA)/MeCN (0.1%
TFA) gradient used.
The arrow indicates the peak corresponding to ferri-coelichelin.
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2.2.3 : Formation of desferri-coelichelin
All glassware was rinsed with concentrated nitric acid followed by deionised water
to remove any metal ion contaminants which may associate with the siderophore. To
form desferri-coelichelin, Fe(III) was removed by using 8-hydroxyquinoline as a
chelating agent (Figure 2-5)52,75.
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Figure 2-5: The scheme of the removal of Fe(III) from ferri-coelichelin by addition of 8-
hydroxyquinoline.
A large excess of 8-hydroxyquinoline was dissolved in methanol and added to a
dilute aqueous solution of ferri-coelichelin in water. The dark-green Fe(8-
hydroxyquinoline)3 complex was extracted using dichloromethane and the colourless
aqueous phase was evaporated and lyophilized.
2.2.4 : RP-HPLC of desferri-coelichelin
As desferricoelichelin is unstable, this step was done without delay. The HPLC
method of Lautru et al.52 was used to purify desferri-coelichelin, monitoring the
absorbance at 210 nm. Fractions that contained the m/z 566 (desferricoelichelin +
H+) and m/z 588 (desferricoelichelin + Na+) were kept on ice after elution. The
retention time of desferri-coelichelin was much shorter (7 minutes) than that reported
in a previous purification (26 minutes)76. The combined fractions were snap-frozen
in liquid N2 and lyophilized.
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Figure 2-6: HPLC chromatogram of the purification of desferri-coelichelin, monitoring the
absorbance at 210 nm.
The desferri-coelichelin peak is indicated by an arrow.
2.2.5 : Formation of gallium-coelichelin
One of the most conclusive ways to determine the organic purity of a compound is to
measure a nuclear magnetic resonance (NMR) spectrum of it. However, the ferric
complex of coelichelin contains paramagnetic high-spin Fe(III), which causes
excessive broadening of the NMR spectra. To form a stable complex which could be
analysed by NMR spectroscopy, the gallium complex was formed using the
published protocol52. Gallium sulfate in dilute sulfuric acid was mixed with a
desferricoelichelin solution and allowed to react for 30 minutes. The solution was
neutralized with NaOH and lyophilized in 15 mL high-sided centrifuge tubes
(because the gallium-coelichelin powder produced was very labile and was sucked
out of round-bottom flasks by the low pressure conditions of the freeze-drier).
0 10 20 30 40 50
Time (min)
0
200
400
600
800
A210
(mAU)
PhD. Thesis: Prakash Patel Chapter 2: Isolation and purification of ferri-coelichelin
40
2.2.6 : RP-HPLC purification of gallium-coelichelin
The gallium-coelichelin complex was dissolved in 10 mM ammonium carbonate
buffer and purification was carried out using the same conditions that was used to
separate desferri-coelichelin (see above), but no fraction corresponding to gallium-
coelichelin was obtained. Instead, a semi-preparative Zorbax C-18 column was
used. The fractions containing gallium-coelichelin (Figure 2-7) was detected by
positive ion ESI-TOF-MS in positive ion mode by the presence of m/z 632 (gallium-
coelichelin + H+). The fractions were combined and lyophilized.
Figure 2-7: HPLC chromatogram of the separation of gallium-coelichelin, with absorbance
monitored at 210 nm.
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The gallium-coelichelin peak is indicated by an arrow. The presence of gallium-coelichelin was
confirmed by ESI-TOF-MS (bottom) from the presence of the peaks m/z 632 (gallium-
coelichelin + H+) and 654 (gallium-coelichelin + Na+).
2.2.7 : 1H NMR analysis of gallium-coelichelin
Ga-coelichelin was dissolved in DMSO-d6, a polar solvent which does not exchange
deuterons for protons, and a 1H NMR spectrum was recorded at 700 MHz. The most
apparent features of the spectrum were large peaks corresponding to the protons
from ammonium carbonate (7.25 ppm; from the HPLC liquid phase) and residual
water (3.25 ppm) respectively, plus three sharp peaks corresponding to DMSO-d6
(2.34, 2.44, 2.53 ppm). Most of the other peaks correspond to those reported
previously for gallium-coelichelin52 and are listed in Table 2-1. COSY and HSQC
spectra of gallium-coelichelin were used to assist in assigning the 1H NMR
spectrum.
2.2.8 : Estimation of concentration of gallium-coelichelin
Prior to addition of FeCl3 to reform the Fe-coelichelin complex, the concentration of
gallium-coelichelin needed to be estimated. To do this, a known concentration of
dibromomethane was added to the NMR tube containing the purified gallium-
coelichelin and the NMR spectrum was measured. The integral of the new peak for
the two protons of CH2Br2 (5.35 ppm) was compared with the integral for the proton
attached to theα-carbon of the L-Thr residue of gallium-coelichelin (4.59 ppm).
2.2.9 : Addition of iron to gallium-coelichelin
As coelichelin is a siderophore, it is a high-affinity chelator of ferric iron with
greater affinity for this ion than for other ions such as Ga(III). To form the ferric
complex, an excess of FeCl3 (1 mM) was added and allowed to react for 12 hours to
displace the Ga(III) ions with Fe(III) ions, using the estimated concentration of Ga-
coelichelin from the NMR analysis to determine the amount of FeCl3 solution to add.
The conversion was monitored by positive-ion ESI-TOF-MS analysis (Figure 2-8).
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The disappearance of the species with m/z 632 (gallium-coelichelin + H+) and the
appearance of a species with m/z 619 (ferri-coelichelin + H+) was observed.
Table 2-1: (1H)NMR assignments of gallium-coelichelin in Lautru et al.52 and this study.
Analysis of the COSY and HSQC spectra was also used to aid assignment of the resonances.
The letters m, dd, d and s denote multiplet, double doublet, doublet and singlet peaks
respectively.
Assignment δH (Lautru et al.52) δH (this study)
hfOrn1-C1 - -
hfOrn1-C2 3.97 dd, 3.0 Hz, 3.0 Hz 3.91 dd, 3.0 Hz, 3.0 Hz
hfOrn1-C3 1.91 m; 1.50 m 1.86 m; 1.40 m
hfOrn1-C4 1.42 m; 1.50 m 1.41 m; 1.50 m
hfOrn1-C5 3.41 m; 3.51 m 3.45 m; 3.56 m
hfOrn1-NH2 - -
hfOrn1-C(O)H 8.17 s 8.20 s
Thr2-C1 - -
Thr2-C2 4.59, 9.0 Hz, 9.0 Hz 4.59, 9.0 Hz, 9.0 Hz
Thr2-C3 3.82 m 3.84 m;
Thr2-C4 1.14 d, 5.5 Hz 1.17 d, 7 Hz
Thr2-NH 8.75 d, 9.0 Hz 8.79 d, 9.0 Hz
Thr2-OH 5.08 5.08
hOrn3-C1 - -
hOrn3-C2 4.24 dd, 8.5 Hz, 11.0 Hz 4.22 dd, 11 Hz, 10 Hz
hOrn3-C3 1.76 m 1.76 m
hOrn3-C4 1.83 m; 1.83 m 1.85 m; 1.84 m
hOrn3-C5 3.45 m; 3.93 m 3.47 m; 3.90 m
hOrn3-NH 7.57 d, 8.5 Hz 7.70 d, 8.0 Hz
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hfOrn4-C1 - -
hfOrn4-C2 4.15 dd, 11.0 Hz, 1.9 Hz 4.05 dd, 11.4 Hz, 2.0Hz
hfOrn4-C3 1.64 m; 2.29 m 1.41 m, 2.17 m
hfOrn4-C4 1.96 m; 1.76 m 1.94 m; 1.76 m
hfOrn4-C5 3.76 m 3.73 m
hfOrn4-C(O)H 8.22 s 8.22 s
hfOrn4-NH2 - -
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2.3 : LC-MS and ESI-MS-MS characterization of purified ferri-
coelichelin
2.3.1 : LC-MS characterization of purified ferri-coelichelin
Using the conditions of Barona-Gomez et al.53, the purified ferri-coelichelin was
analysed by LC-MS to determine if it has a similar retention time to ferri-coelichelin
in concentrated S. coelicolor M145 culture supernatants. The retention time for
purified ferri-coelichelin (3.1 minutes) was very similar to the retention time of ferri-
coelichelin from S. coelicolor M145 and W2 supernatants (3.2 minutes) (Figure 2-9).
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Figure 2-8: ESI-MS spectrum for a partially-ferrated sample of gallium-coelichelin.
The peaks with m/z 632 (Ga-coelichelin + H+) and 654 (Ga-coelichelin + Na+) appear with the
larger ferri-coelichelin peaks with m/z 619 (Fe-coelichelin + H+) and 641 (Fe-coelichelin + Na+).
The ferri-coelichelin conversion was complete (no m/z 632 peak) on addition of an excess of
FeCl3.
2.3.2 : UV-Vis spectrum of ferri-coelichelin
The UV spectrum corresponding to the m/z 619 peak in the pure sample of ferri-
coelichelin was analysed in the HPLC-MS diode array detector from 250 nm to
800nm. The compound had a large absorbance at the violet - ultraviolet end of the
spectrum at 425 nm, close to the 435 nm maximal absorbance distinctive of other
ferric-tris-hydroxamates (Figure 2-10).
2.3.3 : Positive ion mode ESI-MS-MS of characterization of purified ferri-
coelichelin
When pure ferri-coelichelin was analysed by positive ion mode ESI-MS, several
peaks were observed. As well as the peaks with m/z 619 (ferri-coelichelin + H+),
641 (ferri-coelichelin + Na) and 663 (ferri-coelichelin + 2Na+), there were peaks at
m/z 557, 575, 597 and 601(Figure 2-11).
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To investigate whether these were contaminants in the sample or were fragment ions
of ferri-coelichelin, ESI-MS-MS was performed on the m/z 619 peak (Figure 2-12),
which yielded peaks with m/z 601, 583, 575, 557 and 540, which all of them can be
attributed to fragment ions of ferri-coelichelin (Table 2-2).
Figure 2-9: LC-MS analysis of purified ferri-coelichelin and ferri-coelichelin in S. coelicolor
M145 and W2 culture supernatants.
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UV chromatograms at 435 nm from HPLC-MS analysis of purified ferri-coelichelin (top, red)
plus the FeCl3-supplemented supernatants of cultures of S. coelicolor M145 (middle, green) and
W2 (bottom, blue). The chromatograms are overlaid with their corresponding extracted ion
chromatograms (light colours). The arrows indicate the peak in the UV chromatograms that
correspond to ferri-coelichelin.
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Figure 2-10: UV-Vis spectrum of the ferri-coelichelin peak from 3.25 - 3.48 min from the LC-
MS analysis of purified ferri-coelichelin in Figure 2-9.
Figure 2-11: Positive ion mode ESI-MS of a dilute sample of purified ferri-coelichelin in Bruker
micrOTOF.
The presence of 619 m/z, 641 m/z and 663 m/z were indicative of unfragmented ferri-coelichelin,
whilst the other peaks (522 m/z, 557 m/z, 575 m/z, 597 m/z) were indicative of fragmented ferri-
coelichelin, which was confirmed by ESI-MS-MS on the same sample.
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Figure 2-12: ESI-MS-MS spectrum of purified ferri-coelichelin (m/z = 619; m+H+).
The fragmentation pattern of m/z 619 was attributed to the loss of H2O in hydroxamate groups
and the loss of CO2 from a carboxyl group (Table 2-2).
Table 2-2: Possible fragmentation of ferri-coelichelin
m/z Possible ion
619 Fe-cclin + H+
601 Fe-cclin + H+- H2O
583 Fe-cclin + H+- 2H2O
575 Fe-cclin + H+- CO2
557 Fe-cclin + H+- CO2 - H2O
540 Fe-cclin + H+- CO2 - 2H2O
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Chapter 3: Overproduction, isolation and
characterization of recombinant proteins DesE, CchF
and CdtB
3.1 : Introduction
To elucidate unequivocally the routes of ferri-siderophore transport in Streptomyces
coelicolor, one must study the lipoprotein receptors, the high-affinity siderophore
binding proteins that govern ferri-siderophore entry. Given the low concentration of
ferri-siderophores in solution, their binding to the lipoprotein receptors are likely to
be the rate-limiting step in their absorption. The genes encoding the lipoprotein
receptors also have to be expressed under iron limitation. The best indicator of this
is if they are flanked by or adjacent to iron boxes, palindromic sequences to which
the S. coelicolor Fe(II)-dependent repressors DmdR bind.
Searching the S. coelicolor genome for sequences similar to the iron box upstream of
the gene desE (TTAGGTTAGGCTCACCTAA)20, the only lipoprotein receptor
genes that were near this or similar sequence of bases were cchF, cdtB, desE and
SCO2272. In a study of the membrane-associated proteome of S. coelicolor, only
the proteins CchF, CdtB and DesE proteins were identified62, and have been
postulated to play a role in siderophore uptake. Although one cannot rule out the
role of other S. coelicolor genes (SCO2272, SCO0996 and SCO7218) in ferric
siderophore transport, DesE, CchF and CdtB were the best candidates for the binding
and subsequent transport of the cognate siderophores of S. coelicolor.
The general approach was to overproduce the proteins encoded by the S. coelicolor
A3(2) genes desE, cchF and cdtB in Escherichia coli for binding studies, with an N-
terminal His-tag to assist with purification with immobilized metal-affinity
chromatography (IMAC), which is a common strategy for purification of many
bacterial proteins77.
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3.2 : Features of the plasmid used for recombinant protein
production
For recombinant protein overproduction in E. coli, the plasmid pET151-D/TOPO
from Invitrogen78 was used to overexpress of the desE, cchF and cdtB genes. This
plasmid has many attractive features which made it useful for protein
overexpression.
The gene of interest is amplified by polymerase chain reaction (PCR) using primers
complementary to the 5’ and 3’ end of the gene of interest, but with the bases CACC
appended to the 5’ end. This series of bases in the insertion DNA is complementary
to the GTGG sticky end of the plasmid to give directional insertion into the plasmid,
via the enzyme Topoisomerase I (from Vaccinia virus). This system avoids the
multiple DNA ligation reactions usually involved in gene insertion into plasmids.
This reaction takes only 15 minutes and the product is used immediately to transform
competent strains of E. coli.
Once used to transform E. coli, the plasmid product is able to undergo low-copy
replication by the presence of the pBR3222 ori (origin of replication) and rop genes
(Figure 3-1). The E. coli cells that had been successfully transformed with the
plasmid can be selected with the antibiotic ampicillin as the plasmid has the bla gene
(encodesβ-lactamase) which confers resistance to this antibiotic.
When the plasmid is used to transform strains of E. coli containing T7 RNA
polymerase, such as the overproducing strain BL21star (DE3), transcription of the
gene is able to take place. This is regulated by the lac operon, in which the lacI gene
encodes a repressor which binds onto the lac operator region, but the addition of a
lactose analogue such as isopropyl β-D-1-thiogalactopyranoside (IPTG) reduces the
affinity of the LacI protein for the lac operator, enabling T7 polymerase to bind to
the T7 promoter site. RNA transcripts from the T7 promoter site to the T7
termination site (T7 term) are produced. The T7 promoter is a strong promoter,
enabling the production of a large number of RNA transcripts for high-level protein
overproduction.
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Figure 3-1: Diagram of pET151 plasmid with the full-length desE gene.
The desE insert encodes the protein desired to be overproduced when this plasmid is used to
transform E. coli. The regions of the plasmid are explained in the text.
E. coli ribosomes are able to bind to the ribosome binding site (RBS) of the RNA
transcripts and translation is initiated at the start codon ATG to the stop codon of the
inserted gene. Another useful feature of the plasmid is that it encodes the protein to
have an N-terminal hexahistidine tag for purification (Figure 3-2) by immobilized
metal affinity chromatography (IMAC) by Ni-NTA column. The consecutive
histidine residues form coordinate bonds with Ni2+ which immobilizes the protein to
the column. The protein is eluted by addition of high concentrations of imidazole, a
histidine side-chain analogue, which also forms stable coordinate bonds with Ni2+.
After elution, this tag can be cleaved off the recombinant protein by tobacco etch
virus (TEV) protease in a further purification step, leaving an N-terminal tag of six
residues plus the protein sequence desired (Figure 3-2).
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Protein6xHis TEV
Protein
Figure 3-2: Expected motifs of proteins overproduced using the pET151/D-TOPO plasmid.
(Top) The overproduced protein will have N-terminal hexahistidine tag (6xHis) and TEV
protease cleavage site (TEV site) and a spacer (light blue) between the site and the native
protein sequence (pink). (Bottom) After digestion by TEV protease, most of the N-terminal tag
of the protein is cleaved off, leaving the required protein sequence plus a 6-residue N-terminal
tag (GIDPFT).
3.3 : Overproduction and purification of full-length DesE, CchF and
CdtB
3.3.1 : PCR primer design of desE, cchF and cdtB genes
Initially, it was decided the proteins were to be overproduced as full-length proteins,
using the complete gene sequence. They have an N-terminal signal sequence
encoded which is recognised by translocases which transport them to the outer
membrane of S. coelicolor. The protein DesE has been shown to be a substrate by
the S. coelicolor Tat translocase system63, and due to the presence of N-terminal
twin-arginine motifs in CchF and CdtB they may also be transported by this
system63.
Sequences for the S. coelicolor genes desE (SCO2780), cchF (SCO0494) and cdtB
(SCO7399) were obtained from the annotated genome sequence51 accessed via
Entrez NCBI (http://nih.ncbi.gov/Entrez). All primers were designed using the
software Clone Manager Suite79. Forward primers were designed such that they
matched the first 15 – 18 base pairs in the database sequence plus the bases CACC at
the 5’ end. Reverse primers were designed such that they matched the last 15 – 18
base pairs of the complementary strand of the gene sequence.
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3.3.2 : Analysis and purification of PCR product
PCR products were produced as described in the materials and methods (section
8.3.3 :). A strong band at around 1 kbps (kilo base pairs) was indicative of a
successful PCR reaction (Figure 3-3). The expected size of each amplimer is given in
Table 3-1. The concentration of each amplimer was estimated by comparing the
intensity of the bands of known concentration in the DNA size marker. A larger
amount of amplimer solution PCR was run on the gel to separate the desired PCR
product from unused reactants and template DNA. The 1 kbps band was excised
from the gel and subsequently purified before ligation into the expression plasmid.
Figure 3-3: Agarose gel electrophoresis of full-length amplimers cchF, desE and cdtB
(Left) cchF product amplified by polymerase chain reaction (PCR) from S. coelicolor cosmid
SCF94. (Right) The genes desE and cdtB amplified from S. coelicolor M145 genomic DNA.
3.3.3 : Insertion of amplimers into the plasmid pET151/D-TOPO plasmid
(TOPO reaction) and subsequent transformation of E. coli
The protocol described in the manual78 was used to insert the DNA into the
pET151/D-TOPO plasmids. The product was used to transform chemically
competent E. coli TOP10 cells or E. coli MC1061 by electroporation.
3.3.4 : Analysis of the insert of E. coli clones by PCR screening
Eight to ten E. coli transformants were grown overnight for isolation and analysis of
their plasmids, which were extracted using a standard procedure80 and used as the
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template DNA for PCR reactions using the PCR primers and conditions as in the
original gene amplification reactions (but using a cheaper polymerase). The PCR
products are analysed by agarose gel electrophoresis for a band at approximately 1
kbps (see Figure 3-13 for an example with truncated amplimers). This method, PCR
screening, was an effective method for determining whether the gene has been
inserted into the plasmid.
Table 3-1: Expected size of amplified genes (full-length)
Gene Expected size (DNA base pairs)
desE 1050
cchF 1053
cdtB 984
3.3.5 : Analysis of overproduction of proteins
Plasmids containing the correct inserts were used to transform E. coli BL21star
(DE3), an overproducing strain of E. coli containing T7 RNA polymerase. This
strain is able to transcribe the insert region of the plasmid, hence producing the
protein encoded within. Single colonies from overnight LB agar plates were grown
overnight in liquid culture. This starter culture was used to inoculate a larger liquid
culture (500 mL to 1 L), which was incubated at 37 °C until the cell density had
reached OD600 = 0.6 - 0.8. IPTG was added later to induce transcription of the T7
polymerase inside the bacteria at a temperature of 15 °C for 15 – 20 hours. The total
protein and soluble protein (cell-free extract) fractions of the cell paste were
analysed by SDS-PAGE using Coomassie staining to determine if overproduction of
the desired proteins had taken place, and if these proteins were soluble.
All three proteins, His6-DesE, His6-CchF and His6-CdtB were found to be both
overproduced and soluble in E. coli BL21star indicated by bands at around 40 – 45
kDa, but in the case of CchF, two proteins of a similar molecular weight were
overproduced (Figure 3-4). The protein DesE was visible as a single band at 40 kDa,
whilst the band corresponding to CdtB ran at almost 50 kDa, which was much larger
than the predicted molecular weight of the protein.
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Figure 3-4: Overproduction of the full-length proteins His6-CchF, His6-DesE and His6-CdtB in
transformed clones of E. coli BL21star.
Photographs of 8 % SDS-PAGE gels of the total and soluble (cell-free extract) fractions of His6-
CchF (left), His6-DesE (middle) and His6-CdtB (right) overproducing clones of E. coli BL21star
transformed with the plasmid pET151/D-TOPO, against BSA and OVA proteins, which were
used as molecular weight standards.
Table 3-2: Expected protein sizes of His6-DesE, His6-CchF and His6-CdtB
Protein Size (Da)
His6-DesE 40425.0
His6-CchF 41157.8
His6-CdtB 37877.1
3.3.6 : Large-scale purification of His6-DesE, His6-CchF and His6-CdtB by Ni-
NTA IMAC
The integrity of the plasmid clones resulting in protein overproduction was checked
by DNA sequencing using T7 and T7 reverse primers. Clones without mutations or
silent mutations were selected for large-scale protein production. The pET151/D-
TOPO plasmids containing the full-length genes desE, cchF and cdtB will be
denoted by the names given in Table 3-3. These plasmids were used to transform
competent E. coli BL21star prior to protein overproduction.
About 600 mL of E. coli BL21star was grown and protein overproduction induced
by addition of 0.5 mM IPTG and incubated at 15 °C overnight. The cell-free extract
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from the cell paste was obtained from lysis by French Press, and proteases were
inhibited by phenylmethylsulfonylfluoride (PMSF).
Table 3-3: Names of pET151 plasmids containing the full-length genes desE, cchF and cdtB.
Plasmid name Gene inserted into pET151/D-TOPO plasmid
pPP001 desE
pPP002 cchF
pPP003 cdtB
Ni-NTA IMAC (immobilized metal affinity chromatography) is a very common
method for the purification of proteins which have a polyhistidine tag engineered
onto their N-terminus or C-terminus. At these positions the protein is flexible, where
side chains of contiguous six histidine residues to form a stable complex with Ni(II)
immobilized on a nitriloacetic acid (NTA) modified sepharose column. This binding
is greatest at alkaline pH.
To remove proteins that bind non-specifically to the column, it is washed with a
buffer containing a low concentration of imidazole (around 10 mM – 20 mM). This
compound is chemically similar to the histidine side chains and also forms
complexes with Ni(II). To elute the protein from the column, a buffer containing a
high concentration of imidazole (300 mM) is used, which competitively displaces the
His-tagged protein from the material. The eluted protein is filtered and concentrated
to remove the high concentrations of imidazole using a centrifugal filter, and stored
in a glycerol containing buffer at -80 °C.
Purification of His6-CchF from the cell-free extract from E. coli BL21star
overproducing cells (E. coli BL21star transformed with the plasmid pPP002) by
IMAC was attempted unsuccessfully. The large band corresponding to the protein
product as seen in the cell-free extract was not present in the IMAC elution,
indicating the protein was not binding to the Ni-NTA column and washed off (Figure
3-5). The protein bands on the SDS-PAGE were analysed by peptide mass
fingerprinting, which confirmed they are derived from the CchF-encoding sequence.
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A likely explanation for this is that CchF contains a twin-arginine translocase64
(TAT) signal in its N-terminus, which causes CchF to be transported to the outside
surface of the membrane in S. coelicolor. This signal sequence of full-length His6-
CchF could be recognised by the E. coli TAT system, hence it is transported to the
periplasm of the bacteria (Figure 3-6). During the process of translocation, the
signal peptide was cleaved by the system, including the His tag, producing a lower
molecular weight protein which cannot be purified by IMAC.
Figure 3-5: Attempted purification of the protein full-length CchF by Ni-NTA IMAC.
The main protein band (approximately 35 kDa; indicated by the arrow) is clearly visible in the
total and soluble fractions of E. coli BL21star, and also appears in the cell-free extract after
filtration in the Ni-NTA column (CchF Ni2+ wash), but elution of proteins bound to the column
(with a buffer containing 300 mM imidazole), this band was very faint (CchF Ni2+ elute),
implying this protein did not bind to the column hence not have a His-tag. The other bands in
this fraction may correspond to non-specific proteins.
Purification of His6-DesE and His6-CdtB from E. coli BL21star transformed with the
pPP001 and pPP003 plasmids respectively, was less problematic, although the cell
pellet of the strain of E. coli overproducing His6-CdtB had to be frozen overnight at -
20 °C. Both proteins were overproduced, soluble and purified by Ni2+ IMAC, with
yields of around 4 mg per litre of culture (determined by Bradford assay 81). Analysis
of purified His6-DesE and His6-CdtB by SDS-PAGE (Figure 3-7) showed large
bands at 38 kDa and 42 kDa respectively, plus a smaller band at roughly double the
molecular weight.
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Figure 3-6: Proposed explanation for the cleavage of the His-tag in full-length CchF in
overproducing cells of E. coli.
1. The protein (purple) is recognised as a Tat substrate by E. coli from its N-terminal signal
peptide (red) with His-tag (green) and soon after translation is chaperoned to the cytoplasmic
membrane (CM). 2. The proteins in the Tat complex TatBC (blue ovals) and TatA (red ovals)
start the translocation process. 3. More TatA proteins are recruited in the translocation of
CchF, and the translocation is driven by the proton motive force difference between the
cytoplasm and the periplasm. 4. The signal peptide of CchF is cleaved during or after
translocation. 5. CchF resides in the periplasm of the E. coli cells, sans His-tag and signal
peptide.
Figure 3-7: Purification of full-length His6-DesE and His6-CdtB by Ni-NTA IMAC.
(Left) The soluble fraction revealed the presence of a single overproduced protein (His6-DesE
indicated by arrow) of approximately 42 kDa (DesE sol.) but after Ni-NTA IMAC purification
two large bands were seen (DesE after IMAC). (Right) Overproduction of His6-CdtB The
soluble fraction revealed the presence of a single overproduced protein (His6-CdtB; column 2)
of approximately 42 kDa, but after IMAC purification two bands were seen (column 3; arrows).
cytoplasm
CM
H+
1. 2. 3. 4. 5.
periplasm
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3.3.7 : Gel filtration of full-length DesE and CdtB
In an attempt to separate the lower molecular weight protein from the higher
molecular weight protein, gel filtration (size exclusion chromatography) was used.
In the case of full-length His6-DesE (Figure 3-8), two major peaks were observed in
the UV chromatogram with retention volumes of 56.4 mL and 63.8 mL. The
retention time of the smaller peak corresponded to a threefold difference in the
molecular weight of the larger peak, at 123 kDa and 42 kDa respectively. Fractions
were collected at the peaks and analysed by SDS-PAGE. Both peaks corresponded
to the lower molecular weight band, but the higher molecular weight band
reappeared after concentration of the protein. Gel filtration of full-length His6-CdtB
(Figure 3-9) also had two large peaks as with His6-DesE, but in this case all fractions
contained both the higher and lower molecular weight protein by analysis by SDS-
PAGE.
The most likely explanation for the gel filtration results of full-length His6-DesE and
His6-CdtB is that these proteins oligomerize at high concentrations encountered
during the protein purification process, with the dimer appearing even in the
denaturing conditions of SDS-PAGE.
Figure 3-8: Gel filtration chromatograph of full-length His6-DesE.
X-axis: UV absorbance at 280nm. Y-axis: Elution volume in mL. Two large peaks in the
chromatograph (56.4 mL and 63.8 mL) were observed and fractions (1,2 and 4,5 respectively)
were analysed by SDS-PAGE (inset) against His6-DesE before gel filtration (before GF). Both
peaks corresponding to different oligomers corresponded to the same band on SDS-PAGE.
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To confirm the identity of His6-DesE and His6-CdtB, peptide mass fingerprinting
was performed on upper and lower bands that appeared on the SDS-PAGE of
purified His6-DesE and His6-CdtB, which confirmed they were the same protein.
Figure 3-9: Gel filtration chromatograph of full-length His6-CdtB.
X-axis: UV absorbance at 280nm. Y-axis: Elution volume in ml. Two large peaks in the
chromatograph (53 mL and 63 mL) were observed and fractions (A3 and A5 respectively) were
analysed by SDS-PAGE (inset). The A5 fraction had a higher proportion of lower molecular
weight protein than the A3 fraction.
To obtain useful data from siderophores binding experiments, the proteins need to be
a single oligomeric state. Dimer formation creates uncertainties about the location of
the dimer interface and whether one or both siderophore binding sites are partially or
fully observed. Thus we sought to overcome these problems by expressing truncated
forms of DesE, CchF and CdtB lacking their hydrophobic N-termini, which we
expected to be the cause of the oligomerization observed.
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3.4 : Overproduction and purification of 5’-truncated DesE, CchF
and CdtB
3.4.1 : Introduction
In previous studies of other Gram-positive siderophore lipoprotein receptors34,38,
recombinant proteins in which the N-terminus of the native protein sequences were
truncated to the N-terminal cysteine, with this residue was mutated to a methionine.
This removed the hydrophobic signal peptide which was remarked to be the cause of
purification problems. These mutations are presumed to have little effect on binding
site of the proteins as the signal peptide is not part of the mature protein in S.
coelicolor, and the speculative role of the cysteine residue is as the anchor of an
attached lipid which tethers the protein to the outer membrane (hence not involved in
substrate binding). The proposed course of action was to truncate the DesE, CchF
and CdtB proteins and the cysteine residue mutated to methionine to solve the
purification problem (Figure 3-10).
Figure 3-10: Proposed N-terminal modification of the full length proteins to produce the 5’-
truncation proteins.
The native N-terminus containing the hydrophobic signal peptide (red) and the putative
lipidation site cysteine of the full-length proteins are assumed to play no role in the globular
domain involved in binding to ferri-siderophores (pink and purple). The proposed modification
to produce the 5’-truncation proteins is to replace the signal sequence with the N-terminal tag
as encoded in the pET151/D-TOPO with the His-tag (green) and to mutate the cysteine to
methionine.
HHHHHH M
Lipidation site cysteine
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5’-truncatied
protein
HHHHHH
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3.4.2 : PCR primer design for the 5’-truncated desE, cchF and cdtB
The reverse primers used in the amplification of the 5’-truncated genes (desE, cchF
and cdtB reverse) were the same as those used in the amplification of the full length
genes. The forward primers used were designed such that their 5’ ends corresponded
to the first cysteine codon that was predicted to be the lipid attachment site. This
codon was mutated to a methionine codon (ATG) and preceding these bases CACC
for correct insertion into the pET151/D-TOPO plasmid, giving the primers a
CACCATG overhang at the 5’ end (Figure 3-11).
3.4.3 : Amplification of genes by PCR
This was performed as for the full length desE, cchF and cdtB except as template
DNA the plasmids that were used to overproduce the full length proteins (i.e. the
plasmids pPP001, pPP002 and pPP003 respectively). The expected sizes of the
amplimers are given in Table 3-4. The concentrations of the amplimers were
estimated by comparing the intensity of the band on an agarose gel in comparison
with the intensity of an appropriate band from a DNA ladder. The PCR reactions
were separated on an agarose gel to isolate the required amplimer from unused
reactants and template DNA.
Figure 3-11: Design of the primers for the amplification of the 5’-truncated cchF gene.
1. atgctcctcagaacaacgcgtacgaagccctggcgacgactcgcggcggccctgtccgcc
MetLeuLeuArgThrThrArgThrLysProTrpArgArgLeuAlaAlaAlaLeuSerAla
gccgcgctcggcgtcggactcctcgcggggtgcggatccgactcggacgacccggcg
AlaAlaLeuGlyValGlyLeuLeuAlaGlyCysGlySerAspSerAspAspProAla
2. atgctcctcagaacaacgcgtacgaagccctggcgacgactcgcggcggccctgtccgcc
MetLeuLeuArgThrThrArgThrLysProTrpArgArgLeuAlaAlaAlaLeuSerAla
gccgcgctcggcgtcggactcctcgccaccatgggatccgactcggacgacccggcg
AlaAlaLeuGlyValGlyLeuLeuAlaThrMetGlySerAspSerAspAspProAla
Forward Primer
1. First 117 bases of cchF gene with the 90 bases encoding the N-terminal sequence that was
required to be removed from the 5’-truncated protein highlighted in light blue. The twin arginine
residues distinctive of TAT (twin arginine translocase) signal peptides are highlighted in dark
blue, and a codon encoding the N-terminal cysteine predicted to be the lipidation site highlighted
in yellow.
2. The sequence of the new forward primer (highlighted in red) used to amplify the 5’-truncated
cchF gene. This primer was used to mutate the cysteine codon (TGC) to methionine (ATG). The
primer also included the first 15 bases immediately after the cysteine codon plus CACCATG on
the 5’ end of the primer, where CACC is required for insertion into the pET151 /D-TOPO plasmid.
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The 1 kbps band was excised under UV light for subsequent purification using a gel
purification kit. Subsequent purification of PCR product, ligation, transformation,
selection of clones and PCR screening were performed analogously as with the full
length desE, cchF and cdtB. The results of the PCR screening are described in
Figure 3-13.
Table 3-4: The size of amplified DNA of the truncation mutants desE, cchF and cdtB
Gene Size (DNA base pairs)
desE 962
cchF 967
cdtB 923
Figure 3-12: Analysis by agarose gel electrophoresis of the amplification of the 5’-truncated
genes cchF (left), desE and cdtB (right), whose size was approximately 1 kbps.
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Figure 3-13: Agarose gel electrophoresis of the PCR screening of plasmid clones containing the
5’-truncated genes desE and cchF genes.
Minipreps of single colonies of E. coli TOP10 transformed with the products of the TOPO
reaction pET151/D-TOPO + cchF (top) and pET151/D-TOPO + desE (bottom) were analysed
by PCR with the same primers used in gene amplification to determine if the insert was present.
In the case of pET151/D-TOPO + cchF, the clones 1 and 4 did not give a band at 1 kbps
indicative of unsuccessful amplification of cchF. In the case of pET151/D-TOPO + desE clone 7
was rejected, because one could not be sure the insert would encode the correct protein.
3.4.4 : Overproduction of truncated His6-DesE, His6-CchF and His6-CdtB
proteins
E. coli BL21star was transformed with the appropriate plasmids and the truncated
proteins overproduced as described previously for the full length constructs, and the
proteins of the total cell extracts and cell-free extracts were analysed by SDS-PAGE.
All three proteins were overproduced in the soluble fraction, and appeared as one
large band (see Figure 3-14 and Figure 3-15) at molecular weights from 38 – 45 kDa
(see Table 3-6). A few of the plasmids of overproducing clones were submitted for
sequence analysis of their gene inserts. The pET151/D-TOPO plasmids containing
the 5’-truncated amplimers desE, cchF and cdtB without mutations are denoted by
the names given in Table 3-5. These plasmids were used to transform competent E.
coli BL21star prior to large-scale protein overproduction.
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Figure 3-14: Analysis of the overproduction of the 5’-truncated protein His6-CchF by different
clones.
Left: The total protein fractions of truncated His6-CchF overproducing clones of E. coli
BL21star. Right: The soluble protein fraction (cell-free extract) of His6-CchF overproducing
clones of BL21star. Out of the clones tested for overexpression of a protein ~40 kDa, clone 8 did
not overproduce a protein of the correct size.
Figure 3-15: Analysis of overproduction of 5’-truncated His6-DesE and His6-CdtB proteins by
clones by SDS-PAGE.
Left: The total protein content of truncated His6-DesE and His6-CdtB overproducing clones of
E. coli BL21star. Right: The soluble protein fraction (cell-free extract) of truncated His6-DesE
and His6-CdtB overproducing E. coli BL21star clones.
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3.4.5 : Large-scale purification of 5’-truncated His6-DesE, His6-CchF and His6-
CdtB by Ni-NTA IMAC
This was performed using the procedure as described for the full length proteins
His6-DesE, His6-CchF and His6-CdtB. SDS-PAGE analysis of the IMAC purified
proteins yielded a single band at around 40 kDa for all the proteins.
Table 3-5: Names of pET151/D-TOPO plasmids containing the 5’-truncated amplimers desE,
cchF and cdtB.
Plasmid name Gene inserted into pET151/D-TOPO plasmid
pPP004 5’-truncated desE
pPP005 5’-truncated cchF
pPP006 5’-truncated cdtB
Figure 3-16: SDS-PAGE analysis of the purification of 5’-truncated His6-DesE, His6-CchF and
His6-CdtB proteins by Ni-NTA IMAC.
Left: the purification of His6-DesE and His6-CchF proteins, showing the total protein, soluble
protein and elution by 300 mM imidazole from the Ni-NTA column, yielding a band of protein
of the expected molecular weight. Right: the purification of His6-CdtB protein, showing the
soluble fractions and elution by 300mM imidazole from the Ni-NTA column, yielding a band of
protein near the expected molecular weight.
3.4.6 : Proteolytic removal of N-terminal His6 tags with TEV protease
The removal of the His-tag was performed to negate concerns that the tag may
interact with transition metal ions and complexes in binding studies. Although it is
assumed that His tags have little affinity for Fe(III), it would be difficult to rule out
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whether His-tags interact with the transition metal were the cause of any unexpected
phenomena that might be observed (e.g. fluorescence quenching by Fe(III) alone).
The cleavage of the N-terminal His-tags of the proteins was performed using TEV
protease, the common name for the 27 kDa catalytic domain of the Nuclear Inclusion
a (NIa) protein encoded by the tobacco etch virus82. TEV protease recognises the
ENLYFQG motif in proteins and cleaves between the Q and G residues, which in
this study results in the cleavage of the N-terminal histidine tag. This leaves an N-
terminal tag of six residues (GIDPFT) followed by the methionine residue (mutated
from cysteine) and the rest of the protein.
The recombinant TEV protease used contained a polyhistidine tag; thus to separate
the proteolysed protein from the protease and undigested proteins, IMAC was used
but instead the flow-through was collected, which should contain only the cleaved
protein of the interest, with undigested proteins, cleaved His-tags and TEV protease
remaining on the column.
TEV protease was overproduced in E. coli BL21(DE3)-RIL transformed with the
plasmid pRK793, and purification of the protein was carried out analogously to other
His-tagged proteins.
Table 3-6: Expected molecular weights of overproduced truncated His6-DesE, His6-CchF and
His6-CdtB before and after TEV protease digestion to remove the N-terminal His6 tag.
Protein Size (Da) Size after TEV protease digest (Da)
His6-DesE 37742.9 34590.4
His6-CchF 38068.1 34915.6
His6-CdtB 35922.8 32770.3
3.4.7 : Cleavage and purification of TEV protease digested proteins
Purified recombinant TEV protease was added to the His-tagged DesE, CchF and
CdtB proteins to an approximate ratio of 1:50 and incubated at 4 °C overnight to
keep the recombinant proteins cool. The digested protein was passed though a Ni-
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NTA column and the flow-through collected and analysed by SDS-PAGE (Figure
3-17). The protein was concentrated and stored at -80 °C. The concentrations of
purified proteins were determined by Bradford assay.
Figure 3-17: SDS-PAGE analysis of the 5’-truncated proteins His6-DesE, His6-CchF and His6-
CdtB after TEV protease digestion after purification via IMAC.
Left: Different concentrations of His6- DesE after digestion with TEV protease. Right:
Proteins His6-CchF and His6-CdtB before and after digestion with TEV protease. The apparent
molecular weight decrease was indicative of successful TEV protease digestion.
3.5 : Characterization of purified, His-tag cleaved, 5’-truncated
proteins DesE, CchF and CdtB
3.5.1 : Peptide mass fingerprinting of proteins
To confirm the identity of the truncated, TEV protease-digested proteins DesE, CchF
and CdtB, peptide mass fingerprinting was carried out. In this procedure,
electrospray ionization mass spectrometry (ESI-MS) was performed on tryptic
digests of the proteins extracted from an SDS-PAGE gel. Matches between
experimentally observed and theoretically predicted masses of fragments of peptides
were observed: for truncated DesE, 15 peptide fragments were identified, giving
54% sequence coverage; for truncated CchF, 8 peptide fragments were identified,
giving 32% sequence coverage and for truncated CdtB, 3 peptide fragments were
identified, giving 16% sequence coverage.
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3.5.2 : ESI-MS of proteins
The identity of the proteins was confirmed further using ESI-TOF-MS. The proteins
were dialysed in 10 mM ammonium acetate buffer (pH 7.0) to remove traces of
glycerol, to give a final protein concentration of 25 μM. The spectra of the proteins
consisted of multiple peaks, corresponding to different multiply-charged states of a
single species. The mass spectrum was deconvoluted to provide the mass-to-charge
(m/z) ratio of the singly-charged ion.
The spectrum of truncated CchF consisted of several peaks (Figure 3-18) at m/z
3492.5244, 3175.0384, 2910.4381, 2686.7470 and 2494.9563, which corresponded
to 10+, 11+, 12+, 13+ and 14+ charged ions. The spectrum was deconvoluted, and
the m/z for the singly charged ion was deduced to be 34915 (Figure 3-19), which
matches very well with the calculated m/z from its amino acid composition (34917).
Similarly, the spectra of the truncated proteins DesE (Figure 3-20) and CdtB (Figure
3-21) were also deconvoluted by the software, to give the m/z values of the singly
charged species of 34595 m/z and 32774 m/z respectively. These were very close to
the theoretical m/z of the singly charged ions of DesE and CdtB (m/z 34591 and m/z
32771 respectively). These results further confirmed the identity of the recombinant
proteins.
Figure 3-18: ESI-MS spectrum of truncated CchF (25 μM) in 10 mM ammonium carbonate
buffer.
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Figure 3-19: Deconvolution of ESI-MS spectrum of truncated CchF, giving the m/z of the singly
charged ion.
The extra peaks are sodium adducts due to the insufficient acidification of the protein prior to
injection into the ESI-MS.
Figure 3-20: ESI-MS spectrum of truncated DesE and deconvolution.
Left: ESI-MS spectrum of truncated DesE (25 μM) in 10 mM ammonium carbonate buffer.
The four peaks towards the right of the spectrum correspond to the 12+, 11+, 10+ and 9+ ions of
DesE. Right: Deconvolution of ESI-MS spectrum of truncated DesE, showing mass of parent
ion, giving the m/z for the singly charged ion.
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Figure 3-21: ESI-MS spectrum of truncated CdtB and deconvolution.
Left: ESI-MS spectrum of truncated CdtB (25 μM) in 10 mM ammonium carbonate buffer.
The four peaks towards the right of the spectrum correspond to the 11+, 10+, 9+ and 8+ ions of
the CdtB protein. Right: Deconvolution of ESI-MS spectrum of truncated CdtB, showing mass
of parent ion, giving the m/z for the singly charged ion.
3.5.3 : Gel filtration analysis of truncated and His-tag cleaved DesE, CchF and
CdtB
The proteins were analysed by gel filtration in the same way as the full length
proteins. Fractions were collected and analysed by SDS-PAGE. DesE and CdtB
eluted at volumes of 65.4 and 63.7 mL respectively (Figure 3-22 and Figure 3-23),
which correspond to approximately 36.5 kDa and 41.7 kDa respectively. This
demonstrated the proteins were monomeric. The CdtB protein eluted at lower
volumes than DesE, indicating that this protein has a larger hydrodynamic radius
than the latter, despite the lower molecular mass of CdtB.
CchF (Figure 3-24, top), eluted in two peaks at 56.9 and 63.6 mL respectively, which
correspond to approximately 108 kDa and 42.4 kDa respectively. This implied the
protein was a mixture of trimeric and monomeric forms. To obtain a monomeric
form of the protein, an aliquot of protein CchF was incubated at 37 °C for 45
minutes. When analyzed by gel filtration (Figure 3-24, bottom), a large single peak
eluted at 63.6 mL, indicating the protein was exclusively the monomeric form. This
process was used prior to further experiments with truncated CchF to ensure work
was carried out with a homogenous sample of protein.
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Figure 3-22: Gel filtration chromatograph of truncated DesE.
The protein eluted at 65.4 mL (arrow) which corresponds to a monomer. The dead volume of
the column was 40 mL
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Figure 3-23: Gel filtration chromatograph of truncated CdtB.
The large peak (63.8 mL; arrow) corresponds to the monomeric form of CdtB. The other large
peak at 40 mL is the dead volume of the column.
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Figure 3-24: Gel filtration chromatographs of truncated CchF (A) without incubation (B)
incubated at 37 °C for 45 minutes.
SDS-PAGE analysis of fractions corresponding to both peaks (indicated by arrows) of (A)
corresponded to the same band, but analysis of their elution volumes (56.0 mL and 63.8 mL)
corresponded to the former having a molecular weight three times that of the latter. Incubation
of CchF at 37°C (B) eluted mostly the monomeric peak.
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3.6 : Conclusions
The three S. coelicolor A3(2) lipoproteins DesE, CchF and CdtB were recombinantly
overproduced in E. coli in a soluble form with N-terminal His-tags to enable
purification via IMAC. Initially, the proteins were expressed with their N-terminal
signal sequences, but these caused purification problems. When these were removed
from the recombinantly overproduced proteins, along with mutation of N-terminal
cysteine thought to be involved in lipidation to methionine, the truncated DesE,
CchF and CdtB proteins were purified, in a mainly monomeric form.
The truncated proteins had their N-terminal His-tags cleaved by TEV protease, and
the resulting proteins were characterised by peptide mass fingerprinting, mass
spectrometry and gel filtration.
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Chapter 4: Binding studies of receptor proteins with
siderophores
4.1 : Intrinsic fluorescence quenching assay
4.1.1 : Introduction
Fluorescence generally is much more sensitive to the environment of a chromophore
than is light absorption, hence is a most effective technique for following the binding
of ligands to, or conformational changes in proteins83.
Many proteins absorb strongly at ultraviolet wavelengths, and absorbance at 280 nm
is mainly due to the aromatic residues tryptophan, tyrosine and to a much lesser
extent phenylalanine83. These residues are also fluorescent in the ultraviolet, and in
most proteins tryptophan fluorescence dominates83, especially between the
wavelengths 320 – 350 nm. Although tyrosine residues are usually present in larger
numbers in proteins, and tyrosine is a slightly weaker emitter than tryptophan
(emission wavelength 306 nm), its fluorescence is quenched by nearby
tryptophans83.
Also the maximum wavelength of tryptophan fluorescence is dependent on its
environment: free L-tryptophan in water fluoresces at 348 nm, whilst tryptophan
residues in hydrophobic environments can fluoresce as low as 320 nm, and this
behaviour is exploited in structural, stability and binding studies, such as the gradual
unfolding of proteins at high temperatures, where there is a red shift of the intrinsic
fluorescence due to tryptophan residues being exposed to more polar environments.
One of the main uses of monitoring the fluorescence of tryptophan residues in
proteins is the quenching of their fluorescence. Collisional quenching by the
addition of O2 or I- ions in millimolar concentrations can give information about the
exposure of tryptophan residues to the solution83. The other use exploited in this
study is the quenching of tryptophan fluorescence caused by substrate binding84,
where monitoring the fluorescence after the titration of a substrate into a protein
solution one can calculate rate constants and dissociation constants.
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4.1.2 : Other considerations
The purity of the protein solution is important, as contaminants such as other
proteins, DNA and particulates can interfere with the fluorescence measurements.
Filtering of buffer solutions can remove many of the particulates.
One of the problems with measuring fluorescence is photobleaching caused by the
lamp in the spectrometer, reducing the observed fluorescence after exposure to
radiation. This may interfere with subsequent calculations if the titration of ligand
with protein takes a large amount of time. The fluorimeter used in this study, a
Perkin Elmer LS 50B, has a xenon flash lamp which emits a pulse of light at a rate of
50 Hz, which caused little photobleaching to a sample of tryptophan in water, hence
this effect was not considered.
4.1.3 : Intrinsic fluorescence quenching with siderophore binding proteins
Intrinsic fluorescence quenching has been used in several studies to investigate the
binding of ferri-siderophores to purified recombinant siderophore binding
proteins30,32,34,38,61. In the case of ferric siderophores, the fluorescence of residues
such as tryptophan can be quenched by the strong absorbance of the ferri-
siderophore complex around the wavelength of tryptophan fluorescence (and most
have little or no intrinsic fluorescence at this wavelength), hence ferric hydroxamates
which are bound or very near to the protein can absorb the fluorescence. This
phenomenon has been used to monitor the binding of ferric-hydroxamates and ferric-
catecholates to proteins and dissociation constants were calculated on the assumption
of a one-to-one protein-siderophore complex. In support of this assumption, some of
these proteins have been co-crystallized with their substrates28, and the structures of
the apo forms of the proteins show only one binding cleft. All three proteins
examined in this study (DesE, CchF and CdtB) contain tryptophan and tyrosine
residues whose fluorescence could be quenched by addition of ferri-siderophores.
In these studies, there were common procedures that were followed. The
temperature of the reaction used was 21 °C, and buffers were either 10 mM sodium
phosphate buffer at pH 7.5, and were filtered prior to use. The protein was dissolved
in the buffers to various concentrations (80μg/mL – 1.6μg/mL), ferri- and desferri-
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siderophores were added and left to equilibrate for 4 minutes before making a
fluorescence measurement.
The main assumption used in the analysis of intrinsic fluorescence quenching
measurements is that the measure of fluorescence value results from a linear
combination of the unbound and the bound protein, where the bound species has a
lower fluorescence than the unbound protein. For example, if the fluorescence of the
unbound species and bound species is 200 and 100 units respectively at 335 nm, and
a solution of protein and ligand has a fluorescence of 150 units, then it is assumed
that 50% of the protein is bound to the ligand in this solution. The linear
transformation can be summarized as:
min0
0ligandtoboundproteinofProportion
FF
FF

 … (1)
where F0 is the fluorescence of unbound protein, F is the fluorescence of a mixture
of bound and unbound protein and Fmin is the fluorescence of the fully bound protein.
Assuming the protein-ligand binding relationship is one to one, i.e. P + L ↔ PL then 
KD can be calculated by fitting the proportion bound to a relation which is a function
of [PT] and [LT], the total concentration of protein and ligand respectively:
][2
])[][4])[][((-][][ 2
min0
0
T
TTTTDTTD
P
LPLPKLPK
FF
FF 


…(2)
This equation is derived directly from the definition of the dissociation constant
][
]][[
PL
LP
KD  whose derivation is shown in Appendix A.2. In the previous studies
mentioned, the raw fluorescence data was transformed by Equation 1, and then using
a curve-fitting procedure a KD was determined which produced curves (via Equation
2) that simulated the transformed data best.
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4.1.4 : Why not perform a Scatchard analysis?
Scatchard analysis (the plot of [L]free/[L]bound against [P]bound whose gradient is KD) is
a powerful way of calculating dissociation constants and the multiplicity of binding
(n) of the P + nL ↔  PLn type, but fitting data with this method does not put even
bias on all data points (with points on the extremities of the dataset having undue
influence on the results), unlike non-linear fitting methods where there is less bias.
4.1.5 : Estimating Fmin
To estimate Fmin, the fluorescence of the fully bound protein, the most
straightforward way is to add a very high concentration of ligand, and in the case of
ligands which are tight binders (i.e. low KD) this is the most effective way. This may
not be the true value of Fmin as no amount of ligand is able to saturate the protein
unless KD = 0 μM, but the approximation would be adequate. For loose binders (i.e.
high KD) where not enough ligand can be added to saturate the protein sufficiently,
and where the ligands have high absorbance of UV, such as ferri-siderophores, this
method could be problematic as excess concentrations of these ligands could quench
the fluorescence non-specifically.
Previous studies used a variety of methods30,38 to estimate the value of Fmin, where
the derivation of their methods were not shown. More detailed analysis of these
methods (see A.1) on two data sets whose Fmin and KD were known found that these
methods did not estimate Fmin accurately. Instead, the coupled equations as used to
investigate tryptophan fluorescence quenching of human apolipoprotein M to retinol
derivatives85 were used, where the fluorescence quenching data was used to find
both KD and Fmin simultaneously:
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[L] is the concentration of free ligand and is a variable which was used to couple the
two equations. [PT] and [LT] are the total concentration of protein and ligand
respectively. This set of equations was derived from the definition of
[PL]
[P][L]DK ,
and reduces to Equation 2 if Fmin was already known. This method was used to
estimate Fmin and KD simultaneously if Fmin cannot be estimated from addition of a
high concentration of ligand.
4.2 : Siderophore concentration determination
4.2.1 : Preparation of siderophore solutions
All ferri-siderophores and desferri-siderophores were obtained from commercial
suppliers, except for ferri-coelichelin which was purified from S. coelicolor as
described in Chapter 2. Desferrioxamine B was purchased as its mesylate salt, whilst
ferrioxamine B was produced by the reaction of desferrioxamine B with an excess of
ferric chloride, and was purified by RP-HPLC prior to experiments. Ferri-
siderophore and desferri-siderophore solutions were prepared by dissolving in
deionized H2O.
4.2.2 : Spectrophotometric concentration determination of ferri-siderophore
solutions
Ferric-siderophore complexes are usually highly coloured, for example ferrioxamine
B is red and ferri-enterobactin is a dark violet. The red-orange-yellow colour of
ferric hydroxamate solutions in particular is due to the high absorbance of ferric tris
hydroxamates at approximately 435 nm. This is due to the metal-to-ligand charge
transfer transition from the Fe3+ ion to the hydroxamate ligands. The concentrations
of ferric-siderophore stock solutions can be determined by using published extinction
coefficients11, and measuring absorbance at around 435 nm. After obtaining the
concentrations of the stock solutions of the ferri-siderophores, they were diluted with
ultrapure water to produce 500μM, 100μM and 10μM stock solutions.
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4.2.3 : ICP-OES of ferri-siderophore solutions
The concentration of iron in the 500 μM and 100 μM solutions of the ferric
complexes were also measured by inductively coupled plasma optical emission
spectroscopy (ICP-OES). Because there is one iron atom in each ferri-siderophore
complex, the concentration of iron in the solution directly corresponds to the
concentration of siderophore (assuming there is negligible free iron in the solution).
The concentrations determined by ICP-OES corresponded well to the concentrations
estimated by absorbance, except in the case of ferri-albomycin, where ICP-OES
indicated the stock solutions were half the concentration as estimated from
absorbance. This was an unexpected result, which may suggest that ferri-albomycin
forms a 2 ligand – 1 iron complex or the extinction coefficient used was inaccurate.
The latter was assumed, as crystal structures of ferri-albomycin bound to
siderophore-binding proteins show a one-to-one ligand-iron complex23,28.
As the concentrations of the different ferri-siderophore solutions calculated from
ICP-OES can be directly compared against each other, these values were used for all
the experiments described below rather than the concentrations obtained by
absorbance, except for ferri-enterobactin and the desferri-siderophore solutions,
whose concentrations were calculated from the dilution of stock solutions of
concentration approximately 1 mg/mL.
Table 4-1: Concentration of ferri-siderophore solutions (approximately 500μM and 100 μM as
calculated by absorbance) as estimated by ICP-OES
Siderophore solution Concentration estimated by ICP-OES (μM)
~500μM ~100μM
Ferrichrome 550 ± 10 110 ± 3
Ferrioxamine B 750 ± 10 150 ± 3
Ferrioxamine E 450 ± 10 90 ± 3
Ferri-albomycin 250 ± 7 50 ± 2
~300μM
Ferri-coelichelin 300 ± 25
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4.3 : Intrinsic fluorescence quenching of DesE
4.3.1 : Fluorescence spectra of DesE in the absence and presence of ferri-
siderophores
Purified DesE (5’-truncated, His6 tag cleaved) was dissolved in phosphate-buffered
saline solution (PBS) to total concentration 78 μg/mL, which had been filtered
through 0.22 μm cellulose acetate filters prior to use. The instrument used in the
fluorescence quenching experiments was a Perkin Elmer LS 50B luminescence
spectrometer with excitation wavelength of 280 nm with excitation and emission slit
lengths of 5 nm and 8 nm respectively. The fluorescence spectrum was recorded
from 310 nm to 380 nm.
The spectrum of DesE without siderophores had a maximum at 337 nm. On addition
of small concentrations of the ferri-siderophores ferrioxamine B, ferrioxamine E,
ferrichrome and ferri-albomycin, a large decrease of fluorescence was observed
(Figure 4-1). This effect was not observed on addition of similar concentrations of
ferri-coelichelin and ferri-enterobactin. This was also the case on addition of the
desferri-siderophores desferrioxamines E and B, desferrichrome and enterobactin.
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Figure 4-1: Fluorescence spectra of DesE with and without of ferri-siderophores
Ferri-siderophores added: ferrioxamine B (FOB), ferrioxamine E (FOE), ferrichrome (FCr),
ferri-albomycin (ALB) and ferri-coelichelin (cclin).
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Based on the precedent of previous studies30,38,61, this was almost certainly due to the
specific binding of DesE to the ferrioxamines, ferrichrome and ferri-albomycin, but
not to ferri-coelichelin. At 335 nm, the fluorescence of DesE decreased up to 65% on
addition of the ferri-siderophores (Figure 4-2), with nanomolar concentrations of
siderophore able to quench the fluorescence significantly.
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Figure 4-2: Relative decrease of the fluorescence at 335 nm of DesE on addition of ferri-
siderophore.
Key: ferrioxamine B (FOB), ferrioxamine E (FOE), ferrichrome (FCR), ferri-albomycin (ALB),
ferri-coelichelin (CCLIN) and ferri-enterobactin (FeEnt).
4.3.2 : Estimation of dissociation constants
Due to the low amount of DesE fluorescence quenching caused by ferri-coelichelin,
ferri-enterobactin and the desferri-siderophores, a dissociation constant was not
determined for these ligands. To calculate dissociation constants for the other ferri-
siderophores, the fluorescence was monitored at 335 nm without siderophores (F0)
and with various concentrations of siderophore (F). The protein solution in the
fluorescence cuvette had a volume of 90μL and no more than 4.5μL of siderophore
solution was added to this solution. The effect of dilution of the protein on the
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fluorescence of the protein solution was assumed to be negligible as the same
volume of pure water reduced the fluorescence on average less than 3 %.
Fmin was estimated by addition of a high concentration of siderophore as DesE was
saturated easily (the fluorescence did not change very much on addition of
concentrations of ferri-siderophore higher than 5 μM). Equation 1 was used to
calculate the proportion of protein bound to the ligand, using Microsoft Excel.
Fluorescence values from the average of at least three separate titrations were used to
calculate the proportion of bound protein as a function of ligand concentration. The
data was subsequently entered into the data analysis program Origin 6.0
Professional86.
To find KD, the proportion of bound protein was simulated using Equation 2, which
expresses this as a function of KD, the total protein concentration [PT] and the total
ligand concentration [LT]. [PT] was determined by using the molecular weight as
calculated from the amino acid sequence of DesE (Table 4-2). As [LT] was the only
variable, only KD was varied to fit the curve. The “Non-linear Curve Fit” function
was used to find the best KD, using the function file Onesitebind2 (code in Appendix
A.3.1). The data points and curve fits for relative binding against ferri-siderophore
concentration added are given in Figure 4-3.
Table 4-2: The molecular masses of DesE, CchF and CdtB and the molar concentration in a 78
μg/mL solution.
Protein Molecular weight (g/mol) Concentration of 78μg/mL solution (μM)
DesE 34590 2.255
CchF 34916 2.234
CdtB 32770 2.380
The three ferri-siderophores ferrioxamine B, ferrioxamine E and ferrichrome bound
to DesE with nanomolar affinity, whilst the protein had a weaker affinity to ferri-
albomycin (Table 4-3). The dissociation constants were the same range for those
obtained for other Gram-positive siderophore binding proteins38,61. Although the
ferrichrome analogue ferri-albomycin bound less strongly to DesE than ferrichrome
itself, the KD indicates that ferri-albomycin is recognised by DesE. This is an
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interesting result, as S. coelicolor is not sensitive to this antibiotic59. There are
several explanations for this: the affinity of DesE to ferri-albomycin is simply too
low to allow efficient transport of the antibiotic; the DesE-ferri-albomycin complex
may not be recognised by the permease parts of the ABC transporter associated with
DesE, or that it is imported by the ABC transporter, but the cell is able to inactivate
the molecule or export it out the cell, e.g. via a multidrug transporter87
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Figure 4-3: The relative binding of various ferri-siderophores to a DesE solution (78 μg/mL) at
21 °C.
(Top left) ferrioxamine B; (Top right) ferrioxamine E; (Bottom left) ferrichrome; (Bottom
right) ferri-albomycin. The data was fitted to the Onesitebind2 model, and the non-linear curve
fitting function was used to find a suitable KD given [P] = 2.255μM. The KD values are given in
nM.
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The results of this experiment were consistent with the hypothesis of Barona-Gómez
et al.53, based on the genetic experiments that DesE can bind to ferrioxamine E and
ferrichrome, but not ferri-coelichelin
Table 4-3: Calculated dissociation constants for ferri-siderophores from DesE. (N.D. – not
determined as there was insufficient quenching to calculate a dissociation constant)
KD (μM)
Ferrioxamine B 0.090 ± 0.040
Ferrioxamine E 0.011 ± 0.009
Ferrichrome 0.013 ± 0.009
Ferri-coelichelin N. D.
Ferri-albomycin 0.750 ± 0.066
4.4 : Intrinsic fluorescence quenching of CchF
4.4.1 : Fluorescence spectra of CchF in the absence and presence of ferri-
siderophores
The fluorescence spectrum of CchF (5’-truncated, His6 tag cleaved) was rather weak
compared to DesE, hence the same spectrometer conditions were used as with DesE
except the emission slit length was increased from 8 nm to 10 nm to obtain a more
intense signal. Also CchF had an emission maximum at 325 nm, which may suggest
the tryptophan residues that contribute most of the fluorescence at this wavelength
are in hydrophobic environments. The fluorescence of CchF was monitored at 325
nm.
The addition of small amounts of ferri-coelichelin was able to quench the
fluorescence of CchF significantly, indicating a specific binding of this siderophore.
Relatively high concentrations of ferrioxamine B and ferri-albomycin were needed to
quench the fluorescence of CchF significantly, indicating a weaker interaction
between these siderophores and CchF. High concentrations of the ferri-siderophores
ferrioxamine E and ferrichrome were unable to quench CchF sufficiently to allow
dissociation constants to be determined. This was also the case with desferrioxamine
B, E, desferri-ferrichrome, enterobactin and ferri-enterobactin.
PhD. Thesis: Prakash Patel Chapter 4: Binding studies of receptor proteins with siderophores
85
0
50
100
150
200
250
300
350
400
450
500
310 320 330 340 350 360 370 380
nm
F
lu
or
es
ce
n
ce CchF
CchF + 12 uM cclin
CchF + 22 uM FOB
CchF + 20 uM FCR
Figure 4-4: Fluorescence spectra of CchF with and without of ferri-siderophores
Ferri-siderophores added: ferri-coelichelin (cclin), ferrioxamine B (FOB) and ferrichrome
(FCR).
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Figure 4-5: Relative decrease of the fluorescence at 325 nm of CchF on addition of ferri-
siderophores.
Key: ferrioxamine B (FOB), ferrioxamine E (FOE), ferrichrome (FCR), ferri-albomycin (ALB),
ferri-coelichelin (CCLIN) and ferri-enterobactin (FeEnt).
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4.4.2 : Estimation of dissociation constants
To estimate dissociation constants, the fluorescence was monitored at 325 nm. Fmin
was estimated and KD was found in the case of ferri-coelichelin using the methods
that were described for DesE. The graph and curve fit of relative binding against
ferri-coelichelin concentration is given in Figure 4-6 (top).
In the case of ferrioxamine B and ferri-albomycin, full saturation of CchF was not
possible, hence Fmin needed to be estimated. To find KD and Fmin simultaneously,
Ahnström et al. used the coupled equations (Equation 3) to fit the raw fluorescence
data, but for this experiment this data was unreliable as the F0 of the protein solution
was different from day-to-day; this would introduce different errors compared to the
curve for binding of ferri-coelichelin to CchF and it would be unreasonable to
compare the datasets.
Instead, the data was transformed by Equation 1 but using the Fmin calculated for
ferri-coelichelin, to give values of “relative fluorescence decrease compared to fully
saturated CchF with ferri-coelichelin” using Microsoft Excel, and then the equations
of Ahnström et al. were used to fit the data to obtain values of KD and Q
=
)(min0
min0
ncoelicheliFF
FF


, whose physical interpretation is the quenching of the
protein by the ligand compared to ferri-coelichelin. For example, if Q = 2, then the
ligand caused twice as much fluorescence quenching at maximal concentrations than
ferri-coelichelin, whilst if Q = 0.5, the ligand caused only half as much fluorescence
quenching at maximal concentrations than ferri-coelichelin. Optimizing the
parameter Q is analogous to optimizing Fmin directly.
Again, the program Origin 6.0 Professional was used to fit the transformed data for
quenching of CchF fluorescence by ferrioxamine B and ferri-albomycin, and the
“Non-linear curve fitting” function was used but instead the function file
Onesitebind_lipid based on equation 3 from Ahnström et al.85 (named after the
Journal of Lipid Research where the paper was published: see Appendix A.3.2 for
the function file) was used to optimise simultaneously both KD and Q.
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Q was optimized with KD for the ferrioxamine B and ferri-albomycin datasets, with
Q estimated to be 0.5 and 1.3 respectively. The physical interpretation of these
values is that ferrioxamine B would only quench CchF half as much as ferri-
coelichelin at saturating concentrations, whilst ferri-albomycin would quench 1.3
times as much. The data points and curve fit of “relative fluorescence decrease
compared to Fmin (coelichelin)” against ferrioxamine B and ferri-albomycin
concentration is given in Figure 4-6.
It is clear from these results that ferri-coelichelin has a very specific interaction with
CchF compared to the other ferri-siderophores tested. The dissociation constants
calculated for ferrioxamine B and ferri-albomycin are probably too weak for CchF to
mediate their uptake. This observation is consistent with the findings of Barona-
Gómez et al.53 that S. coelicolor mutants whose des cluster (including the desE gene)
was removed but whose cch cluster remained grew poorly when the medium was
supplemented with ferrioxamine B and ferrichrome, but grew well when the medium
was supplemented with ferri-coelichelin.
Table 4-4: Calculated dissociation constants of ferri-siderophores from CchF (N.D. – not
determined as there was insufficient quenching to calculate a dissociation constant)
KD (μM)
Ferrioxamine B 37.1 ± 6.4
Ferrioxamine E N. D.
Ferrichrome N. D.
Ferri-coelichelin 0.33 ± 0.02
Ferri-albomycin 20.4 ± 3.6
The data also support the notion that the cch cluster encodes a self-contained
siderophore synthetase/uptake system where iron acquisition is dependent only on
coelichelin production and uptake. This gene cluster could have evolved separately
in S. coelicolor or in another unknown organism from which it could have been
horizontally transferred to S. coelicolor18.
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Figure 4-6: The relative binding of ferri-siderophores to a CchF solution (78 μg/mL) at 21 °C.
(Top) The relative binding of ferri-coelichelin to CchF. The data was fitted to the Onesitebind2
method, and the non-linear curve fitting function was used to find a suitable KD given [P] =
2.234 μM. (Middle) The relative fluorescence decrease compared to Fmin(coelichelin) for
PhD. Thesis: Prakash Patel Chapter 4: Binding studies of receptor proteins with siderophores
89
ferrioxamine B binding to CchF. (Bottom) The relative fluorescence decrease compared to
Fmin(coelichelin) for ferri-albomycin binding to CchF. The datasets was fitted to the
Onesitebind_lipid model, and the non-linear curve fitting function was used to find a suitable
KD and Q given [P] = 2.234μM.
4.5 : Intrinsic fluorescence quenching of CdtB
4.5.1 : The decrease of the fluorescence of CdtB
The conditions and instrument parameters were identical to those described for
DesE. CdtB (5’-truncated, His6 tag cleaved) had a fluorescence maximum at 335
nm, hence changes in fluorescence intensity was monitored at this wavelength.
Unlike DesE and CchF, the fluorescence of CdtB decreased with time (over a few
hours) when left to stand in solution at 21 °C (Figure 4-7). Also, the wavelength of
the fluorescence maximum of the spectrum increases from 335 nm to 340 nm
(Figure 4-8). This is likely to be due to the instability of the protein at room
temperature. The tryptophan residues which reside in relatively hydrophobic
environments in the folded protein, are exposed to the hydrophilic solvent as the
protein unfolds, resulting in quenching of their fluorescence and a red-shift in the
emission towards the emission maximum of free L-tryptophan in water (348 nm).
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Figure 4-7: Relative fluorescence at 335 nm of CdtB (78 μg/mL) at 21 °C over the course of
seven hours.
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4.5.2 : Spectra of CdtB on addition of ferri-siderophores
Even after standing for seven hours at room temperature, the decrease in
fluorescence of CdtB upon addition of ferri-siderophores was quite large (Figure
4-9), indicating there was still sufficient folded protein to examine binding by
fluorescence quenching. Most of the experiments were carried out within three
hours, and the protein was assumed to remain largely folded over this period.
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Figure 4-8: The fluorescence emission from 310 nm to 380 nm of CdtB (78μg/mL) over 7 hours.
The legend labels show the time elapsed (hours:minutes) after preparation of the protein
solution.
Surprisingly, both ferrioxamine B and ferri-coelichelin were found to quench the
fluorescence of CdtB strongly at low concentrations (Figure 4-9). Only ferrioxamine
B has been implicated by genetic experiments to be a substrate for the ABC
transporter system CdtABC53. Ferri-albomycin was found to quench the
fluorescence of CdtB significantly but only at higher concentrations than
ferrioxamine B and ferri-coelichelin. Ferrichrome and ferrioxamine E were less able
to quench the fluorescence of CdtB, even at high concentrations. Ferri-enterobactin
and the desferri-siderophores tested were unable to quench the fluorescence of CdtB
at all.
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Figure 4-9: Fluorescence spectra of CdtB with and without of ferri-siderophores
Ferri-siderophores added: ferrichrome (FCR), ferrioxamine B (FOB), ferri -albomycin (ALB),
ferrioxamine E (FOE) and ferri-coelichelin (cclin).
4.5.3 : Estimation of dissociation constants
The binding of ferri-siderophores to CdtB appears complicated (Figure 4-10).
Ferrioxamine B and ferri-coelichelin are tight binders, whereas ferrichrome and
ferrioxamine E are much weaker binders to CdtB. Both ferri-coelichelin and
ferrioxamine B caused a similar decrease in the fluorescence of CdtB. Fmin in the
case of ferrioxamine B and ferri-coelichelin was determined to be the fluorescence of
the protein at high concentrations of ferri-siderophore.
Because the protein was partially unfolded during the measurements, the actual value
of [P] was difficult to estimate, but with no way of determining the proportion of
folded to unfolded protein, the initial protein concentration was used, as well as 75%
of this value (assuming that 25% of the protein was unfolded hence could not bind
ferri-siderophores). This value will be explained in the next section.
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Figure 4-10: Relative decrease of the fluorescence at 335 nm of 78 mg/mL CdtB on addition of
various amounts of siderophore.
Ferri-siderophores added: ferrioxamine B (FOB), ferrioxamine E (FOE), ferrichrome (FCR),
ferri-albomycin (ALB), ferri-coelichelin (CCLIN) and ferri-enterobactin (FeEnt).
To estimate KD for ferri-coelichelin and ferrioxamine B, where Fmin was determined
to be the residual fluorescence at high concentrations of ferri-siderophore, the
proportion of protein bound as a function of ligand concentration was simulated by
Equation 2. The “Non-linear Curve Fit” function was used to find the best KD, using
the function file Onesitebind2. The graphs and curve fits for relative binding against
ferri-coelichelin and ferrioxamine B concentrations are given in Figure 4-11.
To estimate KD in the case of ferri-albomycin, ferrioxamine E and ferrichrome, the
Fmin values used for ferrioxamine B binding were used because Fmin could not be
determined due to the high concentrations of ferri-siderophore needed to saturate the
protein. Equation 1 was used to calculate the “relative fluorescence decrease
compared to fully saturated CdtB with ferrioxamine B” in Microsoft Excel, and the
“Non-linear Curve Fit” function in Origin 6.0 was used to fit the data to the model
described by Ahnström et al.85 (Onesitebind_lipid), where KD and Q =
)(min0
min0
FOBFF
FF


were optimized. Ferri-albomycin caused greater total quenching
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than ferrioxamine B, hence Q had a large value (1.9), which was also the case with
ferrichrome (1.3). Ferrioxamine E was unable to cause as much quenching of the
fluorescence of CdtB as ferrioxamine B, even at very high concentrations (77 μM),
but also the fluorescence decrease seemed to plateau at lower concentrations. The
value of Q determined (0.43) can be interpreted as ferrioxamine E causing less than
half the fluorescence decrease caused by ferrioxamine B.
From the values given in Table 4-5, both ferrioxamine B and ferri-coelichelin bind
with high specificity to CdtB. The research carried out by Barona-Gómez et al.53
showed that non-siderophore producing mutants of S. coelicolor lacking the
complete des and cch clusters were able to grow supplemented with ferrioxamine B
as an iron source, thus indicated that other siderophore uptake systems, such as the
ABC transporter system encoded by the cdtABC gene cluster could be used in uptake
of this siderophore.
S. coelicolor M145 is sensitive to the antibiotic ferri-salmycin88, a ferrioxamine B
analogue produced by the bacterium Streptomyces violaceus DSM 8286, but the S.
coelicolor M145 mutant without the cdtABC gene cluster was resistant to the
antibiotic59. Also it was shown that the sensitivity was reduced in S. coelicolor
M145 on supplementation of ferrioxamine B59, indicating the latter was interfering
with transport of ferri-salmycin via the CdtABC system. It would have been
desirable to confirm that the siderophore binding protein used to bind ferri-salmycin
before transport into cells was CdtB, but ferri-salmycin was not commercially
available.
Assuming the 25% CdtB protein had unfolded hardly changed the calculated
dissociation constants (see Appendix A.4) except for ferri-coelichelin (fourfold
increase). If one assumed that only 50% of CdtB was folded, the model as
determined by Equation 2 was unable to fit the data effectively. Despite the
uncertainty of finding out how much active protein is in the solution, and taking the
upper limit as the concentration determined by Bradford assay, the data does indicate
unequivocally that the binding of CdtB to ferrioxamine B and ferri-coelichelin was
much stronger than with the other ferri-siderophores tested.
PhD. Thesis: Prakash Patel Chapter 4: Binding studies of receptor proteins with siderophores
94
0 5 10 15 20 25
0.0
0.2
0.4
0.6
0.8
1.0
Data: FOB_B
Model: Onesitebind2
Chi^2 = 0.00129
R^2 = 0.99331
Kd 80 ±24.95423
P 2380 ±0
R
el
at
iv
e
bi
nd
in
g
M
-2 0 2 4 6 8 10 12 14 16 18 20
0.0
0.2
0.4
0.6
0.8
1.0
Data: Coelichelin_B
Model: Onesitebind2
Chi^2 = 0.0012
R^2 = 0.99077
Kd 38.78556 ±20.72671
P 2380 ±0
R
el
at
iv
e
bi
nd
in
g
M
-2 0 2 4 6 8 10 12 14 16
0.0
0.2
0.4
0.6
0.8
1.0
Data: ALB_B
Model: Onesidebind_lipid
Chi^2 = 0.00111
R^2 = 0.99233
Kd 12284.76483 ± 425.51533
P 2380 ±0
Q 1.9 ±0
Re
la
tiv
e
flu
or
es
ce
nc
e
de
cr
ea
se
co
m
pa
re
d
to
F
m
in
(F
O
B
)
M
0 20 40 60 80 100
0.0
0.2
0.4
0.6
0.8
1.0
Data: FOE_B
Model: Onesidebind_lipid
Chi^2 = 0.00078
R^2 = 0.96099
Kd 8688.83054 ±1873.15263
P 2380 ± 0
Q 0.43745 ±0.02759
R
el
at
iv
e
flu
or
es
ce
nc
e
de
cr
ea
se
co
m
pa
re
d
to
F m
in
(F
O
B
)
M
Figure 4-11: The relative binding of ferri-siderophores to a CdtB solution (78μg/mL).
(Top left) ferrioxamine B; (Top right) ferri-coelichelin. The relative fluorescence decrease
compared to Fmin of ferrioxamine B bound to CdtB of (Bottom left) ferri-albomycin; (Bottom
right) ferrioxamine E.
Table 4-5: Estimated dissociation constants (in μM) for ferri-siderophores from CdtB all
protein was active in binding (100%) and only 75% was active in binding.
CdtB (100 %) CdtB (75 %)
Ferrioxamine B 0.080 ± 0.024 0.100 ± 0.056
Ferrioxamine E 8.7 ± 1.9 8.9 ± 1.8
Ferrichrome 77 ± 3 77 ± 3
Ferri-coelichelin 0.039 ± 0.021 0.172 ± 0.023
Ferri-albomycin 12.3 ± 0.4 12.6 ± 0.4
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4.6 : Circular dichroism spectroscopy of DesE, CchF and CdtB
proteins
Previous studies of conformational change upon binding of various ferri-
siderophores of the E. coli periplasmic binding protein FhuD28,89 and the S. aureus
lipoprotein receptor FhuD238 found there was little effect. These studies involved X-
ray crystallography and small-angle X-ray scattering in solution respectively. To
investigate whether DesE, CchF and CdtB undergo conformational change on
binding to ferri-siderophores, circular dichroism spectroscopy was used to
investigate the secondary structure before and after binding. Circular dichroism (CD)
measures the difference in absorbance between left and right circularly polarized
light83, and different secondary structural features such asα-helices andβ-sheets can
produce either positive or negative signals from 180 – 260 nm wavelengths of light
due to their chiral nature.
The three proteins, DesE, CchF and CdtB were dissolved in 10 mM sodium
phosphate buffer, and an excess of ferri-siderophore (either ferrioxamine B,
ferrioxamine E or ferri-coelichelin) was added. CD spectra were measured at 21 °C
from 190 nm to 260 nm, with the spectrum of the buffer subtracted from the spectra
of the proteins. The results were processed in MS Excel with the baseline of buffer
subtracted from the spectra.
These experiments show that the DesE (Figure 4-12) and CchF (Figure 4-13)
proteins were fully folded with prominent α-helical content, but the spectrum of
CdtB (Figure 4-14) seemed to be a combination of fully-folded and unfolded protein,
with the latter being up to 25% in abundance90 . This was indicated by a lack of a
positive signal at 195 nm and the strong negative signal at 200 nm, which correspond
to the CD spectrum of a random coil. The negative signals at 206 nm and 220 nm
were indicative ofα-helices in fully-folded proteins. These results, together with the
early elution from the gel filtration column (earlier than the more massive proteins
DesE and CchF - indicative of the larger hydrodynamic radius of the unfolded
protein) and the gradual decrease of fluorescence upon standing at room temperature
suggest that CdtB is unstable.
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Addition of binding ferri-siderophores that bind tightly to the receptors did not
change the CD spectra of the siderophore binding proteins DesE, CchF and CdtB
significantly, indicating little change in secondary structure. This result was not
unexpected considering the X-ray crystal structures of the E. coli ferric hydroxamate
binding protein FhuD and E. coli vitamin B12 binding protein BtuF did not alter
significantly on co-crystallization with their substrates. This was further confirmed
from the X-ray crystallographic structures of apo-DesE and DesE-ferrioxamine B as
discussed in the next chapter. The results of CdtB with its substrates ferrioxamine B
and ferri-coelichelin ruled out the possibility that the reduction of fluorescence on
addition of these ferri-siderophores was due to catalysis of protein unfolding; the CD
spectrum hardly changed on addition of these ferri-siderophores, indicating little
change in the secondary structure.
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Figure 4-12: CD spectra of DesE with ferri-siderophores ferrioxamine B and ferrioxamine E.
80 μg/mL protein and 5 μM of ferri-siderophore were used in each case. Ferri-siderophores
added: FOB (ferrioxamine B) and FOE (ferrioxamine E).
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Figure 4-13: CD spectra of CchF with ferri-coelichelin.
80 μg/mL protein and 5 μM of ferri-siderophore was used. Ferri-siderophores added: cclin
(ferri-coelichelin).
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Figure 4-14: CD spectra of CdtB with ferri-siderophores ferrioxamine B and ferri-coelichelin.
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80 μg/mL protein and 5 μM of ferri-siderophore were used in each case. Ferri-siderophores
added: FOB (ferrioxamine B) and cclin (ferri-coelichelin). The absence of signal at 195 nm and
the negative signal at 200 nm are indicative of the presence of random coils.
4.7 : Conclusions and future work
In the model of siderophore-mediated iron acquisition in S. coelicolor A3(2)
proposed by Barona-Gómez et al., the siderophores desferrioxamine B,
desferrioxamine E and desferri-coelichelin are produced and are exported out of the
cell. These bind to extracellular ferric iron to form their ferric complexes. The ferric
complexes bind to the siderophore binding proteins DesE, CchF and CdtB, with
DesE binding to both ferrioxamines B and E, CchF binding to ferri-coelichelin and
CdtB binding to ferrioxamine B.
The fate of the DesE-ferrioxamine E complex seems to be straightforward, with the
siderophore being transported via a yet unknown permease-ATPase complex into the
cell, and it is assumed this is also the fate of the DesE-ferrioxamine B due to the
similarity of the complexes formed. The fate of the CchF-ferri-coelichelin complex
also seems simple enough, with the siderophore being transported via the permeases
CchC and CchD and ATPase CchE also encoded in the coelichelin biosynthetic gene
cluster. The fate of the CdtB-ferrioxamine B complex seems to be straightforward,
with the permease-ATPase CdtAC importing the siderophore into the cell.
The xenosiderophores ferrichrome and ferri-albomycin were found to bind DesE.
The fate of DesE-ferrichrome seems to be identical to that of DesE-ferrioxamine E,
but the fate of the DesE-ferri-albomycin is unclear as S. coelicolor is not sensitive to
this antibiotic. There may be several explanations for this: DesE-ferri-albomycin is
transported into cells but do not kill them, or the DesE-ferri-albomycin binding may
be too weak for its efficient uptake.
The most surprising aspect of the research was that CdtB also bound strongly to
ferri-coelichelin, as the results of Barona-Gómez et al. suggest the CdtABC system
is not essential for ferri-coelichelin uptake in S. coelicolor. As the CdtB protein was
unstable in solution, this result should be treated with caution: for example, the
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protein may be able to slightly unfold to cause a change in the binding site, which
can now accommodate ferri-coelichelin, whilst the stable protein in S. coelicolor is
unable to unfold to accommodate ferri-coelichelin. This could be investigated by
comparing the kinetics of the formation of the CdtB-ferri-coelichelin to CdtB-
ferrioxamine B complexes or other structural techniques.
If ferri-coelichelin does bind to fully-folded CdtB, does this mean the gene cluster
cdtABC is involved in ferri-coelichelin transport? Barona-Gómez et al.53 showed
that non-siderophore producing mutants of S. coelicolor without the complete
coelichelin (cch) gene cluster were unable to grow when supplemented with ferri-
coelichelin (but grew on ferrioxamine B supplementation). The concentration of
ferri-coelichelin added to the media was not determined in the study, hence it was
not determined if the supplementation was at the same concentration as ferrioxamine
B. But these concentrations of ferri-coelichelin stimulated growth on non-
siderophore producing mutants of S. coelicolor containing most of the cch cluster
(except for the NRPS gene cchH), hence the cdtABC cluster may not be essential for
ferri-coelichelin uptake.
The genes that are essential to ferri-coelichelin uptake are very likely to be the genes
that encode the CchCDEF ABC transporter system, but are all of the genes essential?
It could be possible that CdtB-ferri-coelichelin could interact with the permeases
CchC and CchD to transport ferri-coelichelin into S. coelicolor, which could be
investigated by deletion of the cchF gene.
Another possible explanation of why the CdtABC system may be unable to import
ferri-coelichelin is that the CdtB-ferri-coelichelin complex is not recognised by the
CdtAC complex, whilst the CdtB-ferrioxamine B complex is recognised and the
siderophore transported. The bound siderophore may have a large role in
recognition of lipoprotein receptors by ABC transporters, which there is strong
evidence in the literature.
Sebulsky et al.38 reported mutants of the gene fhuD2 gene (encoding a
Staphylococcus aureus ferric-hydroxamate lipoprotein receptor FhuD2) which
prevented the growth of S. aureus H431 on media supplemented with Fe(III)-
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hydroxamates. The double mutation E97A/E231A was found to cause a profound
decrease in growth of S. aureus H431 supplemented by ferrioxamine B and several
other ferri-siderophores compared to S. aureus H431 with the wild-type fhuD2.
However, this mutation had little effect on growth when supplemented by
ferrichrome. The wild type and the E97A/E231A mutants of FhuD2 were
overproduced in E. coli and were found to have almost exactly the same dissociation
constants from ferrioxamine B, ferrichrome and the other ferri-siderophores. Thus,
these mutations did not affect the siderophore binding site of FhuD2. It was
concluded that ferrichrome could assist with the recognition of the receptor-ferri-
siderophore complex by the permeases ABC transporter. Ferrichrome was proposed
to compensate for the loss of the two glutamate residues that had a detrimental effect
on ferrioxamine B uptake. Ferrichrome could do this in one of two ways: the
siderophore interacts directly with the permease, or ferrichrome binding induces a
different conformational change in FhuD2 than ferrioxamine B binding. The latter
was investigated using small angle X-ray scattering, which showed little difference
in the conformational change of FhuD2 on binding to ferrichrome compared to
ferrioxamine B.
In support of the hypothesis that the siderophore interacts directly with the permease,
an X-ray crystallographic structure26 of the E. coli vitamin B12 periplasmic binding
protein BtuF (analogous to the siderophore binding proteins) in complex with its
ABC transporter permease-ATPase BtuCD, was proposed to show the BtuC2D2F
complex after translocation of vitamin B12. The structure of BtuF without the
vitamin, analogous to the siderophore binding proteins, was found with the substrate
binding site directly interacting with the BtuC permease dimer, suggesting that the
vitamin may play a role in the interaction of BtuF with the permease BtuC. Also two
glutamate residues of BtuF were found also to interact with the BtuC permease
dimer, which the study suggested also played a large role in recognition of the BtuF-
vitamin B12 complex by BtuC as suggested by Sebulsky et al. for FhuD2.38
Another possible explanation of non-transport of ferri-coelichelin by the CdtABC
system is that the CdtB protein is present in an “open” or “closed” form in solution.
X-ray crystal structures of the E. coli SBP FitE91 found an open and closed form of
the protein, analogous to the E. coli open BtuF form when bound to the BtuCD
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dimer26 and apo-BtuF27 respectively. Ferrioxamine B may bind to the closed form
of CdtB, whilst ferri-coelichelin may bind to the open form, but only the closed,
substrate-bound form of CdtB is recognised by CdtAC, hence only ferrioxamine B is
taken up.
CdtB appears to discriminate between two very similar molecules: ferrioxamine B
and ferrioxamine E; CdtB has more than 100 times the affinity for the former than
the latter. Finding the molecular basis of this amazing specificity could be achieved
by solving the structure of the protein by X-ray crystallography or by homology
modelling of proteins of similar sequence.
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Chapter 5: X-ray crystallographic structures of apo-
DesE and DesE in complex with ferrioxamine B
5.1 : Introduction
The research in this section was carried out in collaboration with the group of
Professor James Naismith of the University of St. Andrews. We provided the E. coli
pPP004 plasmid which overexpresses the gene encoding the N-terminal truncated
His6-DesE. We also provided the ferrioxamine B used in the co-crystallization
experiments which was prepared by reaction of the mesylate salt with an equimolar
amount of FeCl3.7H2O and subsequent freeze-drying. The purification,
crystallization, X-ray diffraction and structure determination of apo-DesE and
ferrioxamine B-DesE was carried out by researchers in St. Andrews.
5.2 : Crystallography details
Apo-DesE was crystallized by the hanging drop method using 0.1 M Tris-HCl (pH
7.0) with 3.2 M sodium malonate. The phasing data was obtained by soaking in the
above buffer plus 0.5 M sodium bromide. The crystal for DesE-ferrioxamine B was
obtained by soaking crystals of apo-DesE in a 1 mM solution of ferrioxamine B.
The crystals were cryogenically frozen and the diffraction data was obtained at the
European Synchrotron Radiation Facility (Grenoble, France). The resolution of the
crystal structures of apo-DesE and DesE-ferrioxamine were 1.5 Å and 1.96 Å
respectively.
5.3 : The structure of apo-DesE
The structure of S. coelicolor DesE is very similar to several bacterial siderophore
and vitamin B12 binding proteins. In particular, DesE has a very similar structure to
FeuA, a ferric-bacillibactin lipoprotein receptor protein from the Gram-positive
bacterium B. subtilis34,35. DesE also shares many structural similarities with the
vitamin B12-binding protein BtuF from E. coli and the siderophore-binding
periplasmic lipoprotein CeuE from the Gram-negative bacterium Campylobacter
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jejuni36, such as a rigid backbone of three α-helices bridging two β-sheet regions,
whose loops form part of the substrate binding cleft (Figure 5-1).
apo-DesE (left), DesE with ferrioxamine B bound (right)
B. subtilis FeuA
E. coli BtuF with vitamin B12
bound
C. jejuni CeuE (bound ferric
MECAM is not shown)
Figure 5-1: Comparison of the structure of apo-DesE and DesE with ferrioxamine B bound to
other bacterial siderophore and vitamin B12 binding proteins.
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5.4 : The structure of DesE with ferrioxamine B
The co-crystallization of the siderophore ferrioxamine B bound to DesE (Figure 5-1:
top right) confirmed the affinity of the protein for the ferri-siderophore as indicated
by the fluorescence quenching experiments described in Chapter 4. The co-complex
structure identified tryptophan residues in the ferrioxamine B binding site which
were close to or may directly interact with the ferri-siderophore (Figure 5-2), which
were quenched very strongly in the fluorescence quenching experiments described in
Chapter 4.
5.4.1 : Conformational change in DesE on binding of ferrioxamine B
DesE is related to the maltose binding protein (MBP) family of receptors involved in
ABC importers25. MBP is a well-studied binding protein whose fold changes
markedly on substrate binding. By contrast, the fold of siderophore-binding proteins
has been observed to change very little on substrate binding. To examine whether
DesE conforms to this paradigm, the structures of apo-DesE and DesE-ferrioxamine
B were superimposed using the MOE package (Figure 5-3). This showed that the
apo- and holo- forms of the protein have very similar structure (although part of the
N-terminus of DesE was not observed in the crystal structures, presumably because
it was disordered in the crystals).
Figure 5-2: The ferrioxamine B binding site of DesE. The siderophore is in the centre.
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5.4.2 : Residues involved in ferrioxamine B binding
As well as three tryptophan residues (W122, W150 and W270) that line the
ferrioxamine B binding site, there was close contact of the ferric siderophore with
the aromatic residues F143, F271 and Y236. The two residues S229 and E323
complete the binding pocket, but do not make close contact with ferrioxamine B. By
far the most intimate contact between DesE and ferrioxamine B involves the R292
residue. Two of the hydrogen atoms of the guanidinium group in the side chain of
this residue point towards to the hydroxamate oxime oxygen atoms of the ferri-
siderophore, which may indicate the presence of hydrogen bonds. A close
interaction between an arginine residue in E. coli FhuD to ferri-albomycin, ferric
coprogen and ferric coprogen was also observed in X-ray crystal structures28. This
interaction may be very important in stabilizing the complex, enabling the ligand to
bind to the protein at nanomolar concentrations.
Figure 5-3: Superposition of DesE and DesE-ferrioxamine B.
Left: Stick models of apo-DesE (red) and DesE with ferrioxamine B bound (green). Right:
Cartoon representations of apo-DesE and DesE-ferrioxamine B superimposed.
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5.4.3 : The absolute configuration of bound ferrioxamine B
Free ferrioxamine B is a racemic mixtures of Λ and Δ isomers, which is confirmed 
by the observation that it crystallizes as both these isomers72,92. There are 16
possible geometrical and optical isomers of ferrioxamine B (which is also the case
with the ferric complexes of linear hydroxamate siderophores) as the hydroxamate
groups are inequivalent11. According to IUPAC rules, the first step in determining
the configuration of ferrioxamine B is to determine whether the complex is of the
left- or right handed propeller (Λ or Δ respectively).  The next step is to give each 
hydroxamate group a number, starting from the group closest to the pendant NH3+
group in the case of the ferrioxamines. The numbers are assigned anti-clockwise and
clockwise in Δ or Λ isomers respectively. Next, one must orient the molecule such
that the hydroxamate groups read 1, 2, 3 when read anticlockwise in the case of Δ 
isomers (clockwise in the case of Λ isomers), then determine whether the oxime
nitrogen is above (towards the page) or below (further into the page) than its
corresponding carbonyl carbon in the first hydroxamate group. If the nitrogen is
below the carbonyl carbon the complex is denoted N, otherwise it is denoted C. The
hydroxamates 2 and 3 are compared with the first hydroxamate, in particular whether
the orientation of the oxime nitrogen and carbonyl matches. If they do match, it is
denoted cis, otherwise it is trans. The eight isomers of the Δ configuration are 
illustrated in Figure 5-4. The absolute configuration of ferrioxamine B in the
binding pocket of DesE was sufficiently determined from the electron density map
(Figure 5-5), and is of an unusual configuration (Δ-N-trans-cis: Figure 5-6).
Ferrioxamine B bound to E. coli FhuD adopted a Λ-C-trans-cis configuration
(although the reference says it is Λ-cis) 28.
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Figure 5-4: The eight geometrical isomers of a ferric-tris-hydroxamate with inequivalent
hydroxamates in a Δ configuration.  
In the case of ferrioxamine B, hydroxamate 1 corresponds to the group closest to the free amino
group.  The equivalent Λ isomers are the mirror images of the corresponding Δ isomer.  Figure 
from 11.
Figure 5-5: The electron density map of the DesE-ferrioxamine B around the ferri-siderophore.
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Figure 5-6: Ferrioxamine B isomers.
From left to right: Ferrioxamine B bound to DesE (configuration Δ-N-trans-cis); Ferrioxamine
B bound to FhuD (configuration Λ-C-trans-cis); free ferrioxamine B crystal structure
(configuration Δ-N-cis-cis)92.
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Chapter 6: Molecular modelling of ferric
hydroxamates
6.1 : Introduction
The aim of this chapter was to construct a molecular mechanics force field model
that accurately reproduced bond lengths, angles and the energetics of trigonal twists
of ferric-tris-hydroxamate complexes such as siderophores. This model may
ultimately be used for molecular dynamics simulations of siderophore binding
proteins.
6.2 : Hydroxamate complexes
To understand more about the nature of siderophore complexes it is important to
consider the interactions between the siderophore ligands and the Fe(III) ion. This
ion has a high-spin d5 electronic configuration in hydroxamate complexes – a half-
filled d-electron shell – and consequently there are no ligand field effects caused by
an uneven distribution of electron density in this shell, and form thermodynamically
stable hexacoordinate octahedral complexes, mainly with oxygen donors.
Siderophores, such as the ferrioxamines and ferrichromes, chelate Fe(III) to form
tris-hydroxamate complexes. The lone pairs of the deprotonated oxime and the
carbonyl oxygens of the hydroxamate form coordinate bonds with Fe(III) to form a
complex which is structurally and thermodynamically very stable11, due to the
delocalization of the deprotonated hydroxamate on Fe(III) binding93, whose
resonance forms are shown in Figure 6-1.
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Figure 6-1: The resonance forms of the hydroxamate-Fe3+ five membered ring93.
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The formation constants of hydroxamate siderophores with Fe(III) vary (Table 6-1),
but in general their affinities are less than catecholate-type siderophores such as
enterobactin11. There is a variety of influences on this property, including the outer
structure of the siderophore or the entropic change on binding.
Table 6-1: Formation constants11, β110, of ferric tris-hydroxamate siderophores for the
reaction nn   33 FeLLFe , where ]][L[Fe
][FeL
n3
3
110 


n

.
Siderophore log10β110
Ferrioxamine E 32.5
Coprogen 30.2
Ferrioxamine B 30.5
Ferricrocin 30.4
Ferrichrysin 30.3
Ferrichrome A 32.0
Ferrichrome 29.1
The shape of the ferric complex is very important in the recognition of microbes in
determining the uptake of these complexes, and in particular the local coordination
environment of Fe(III): for example, the earlier chapters demonstrated that three
siderophore binding proteins from Streptomyces coelicolor A3(2) had different
specificities to the ferric-tris-hydroxamates ferrioxamine E, ferrioxamine B, ferri-
coelichelin, ferrichrome and albomycin. As well as the overall shape of the complex
being important for recognition, the absolute configuration of the hydroxamate
ligands around the Fe(III) ion may also play a role in recognition11 .
6.3 : Survey of X-ray Crystallographic Structures
To construct a molecular model which was effective at modelling ferric tris-
hydroxamates, the X-ray crystallographic structures of the complexes were used as
the minimal energy conformers of the tris-hydroxamates.
The crystallisation of siderophores with Fe(III) is the orthodox method for
determining the structure of complexes. As such complexes are small (about 100
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atoms), the resulting crystal structures were usually very accurately determined
without much disorder, and, in principle, should correspond to a energy minimized
configuration, but may also co-crystallise with another conformer if they were very
similar in energy, as in the case of ferric tris-acetohydroxamate, where both the fac
and mer isomers co-crystallized71 .
The weakness of this information is that only one conformer is usually found in the
structurally static crystal. If there were different conformers in solution with similar
energies only one would be found – there is no information about any flexibility of
the molecule. Also the conditions of the crystallisation are usually different to the
physiological environments they are naturally found in.
A promising approach to obtain a solution-state structure is to use nuclear magnetic
resonance (NMR) on a metal-siderophore complex where Fe(III) is replaced by a
non-paramagnetic ion of similar atomic radius such as Ga(III) or Al(III). The
structure can be obtained for small conformers, but if there was more than one
conformer the structure obtained would be an average of all possible conformers.
This would introduce disorder into the system, but would give a more realistic
picture of the flexible nature of their structures.
The Cambridge Crystallographic Structural Database (CCSD) was used to obtain
ferric tris-hydroxamate crystal structures. There were 27 ferric tris-hydroxamate
complexes present in the Database, including binuclear complexes such as ferric
alcaligin94.
All the complexes in the Database were close to octahedral in the coordination
environment of the Fe(III) ion, with most exhibiting the fac geometry, where the
three carbonyl oxygen atoms were on a plane opposite the three oxime oxygen
atoms. There was a significant difference of Fe – O bond lengths of 0.055Å on
average between the formally negatively charged oxime oxygen O(N) to that of the
lone pair bond of the carbonyl oxygen, O(C), with the Fe – O(N) being shorter than
Fe – O(C) (Table 6-2). This was to be expected from the electrostatic attraction
between the O- and formally positively charged Fe3+ ion, but in ferrioxamine E, this
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difference was 0.1Å, which could be due to the influence of the cyclic structure of
the siderophore.
Table 6-2: Average bond lengths and angles from 27 ferric tris-hydroxamate metal centres from
X-ray crystallographic structures.
Average Standard Deviation
1. Fe – O(C) bond length 2.039 Å 0.022 Å
2. Fe – O(N) bond length 1.980 Å 0.017 Å
3. O(N) – Fe – O(C) bite angle 78.5° 0.66°
4. C = O bond length 1.278 Å 0.0125 Å
5. N – O bond length 1.377 Å 0.0135 Å
6. C – N bond length 1.319 Å 0.0256 Å
Trigonal Twist 41.7° 3.7°
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The O(N) – Fe – O(C) bond angle within one hydroxamate (the ligand bite angle) is
much smaller than 90°, hence hydroxamate complexes were not rigorously
octahedral with respect to the oxygens surrounding the Fe(III) centre, but closer to
D3d or C3 symmetry. The metal-hydroxamate ring is planar, probably due to the
influence of the delocalization of theπ-system around the hydroxamate.
6.3.1 : Trigonal distortion: measuring trigonal twist
In all the tris-hydroxamate structures, there was little variation in bond lengths and
bite angles around the metal centre. The main distortion from the unrestrained ferric
tris-hydroxamate complexes caused by the tether of the siderophore structures is the
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departure from a roughly octahedral complex (approximately D3d) to a trigonal
prismatic C3v structure (see Table 6-2). Most hydroxamate complexes are in between
these two extremes.
This distortion is known as the trigonal twist, and is measured as follows. Viewing
from a pseudo-C3 axis of a tris bidentate complex, the ligands’ donor atoms in a
perfectly octahedral complex would look like two triangles whose vertices line up to
the midpoints of the other triangle’s edges in a staggered formation, whilst in a
trigonal prism, a configuration with no trigonal twist, these triangles would be
eclipsed (Figure 6-2). This can be quantified by measuring the angle α(the twist
angle) which is 0° for a trigonal prism and 60° for a perfectly octahedral
complex93,95.
Fe
Fe
Trigonal Distortion 
Figure 6-2: Defining the twist angle of a bidentate ligand.
The red and green lines represent the triangles seen from above with the C3V axis pointing out
of the page. The thick pink lines represent one bidentate ligand (e.g. one hydroxamate). In
trigonal distortion, αis reduced from an “octahedral” complex (left) to a trigonal prismatic
complex (right).
To measure the trigonal distortion in fac ferric hydroxamate complexes, the vertices
of one of the triangles were formed by the carbonyl oxygen atoms, and the other
triangle had the oxime oxygen atoms of the hydroxamate (for meridional isomers
any two carbonyl and one oxime oxygen would form a suitable triangle if they are
from different ligands).
The pseudo-C3 axis is constructed by the vector that passes through the centroids of
both triangles. Then the twist angle αfor a fac isomer is simply the angle between
the vector of a carbonyl oxygen and its centroid, and the corresponding oxime
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oxygen and centroid of the same ligand, calculated by application of the dot product.
The value calculated by this method may be inaccurate if the planes containing the
carbonyl oxygen atoms and the oxime oxygen atoms were not close to parallel, or
the metal atom is significantly displaced from the C3 axis.
In reality, the trigonal twist of the complexes was rarely as large as 60°, and the
optimal trigonal twist is largely dependent on the ligand bite: the O…O distance in a
hydroxamate group divided by the M…O bond length. The trigonal twist of ferric
hydroxamates can be estimated from the ligand bite96, and a relation between twist
angle and ligand bite has been presented:
Twist angle = -73.9 + 94.1 b
where b denotes the ligand bite. There was a markedly greater variation in trigonal
twists between complexes than bond lengths and angles, and seemed to be the main
distortion caused by the constraints of a backbone structure of a siderophore
compared to an unconstrained tris-hydroxamate. For ferric fac tris-
acetohydroxamate71 the trigonal twist was 44.6°, whilst for ferrioxamine B and
ferrichrome they were 44.1° and 42.9° respectively.
The mer isomers in the database, in particular mer tris-acetohydroxamate,
neocoprogen I and ferric alcaligin had lower trigonal twists than the fac isomers,
with an average of 37.0°. Also, some ferric-tris-hydroxamate complexes with bulky
phenyl groups showed low trigonal twists of 35°. This could be due to the electronic
effects due to the aromatic groups or possibly due to crystal packing effects.
6.4 : Computational studies on transition metal complexes
Quantum mechanical (QM) methods are by far the most accurate method of
determining structures and properties of small molecules, especially transition metal
complexes. QM treats a molecule as a system of electrons and fixed, heavy,
positively-charged nuclei. A plethora of information can be obtained from QM with
high accuracy, such as absolute/relative energies, spectra and structures. The
downside is the computational cost – a 100 atom system could take up to 2 weeks on
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a 3.0 GHz processor – hence approximations have to be made, compromising
accuracy.
In contrast, molecular mechanics (MM) methods represent a molecule as point
charges with bonds modelled by springs between them in the simplest case. Note
MM does not explicitly take into account the electronic properties of the complex,
hence is an extreme approximation to a molecule. It is a highly empirical method,
where properties of such as bond lengths, angles, torsional terms and partial charges
for electrostatics have to be estimated to produce reasonable answers in a particular
context. A particular model or parameterization is known as a force field. Despite
these shortcomings, MM has been a very successful method for modelling
macromolecules such as proteins and lipids, and results are comparable with QM for
molecules containing main group elements.
6.4.1 : Density Functional Theory (DFT)
Quantum mechanical calculations are commonly used to calculate accurate
properties of a molecule. In principle this is done by solving the time-independent
Schrödinger wave equation for the system, where n is the number of electrons and
nuclei:
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The Hamiltonian H describes the energetic interactions between the particles (nuclei
and electrons) in the system whilst the waveform describes their spacial distrubution.
The Hamilitonian is the sum of the kinetic energy terms and potential energy terms,
T and V, where subscripts A and i are sums over nuclei and electrons respectively.
MA and ZA are the relative mass and charge of nucleus A relative to an electron
and 2 is the Laplacian operator in three dimensions:
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This cannot be solved exactly for systems with more than one electron, hence to
investigate larger systems, an approximation has to be made. The Born-
Oppenheimer approximation assumes that the larger nuclei move much more slowly
than electrons and so can be treated as static. Hence the Hamiltonian H becomes:
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where the kinetic energy term involving the nuclei disappears (because the nuclei are
not moving) and the final term in the potential energy is constant. The wavefunction
Ψ(ri; RA) is now a function of only electron positions ri with parameters RA – the
coordinates of fixed nuclei.
As this is an approximation, energies and spectra gained from this method are no
longer exact, but the size of the error significantly reduces as the molecule becomes
larger. To evaluate the minimal energy geometry, different nuclear positions are
calculated, which give rise to different wavefunctions Ψ which give different
energies E, until there exists a wavefunction which any variation of nuclear positions
increases the energy.
One of the first approaches of QM is the Hartree-Fock method (HF)97, where the
complete wavefunction is approximated by a combination of one-electron
wavefunctions. Each electron’s potential is calculated by considering all the other
electrons and nuclei, but it neglects electron correlation - it assumes that the
movement of a particular electron is independent to the rest of the electrons (which is
untrue as two electrons cannot occupy the same quantum state). Also, it is
increasingly computationally expensive as the system becomes larger.
The electron exchange energy calculated by HF methods becomes increasingly
inaccurate for heavier nuclei such as those in transition metals – instead the Møller-
Presset peturbation97 (MP2) method can be used, which reduces this error
significantly. The only problem is the computational effort for MP2 is now five
orders of magnitude instead of four.
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The other popular approach is density functional theory (DFT)97. Instead of solving
the many-body electronic wavefunction, the electron density is considered instead,
which is a function of three variables instead of 3N variables (where N is the number
of electrons) in HF theory. The lynchpin to this method is the Hohenberg-Kohn
theorem, which states that the ground state electron density minimizes the total
electronic energy of the system. The problem with this method is that it treats the
system with non-interacting electrons hence electron correlation and electron
exchange terms have to be added explicitly.
The performance of DFT methods has improved greatly during the 1990s where it
can now compete with HF-based methods for accuracy. Geometries calculated using
the local density approximation (LDA), where the initial estimate of the electron
density around the orbitals is that it is completely homogeneous (a uniform electron
gas), underestimates bond lengths, but these errors are smaller than the
overestimation of bond lengths given by HF theory. These methods are combined in
the Becke’s hybrid method B3LYP97, which is commonly used in many QM
calculations on main group elements. Instead, using DFT methods with LDA with
gradient corrected functionals gives similar results to MP2 but much faster, at three
orders of magnitude, hence it is the most popular method for calculations on
transition metal complexes.
6.4.2 : Molecular Mechanics
To deal with much larger complexes within a reasonable timescale, empirical
methods such as molecular mechanics (MM) must be used, which is an effective
method for very large molecules such as proteins. The strain energy E of a system of
molecules in MM is calculated by:
crosselvdwtorsbendstr EEEEEEE 
where Estr, Ebend, Etors, Evdw, Eel and Ecross are the stretch energy between two atoms,
angle bend strain between three atoms, torsional strain between four atoms, van der
Waals strain between atoms, electrostatic interactions between atoms, and cross
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terms (e.g. stretch bends) respectively. The stretch energy between two atoms A and
B is given by the general formula:
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where the ideal bond length ABR0 terms and force constants k2, k3 and k4 have to be
determined, and there are similar expressions for the other terms. A scheme of these
constants is termed a forcefield. In many forcefields, for example Halgren’s
MMFF94 forcefield98, the parameterisation of the forcefield is based on QM
calculations on main group molecules. To find the minimum energy structure, the
strain energy E is minimised.
The central idea of molecular mechanics is that these constants are transferable to
other molecules. Most atoms in organic molecules adopt very similar bond lengths
and angles depending on the geometry of the atom. Most C – H bond lengths are
1.06 to 1.10 Å in just about any molecule, with stretching frequencies between 2900
and 3300 cm -1. This strategy is refined using different “atom types”- for example a
sp3 hybridised carbon atom in ethane would have different properties than a sp2
hybridised carbon atom in ethene which would be reflected in the forcefield
properties. In the MMFF94 forcefield98, the ethane carbon would be denoted by the
symbol C whilst C= would denote the ethene carbon. Other terms such as out-of-
plane bends may be added to account for other effects (e.g. a nitrogen atom in an
amide bond is planar contrary to many nitrogen-hydrogen compounds which are
pyramidal) to refine the forcefield even further.
The main problem with this method is that it takes no account of the electronic
environment of the atoms, which can cause problems if this is not taken into account
beforehand by the forcefield applied.
6.4.3 : Molecular mechanics on Fe(III)
Transition metal complexes are usually hard to model in an MM scheme because of
high coordination numbers, variable oxidation states, different spin states, and other
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electronic effects such as Jahn-Teller distortions which are absent in molecules
containing only light elements. To capture the behaviour of transition metals into an
MM scheme, a number of models have been proposed, such as DOMMIMOE73,
SHAPES99, which employs a Fourier transform description of the angular potential,
VALBOND100, which uses valence bond theory on transition metals, and
MOMEC101, a purely ligand-ligand repulsion approach.
The program used in this report, DOMMIMOE73, offered capabilities which make it
especially useful for handling transition metal complexes. The d-electrons around a
transition metal can exert a strong influence on the energy and geometry in a
complex. These are known as ligand field effects and can be incorporated into the
MM scheme by adding a term called the ligand field stabilization energy (LFSE)102.
To calculate the LFSE, a bond-centred form of ligand field theory known as the
angular overlap model (AOM) is used, where the interaction energy of the ligand
bonding and antibonding orbitals is calculated with respect to the probable d-electron
density of the metal. The metal-ligand bond stretch potential function is modelled by
a Morse function, which has a very similar shape to the realistic Lennard-Jones
potential at short distances.
The positioning of the ligands around the metal centre is modelled by a purely
repulsive interaction. If there is no ligand field effect, then this becomes a purely
points-on-a-sphere model where the ligands are ideally arranged as far away as
possible, which accounts for the mainly trigonal bipyramidal, octahedral and square
antiprismatic geometries for most 5, 6 and 8 coordinate metal complexes.
Hydroxamate and other ferric siderophore complexes are almost entirely high-spin d5
Fe(III). There is no ligand field effect hence the LFSE is zero. This meant the model
can be parameterised by bond stretch terms between the Fe and hydroxamate O
atoms, ligand-ligand repulsion terms between the hydroxamate O atoms, and an
atomic partial charge scheme for electrostatic interactions. If Fe(II) binding has to
be considered, for example in studies investigating the reduction of the Fe(III) centre
to Fe(II) as in proposed models of iron release from siderophores once in the cell,
explicit ligand field effects have to be considered for the ferrous complexes.
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The other advantage of DOMMIMOE is that it is implemented into the popular
molecular mechanics package Molecular Operating Environment74 (MOE), which
has a graphical user interface which facilitates construction and manipulation of
molecules and also has an expandable pharmacological functionality with its own
programming language called SVL (scientific vector language), where programs can
be written to automate processes. Recently, molecular dynamics has been
implemented into DOMMIMOE, hence ferric siderophores could be modelled with
siderophore-binding proteins in an aqueous environment to obtain binding
information.
6.4.4 : Previous computational studies on ferric hydroxamates
Considering the importance of siderophores in medicinal chemistry, there are
surprisingly few computational studies on these small molecules. This is due to the
complexes being too large for effective quantum mechanical treatment (>100 atoms)
whilst being too small coupled with inadequate methods of treating the metal centre
with MM (hence giving bad relative comparisons to known X-ray crystal structures).
Zinelabidine et al. (1993)103 use an MM technique to model the Fe(III) ion in
catecholate, hydroxamate and EDTA derivatives to calculate a rudimentary strain
energy change when complexed with Fe(III). A model of ferric tris-
acetohydroxamic acid and ferrioxamine E was constructed, and this was compared
with the X-ray crystallographic structure of the latter104.
Herrera et al (2006).105 constructed an empirical forcefield in the program FORCES-
2000 to model ferric-tris-hydroxamates. They parameterized the forcefield using
both X-ray crystallographic data and ab initio calculations (Hartree-Fock) to model
geometries of isomers of the ferric complexes of acetohydroxamic and N-
acetohydroxamic acids, and calculate the relative energies of Δ, Λ, fac and mer
isomers. They concluded the facial isomers were energetically favoured, but the
energies of the meridional isomers were quite close, leading to the conclusion they
could interconvert, especially in siderophores such as ferrioxamine E and
ferrichrome although these siderophores were not tested in the model.
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In Edwards and Myeni (2005)106, quantum mechanical calculations (DFT and
B3LYP) were used to justify XAFS experiments on ferric tris-(cis-acetohydroxamic
acid) and ferrioxamine B to determine the Fe – O bond lengths in solution. In the
study, they determine the protonation state of Fe tris-(cis-acetohydroxamic acid) as
neutral except in very alkaline conditions, where the oxime hydrogen is
deprotonated, and that ferrioxamine B has a formal charge of +1 in aqueous
solutions.
Felder and Shanzer (2003)107 have also developed an empirical force field for the
modelling of ferri-siderophores such as ferrioxamine B and ferrichrome, but have not
disclosed geometric and energetic information accompanying their results.
6.5 : Parameterization of Fe tris-hydroxamates in DOMMIMOE
6.5.1 : Aim of the parameterization
The first aim of the model was to produce a forcefield that accurately reproduces the
bond lengths and angles of ferric tris-hydroxamate complexes, and also to reproduce
the trigonal twist of the complexes, as it was the main distortion amongst the X-ray
crystallographic structures (as summarized in Table 6-2) and also may be important
for recognition by outer membrane receptors. It would be achieved by the search of
suitable parameters for DOMMIMOE, in particular bond stretch terms between the
Fe and hydroxamate O atoms, ligand-ligand repulsion terms between the
hydroxamate O atoms and the charge scheme for electrostatics.
In the MMFF94 forcefield, the carbonyl oxygen in the hydroxamate is denoted by
the symbol O=, and the oxime oxygen by OM. These symbols will be used from this
point onwards in this chapter.
6.5.2 : DFT calculations on simple ferric-tris-hydroxamates
MM has the useful feature that a parameterization of a small complex is transferable
to larger complexes, so if the parameters produce the desired behaviour for small
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complexes they would give reasonable results for larger complexes. Hence, one
must start on the simplest of ferric tris-hydroxamates, namely ferric tris-(cis-
acetohydroxamic acid) denoted Fe(hydr)3, and ferric tris-(cis-N-methyl-
acetohydroxamic acid) denoted Fe(Nmhydr)3, which were representative of atom
types found in ferri-siderophores. To obtain accurate energetic information of these
complexes, it was necessary to perform DFT (quantum mechanical) calculations to
obtain another handle to optimize the molecular mechanics.
6.5.2.1 : Facial and meridional isomer calculations
Quantum mechanics calculations were performed on the following complexes: fac
Fe(hydr)3, mer Fe(hydr)3, fac Fe(Nmhydr)3 and mer Fe(Nmhydr)3. There were X-ray
crystallographic structures for the two isomers of Fe(hydr)3, whilst Fe(Nmhydr)3 was
a theoretical complex. Quantum mechanics was used to optimize the structures of
these four complexes, which in the case of the two isomers of Fe(hydr)3 gave
structures which were almost identical to the crystal structures. As the same method
was applied to the Fe(Nmhydr)3 complex, it was assumed this was an accurate
reproduction of the structure.
The fac and mer isomers of Fe(hydr)3 had an absolute energy difference of 1.31
kcal/mol, with the fac isomer being lower in energy (Table 6-3). This difference was
very small, and goes some way in explaining why both isomers co-crystallized. By
contrast, the fac isomer of Fe(Nmhydr)3 was lower in energy by 4.01 kcal/mol than
the mer isomer, which may explain why fac isomers are more commonly seen in
metal-siderophore complexes than mer isomers.
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Table 6-3: The DFT energies of minimized structures of fac and mer isomers of simple ferric-
tris-hydroxamates.
Structure Description DFT energy
(kcal mol-1)
NO
N
OO
N
O
O
Fe O
H
CH3 H
CH3
HCH3 fac ferric tris-
(cis-
acetohydroxamic
acid)
-3960.32 (0.0)
N
OO
N
O
O
Fe
H
CH3
HCH3
N
O
O
H
CH3
mer ferric tris-
(cis-
acetohydroxamic
acid)
-3959.01 (+1.3)
NO
N
OO
N
O
O
Fe O
CH3
CH3 CH3
CH3
CH3CH3 fac ferric tris-
(cis-N-methyl-
acetohydroxamic
acid)
-5085.46 (0.0)
N
OO
N
O
O
Fe
CH3
CH3
CH3CH3
N
O
O
CH3
CH3
mer ferric tris-
(cis-N-methyl-
acetohydroxamic
acid)
-5081.45 (+4.0)
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6.5.2.2 : Facial isomers with 0° trigonal twist
To estimate the energies required for a trigonal twist of these simple complexes,
quantum mechanical calculations were performed on fac isomers of Fe(hydr)3 and
Fe(Nmhydr)3 such that they had a trigonal twist value of 0°. This was achieved by
constructing the complexes such that the planes of the hydroxamate groups were
perpendicular to the planes formed by the oxime and carbonyl oxygen atoms, and
then imposing C3v symmetry when optimizing the structure of the complex (Table
6-4). The difference in energies between the minimized (“octahedral”) fac isomers
of Fe(hydr)3 and Fe(Nmhydr)3 and their C3v minimized structures were 6.29 kcal
mol-1 and 5.83 kcal mol-1 respectively.
Table 6-4: The DFT energies of minimized simple ferric-tris-hydroxamates with C3v symmetry
imposed.
Structure Description DFT energy
(kcal mol-1)
N
O O
H
CH3
N O OH
CH3
Fe
N
O
O
H
CH3 fac ferric tris-
(cis-
acetohydroxamic
acid)
C3v minimized
-3954.03 (+6.3)
N
O O
CH3 CH3
N
O
OCH3 CH3
Fe
N
O
O
CH3 CH3 fac ferric tris-
(cis-N-methyl-
acetohydroxamic
acid)
C3v minimized
-5079.63 (+5.8)
6.5.3 : Parameterization of DOMMIMOE
The search for parameters in DOMMIMOE focussed on replicating the DFT
structures of two simple ferric tris-hydroxamates: fac Fe(hydr)3 and fac
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Fe(Nmhydr)3. The other focus was to reproduce the energy difference of minimized
Fe(hydr)3 and Fe(Nmhydr)3 with their C3v symmetry minimized structures such that
DOMMIMOE could be able to model trigonal distortion these ferric hydroxamates.
6.5.3.1 : Morse function parameters
The Fe – OM (Fe to oxime oxygen bond) and Fe – O= (Fe to carbonyl oxygen bond)
bond stretch potentials in DOMMIMOE were modelled by the Morse function,
which is given by the formula 2)( ]1[)( 0rreDMorseE   where r0 denotes the
reference bond length, D the depth of the potential ‘well’ andαthe curvature of the
well (Figure 6-3). As the Fe – oxygen distance approaches infinity, the Morse
function tends to D, whilst the minimum is at r0 with 0)( MorseE . As the metal-
ligand distance becomes shorter than r0, the energy rises steeply, mimicking the
effect of strong repulsion caused when atoms come too close. The curvature
parameter αwas important when considering bond vibrations and energies away
from the minimal geometry. In the optimization of these parameters, the parameters
αand D were set to 0.6 and 60 respectively (these parameters have little effect on the
geometry of the complex), hence only the r0 parameters were varied.
Figure 6-3: Morse function with parameters D = 60,α= 0.6, r0 = 2.
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The y-axis represents relative energy which is lowest at x=2 (the optimal bond length) but rises
steeply at smaller bond lengths and less steeply at larger bond lengths. D is the depth of the
energy “well” which is relative to the energy if the two atoms are infinitely apart.
6.5.3.2 : Ligand-ligand repulsion terms
The other DOMMIMOE parameters that needed to be set were the Fe – OM and Fe –
O= ligand-ligand repulsion terms, All. The ligand-ligand repulsion terms were
important as these separate the oxygen atoms as far out as possible, which in a
system where the ion is surrounded by six atoms these are arranged at the vertices of
an octahedron. Large ligand-ligand repulsion terms increase the repulsion between
the carbonyl and oxime oxygen atoms and will increase the Fe – oxygen distances.
The parameters that were optimized simultaneously and the constants that were set
beforehand are summarized in Table 6-5.
Table 6-5: DOMMIMOE parameters modified for ferric tris-hydroxamates.
Question marks represent unknown values or values that need to be found.
Parameter name Description Value set
Fe+3 – O= Fe to carbonyl oxygen bond
r0 Optimal distance in Morse function ?
All Ligand-ligand repulsion term ?
α Curvature parameter in Morse function 1.5
D Depth parameter in Morse function 60
n Ligand-ligand repulsion term 6
Fe+3 – OM Fe to carbonyl oxygen bond
r0 Optimal distance in Morse function ?
All Ligand-ligand repulsion term ?
α Curvature parameter in Morse function 1.5
D Depth parameter in Morse function 60
n Ligand-ligand repulsion term 6
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6.5.3.3 : Partial charges
Another part of molecular model which has to be specified is its partial charges, in
particular around the metal centre. The forcefield MMFF94 assigned partial charges
between main group elements, which were not altered, but the charges around the Fe
atom had to be specified. In metal complexes there is usually a highly charged metal
cation surrounded by anionic or neutral ligands, and there is an issue in how much
donation of electron density there is from the negatively charged ligands to the
positively charged metal. Initially, a charge scheme based on natural charges given
by the Jaguar quantum mechanical program108 was used for the ferric-tris-
hydroxamates, but suitable parameters could not be found by the parameter
optimizing procedures explained later. Instead, the forcefield charges assigned by
MMFF94 were used, with an extra bond charge increment term to decrease the
positive charge on Fe(III) (Table 6-6).
Table 6-6: Charge schemes used in the parameterization of the MMFF94 forcefield of ferric-
tris-hydroxamates in DOMMIMOE.
MMFF94
atom type
Description Jaguar-based
partial charge
scheme
Bond charge
increment scheme
Fe+3 Fe3+ ion 2.400 1.350
OM oxime oxygen -0.712 -0.512
O= carbonyl oxygen -0.670 -0.470
NC=O oxime nitrogen atom in Fe(hydr)3 -0.418 -0.468
NC=O oxime nitrogen atom in
Fe(Nmhydr)3
-0.348 -0.398
C= carbonyl atom 0.569 0.569
HN2 hydrogen atom attached to oxime
nitrogen (only in Fe(hydr)3)
0.370 0.370
6.5.4 : Parameter optimization by simulated annealing
In this study four parameters in DOMMIMOE were optimised: r0 and All for Fe –
O=, and r0 and All for Fe – OM, which was sufficient to recover a suitable
parameterization such that the DFT geometries of the fac isomers of Fe(hydr)3 and
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Fe(Nmhydr)3 were reproduced accurately and also the energy difference between the
absolute energies of these complexes were 5-6 kcal/mol less than their C3v
minimized geometries as in DFT. This was achieved by running a series of SVL
scripts to find the parameters that optimized a cost function which was minimal
when the MM geometries matched the DFT structures and the absolute energy
difference between these geometries and their C3v structures were close to 5
kcal/mol.
6.5.4.1 : Comparison of structures obtained by DOMMIMOE and DFT
From a given set of parameters it was necessary to obtain some measure of how the
DOMMIMOE structures compared against the DFT structures. The most common
indicators are the many bond lengths, internal bond angles, external bond angles and
torsion angles needed to be matched, but this was difficult to implement. Another
more straightforward way was to superimpose the structures at the Fe atom to obtain
a measure of fit. This was straightforward to implement as MOE has an internal
function called Superpose which did this process by finding the optimal
superposition by minimizing the mean square deviation (MSD) between the atom
positions in the two molecules. The Superpose function accepted two different
structures of the same molecule and produced a smaller number if the structures fit
better. A value of 0 from Superpose was indicative of a perfect match of geometries.
6.5.4.2 : Optimizing C3v structures in DOMMIMOE
The optimization of the unsymmetrical structures by DFT in DOMMIMOE was
obtained by using the DOMMIMOE_Minimize function. As DOMMIMOE had no
inbuilt symmetry-restricted structure optimization of C3v structures analogous to
ADF, the DOMMIMOE_Minimize function was used again but with the Fe and
surrounding oxygen atoms were fixed to stop the minimization to an “octahedral”
structure. Due to the artificial “fixing” of seven atoms in the system in
DOMMIMOE, the C3v structures obtained was not compared to those obtained by
DFT.
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6.5.4.3 : Structure of the cost function
The two requirements of the cost function were that it was minimal when the
minimal DOMMIMOE structures of fac Fe(hydr)3 and fac Fe(Nmhydr)3 matched the
geometries obtained by DFT, and the absolute energy difference between the
minimized and C3v structures of fac Fe(hydr)3 and fac Fe(Nmhydr)3 in DOMMIMOE
were the same as DFT. The structure of the cost function C is given in Equation 1.
The optimization the DOMMIMOE parameters of simple ferric-tris-hydroxamates
was reduced to minimizing the cost function C.
Equation 1: The structure of the cost function C used in parameter optimization.
Fe(hydr)3MOE and Fe(hydr)3DFT represent the minimal structures of Fe(hydr)3 in DOMMIMOE
and DFT respectively. E(Fe(hydr)3MOE) and E(Fe(hydr)3C3v) represent the absolute energy of the
minimal and C3v structures in DOMMIMOE in kcal mol-1 respectively. αand βare arbitrary
constants.
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6.5.5 : MCMC and simulated annealing
There are many different methods and algorithms which could be used to minimize a
cost function, whose suitability depends on a number of factors. Simulated
annealing is commonly used class of algorithms to find suitable parameters to
minimize a cost function; especially suitable if the parameter space contains many
local minima or has an unknown distribution. It uses the results of Markov Chain
Monte Carlo (MCMC) which is used by statisticians and other disciplines to find out
information about unknown distributions.
6.5.5.1 : Theory of MCMC
MCMC is a way of sampling an unknown distributionπ(x) by performing a “random
walk” on it. Strictly, the distribution should be a probability density function whose
area or sum is identical to one, but the results are applicable to positive distributions
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(i.e. π(x) > 0). In MCMC109, one constructs an ergodic Markov Chain that has a
limiting distribution π(x). In the case of simulated annealing, this is done by an
algorithm called the Metropolis-Hastings sampler109, whose principle is summarized
below.
1. Choose a starting point x
2. Choose a next state y from a proposal distribution q(x,y), so-called as it
suggests the next step in the Markov Chain. q can be any distribution, but in
the case of simulated annealing and many other MCMC algorithms this is a
uniform distribution.
3. Accept y as the next step with probability α(x,y) = },1min{ )(
)(
y
x

 if q(x,y) =
q(y,x). This is known as the Metropolis criteria. The interpretation of this
is: if y<x then accept the new step, otherwise accept the step with probability
π(x)/π(y).
4. If y is accepted, then let y be the next step of the Markov Chain. Otherwise
let x be the next step.
5. Repeat steps 1-4
6.5.5.2 : Simulated annealing
In simulated annealing, the parameter space is explored by an ergodic Markov chain
which has a tendency to move ‘downhill’. To minimize the cost function )(xC ,
starting from x, another move x’ is proposed from a uniform distribution U[x – VM, x
+ VM]. VM is the maximum stepsize, and is adjusted such that the steps in the
Markov chain are not too big or small. If )()'( xCxC  then let x’ be the next step,
otherwise accept x’ to be the next step with probability
T
xC
xC /1
)'(
)( where 10 T .
Downhill moves are always accepted; uphill moves can be accepted, but less so the
larger the uphill step proposed is.
The temperature factor T is the key concept in simulated annealing. At the start of
the optimisation T is set to 1 (the Markov chain is trained on C(x) initially), but
decreases as it progresses. Before a change of T, the algorithm starts from x such
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that C(x) was minimal. A smaller T reduces the chance of accepting larger steps, and
as T decreases the calculation is hoped to settle at the global minimum (Figure 6-4).
A FORTRAN-based simulated annealing algorithm110 was translated into SVL to
minimize the penalty function ),,,C( 00
OMFe
ll
OMFeOFe
ll
OFe ArAr  within the bounds
given in Table 6-7. When using the charge scheme based on the natural charges
suggested by the Jaguar quantum mechanical program, the energy difference
between the octahedral and C3v structures were too high in DOMMIMOE compared
to the DFT difference although the geometry fits were almost perfect. Attempts to
find parameters which reproduced the energy difference involved introducingαand
D terms into the penalty function in the simulated annealing to increase the
flexibility of the parameter search. Eventually, the problem was solved by using the
MMFF94 charge scheme with bond-charge increments.
Table 6-7: Bounds of the simulated annealing parameter optimization.
Parameter name Bounds
Fe+3 – O=
r0 1 < x < 3
All 500 < x < 20000
Fe+3 – OM
r0 1 < x < 3
All 500 < x < 20000
6.5.6 : Results of simulated annealing
After the optimization (whose parameters are summarized in Table 6-8), the
geometries and energy differences of DOMMIMOE compared to the DFT
calculations were good (Table 6-9). The slightly higher RMSD value for
Fe(Nmhydr)3 compared to Fe(hydr)3 was due to the rotation of the three hydrogen
atoms on the extra methyl groups on the nitrogen due to the forcefield.
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Table 6-8: Table of parameters found by simulated annealing applied on a penalty function
given by Equation 1.
Parameter name Value
Fe+3 – O=
r0 2.050
All 2504
Fe+3 – OM
r0 1.986
All 1505
Table 6-9: The performance of the parameters found by simulated annealing.
Complex MSD (RMSD) of
DOMMIMOE
from DFT
structure (Å)
DOMMIMOE Energy
difference from C3v
structure kcal mol -1
DFT Energy
difference from C3v
structure kcal mol-1
Fe(hydr)3 0.03341
(0.1828)
6.358 6.29
Fe(Nmhydr)3 0.23918
(0.4891)
5.962 5.83
6.5.7 : Parameter Refinement
Although DFT structures compared very well with X-ray crystallographic structures,
they were not exact. For example, DFT overestimated the Fe – O bond lengths in
both facial and meridional isomers of Fe(hydr)3 by 0.06 Å from the X-ray
crystallographic structure by Failes and Hambley71. Hence, a parameter refinement
was performed against 23 X-ray crystallographic structures of mononuclear ferric
tris-hydroxamates (given in Appendix table 2). This required construction of a new
cost function C’(x), which was the MSD between the X-ray structures and their
DOMMIMOE minimized counterparts, calculated again using the internal
Superpose function that calculates the RMSD between two structures (Equation
2). As a local optimization of parameters was required, Nelder-Mead simplex
optimization was performed instead of simulated annealing, which was faster.
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Equation 2: Cost function C’ for parameter refinement by simplex optimization.
The terms structureX-ray and structureMOE represent the X-ray structure in the database and its
DOMMIMOE minimized structure respectively.
],[)(' MOErayX
24
1
structurestructurexC
structure


 Superpose
6.5.7.1 : Nelder-Mead simplex optimization
The Nelder-Mead simplex method111 is a commonly used nonlinear optimization
algorithm for minimising an objective function in a many-dimensional space. It is a
rather robust algorithm and is rather fast at converging to minima, but does not
explore the parameter space very effectively, hence is likely to converge to local
minima. As only a little parameter refinement is needed and evaluating the new cost
function takes approximately 2 minutes (from the time take to minimize 23 ferric
tris-hydroxamate structures in DOMMIMOE) compared to 5 seconds with the
previous cost function, a method which explored local parameter space plus did not
require as many penalty function evaluations as simulated annealing .
The algorithm starts from a point x1 in n-dimensional parameter space. Then a
simplex of n+1 vertices in n dimensions is constructed, for example, if x1 is two
dimensional then two other points are chosen nearby x2 and x3. In the two-
dimensional case the simplex is a triangle. The cost function is evaluated at these
points and depending on its values the triangle is reflected, extended or contracted
until a minimal or maximal triangle of points is constructed, depending if the
function needs to be minimized or maximized respectively. The optimization on the
cost function ),,,(C' 00
OMFe
ll
OMFeOFe
ll
OFe ArAr  was a four-dimensional problem
hence a five-dimensional simplex was constructed.
The simplest step is to replace the worst point with a point reflected through the
remaining N-1 points considered as a plane. If this point is better than the best
current point, then the algorithm will try to stretch out exponentially along this line.
On the other hand, if this new point is not much better than the previous value then
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the algorithm shrinks the simplex towards the best point, as there is a ‘valley’
between the worst and new points which required exploration (Figure 6-5). The
algorithm was translated into SVL from the MATLAB code of the fminsearch.m
function.
Figure 6-4: The concept of simulated annealing.
The curve represents an unknown distribution such as a cost function with multiple minima. A
Markov chain is trained onto the curve to explore the state space. After multiple iterations, the
Markov chain is started onto the minimum encountered so far, but with the simulated
annealing temperature T reduced, which has the effect of making the state space ‘steeper’,
keeping the chain around the minima. This process is repeated until a minima is reached,
which hopefully will be the global minimum.
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1. 2.
3. 4.
Figure 6-5: Simplex optimization in two dimensions.
In this example, parameter space is in two dimensions. (1) The initial simplex is a triangle,
where x1, x2 and x3 represent initial guesses to the minimum of the cost function C(x). For
instance if C(x1)≤C(x2)≤C(x3) i.e. x3 is the worst point, then a reflection of x3 off the line x1x2 is
computed, xr. (2) If C(xr) < C(x1) i.e. xr is the current minimum then an extension along the line
x3xr is computed. If C(xe) < C(xr) make new simplex with x3 replaced by xe otherwise replace
with xr. (3) If C(xr) > C(x2) then a contraction is performed towards the line x1x2. If C(xc) <
C(x3) then reject x3 for xc in the new simplex. (4) If C(xr) > C(x3) i.e. xr is the worst point then
shrink the simplex to x1. The process is repeated on the new simplex until it is sufficiently small.
(Bottom) An example path to a minimum by the Nelder-Mead simplex algorithm.
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6.5.7.2 : Results of Parameter Refinement
The parameter search took approximately 36 hours on the 3.0 GHz system as
described in the Experimental section, and are given in Table 6-10.
Table 6-10: Table of parameters found after parameter refinement via 23 X-ray crystal
structures of the parameters found by simulated annealing
Parameter name Parameter found
Fe+3 – O=
r0 1.9860
All 2151
Fe+3 – OM
r0 1.9251
All 1375
To demonstrate the performance of these parameters on the modelling of ferric-tris-
hydroxamates, the bond lengths, bite angles and trigonal twist RMSDs around the
metal centre against the 23 X-ray crystal structures in the database were calculated.
This is summarized in Appendix Table 0-3.
6.6 : Performance of parameters
6.6.1 : Fe – O bond lengths
The Fe – O (carbonyl) bond lengths were overestimated by on average 0.0011 Å by
DOMMIMOE compared to the X-ray crystal structures, with standard deviation of
0.016 Å. The root mean squared deviation (RMSD) of these bond lengths was 0.017
Å on average. The Fe – O (oxime) bond lengths were underestimated on average
0.0018 Å by DOMMIMOE, with standard deviation 0.016 Å. The RMSD of these
bond lengths was 0.017 Å on average.
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6.6.2 : O – Fe – O bite angles in the same hydroxamate
The O(carbonyl) – Fe – O(oxime) bite angles were overestimated by 0.02° by
DOMMIMOE compared to the X-ray crystal structures, with standard deviation 0.8°.
The RMSD of these bond angles was 0.7° on average.
6.6.3 : Trigonal twists
The trigonal twist (see section 6.3.1) was the main distortion amongst ferric-tris-
hydroxamates. The parameterization of DOMMIMOE overestimated the trigonal
twists of the crystal structures on average by 5.4°, with standard deviation 3.8°,
whose interpretation is that DOMMIMOE makes the ferric complex more
“octahedral” than the X-ray crystallographic structure. There was much local
variation: the trigonal twist difference between the DOMMIMOE and X-ray crystal
structure of fac ferric-tris-acetohydroxamic acid71 (SUXREI) and ferrioxamine E104
(FEROXE10) was only 3.7° and 4.3° respectively, whilst ferricrocin112
(FERCRN10) and tris(Benzohydroxamato-O,O')-iron(iii)71 (FEBOAH02) had a
difference of 5.7° and 12.2° respectively. The trigonal twists of the mer complexes
COFDIK10113 (neocoprogen I) and meridional ferric-tris-acetohydroxamic acid
were overestimated on average 0.7° and 9.3° respectively. The RMSD of the twist
angles was 6.6° on average.
6.6.4 : Superposition of DOMMIMOE and X-ray structures
To demonstrate the performance of the DOMMIMOE parameters, the minimized
structures were superimposed onto the original X-ray crystal structures, with the Fe
atom set at the centre (Table 6-11). The superpositions of fac- and mer- Fe(hydr)3,
ferrioxamines E and B and ferrichrome show a very good correspondence between
the DOMMIMOE and crystal structures, and even in ferricrocin (FERCRN10) and
tris(Benzohydroxamato-O,O')-iron(iii) (FEBOAH02) where the discrepancy between
the trigonal twists are large, the structures show reasonable correspondence.
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Table 6-11: Superposition of seven X-ray ferric tris-hydroxamate structures with the
DOMMIMOE optimized structures, with the superposition centred on the Fe(III) ion and its
surrounding oxygen atoms.
Yellow – X-ray structures, Blue – DOMMIMOE optimization; lighter colours – Fe and
neighbouring oxygen atoms.
Name and CCSD
Refcode
DOMMIMOE/ X-ray structure superposition
SUXREI
(fac- Fe(hydr)3)
SUXREI
(mer- Fe(hydr)3)
UNEWAL
(Ferrioxamine B)
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FEROXE10
(Ferrioxamine E)
FERRID10
(Ferrichrome)
FEBOAH02
tris(Benzohydroxamato-
O,O')-iron(iii)
FERCRN10
(Ferricrocin)
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6.7 : Geometry scans
6.7.1 : Stretch strain energies of Fe(hydr)3 and Fe(Nmhydr)3 in DOMMIMOE
compared to DFT
To test whether stretching distortions could be modelled by DOMMIMOE, the
ligands of the complexes Fe(hydr)3 and Fe(Nmhydr)3 - in particular the centroids of
the hydroxamate groups - were systematically shifted away or towards the Fe atom
in 0.05 Å increments (Figure 6-6), and the single point energy (without
minimization) was taken in DOMMIMOE and in ADF. The absolute energy of the
minimal complex was subtracted from the single point energies and graphed to
illustrate a “stretching strain energy” as the ligands move towards or away from the
minimal structure (Figure 6-7). The curves show excellent agreement.
Fe
O
O
O
OO
O
Fe
O O
O O
O
O
Figure 6-6: Diagram showing the adjustment of the hydroxamate ligands in the measuring of
the stretch potentials.
The ligands were systematically moved towards or away from the Fe atom by moving the
centroid of the hydroxamates.
6.7.2 : Trigonal distortion strain of Fe(hydr)3 and Fe(Nmhydr)3 in
DOMMIMOE compared to DFT
To test whether the energies required for trigonal distortion could be modelled by
DOMMIMOE, geometries of the complexes of the facial isomers of Fe(hydr)3 and
Fe(Nmhydr)3 were constructed where their trigonal twists approached zero (Figure
6-8). This was achieved by rotating the hydroxamate ligands about their Fe –
centroid axes in increments of 0.05 radians to 0.6 radians, and their single point
energies recorded and subtracted from the minimal geometry energy to calculate a
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“trigonal distortion strain energy”. A similar process was also carried out in DFT,
using the DFT minimized Fe(hydr)3 and Fe(Nmhydr)3 as a starting point (Figure
6-9).
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Figure 6-7: The difference in absolute DFT/ DOMMIMOE energies from optimal geometries
when each hydroxamate ligand is extended simultaneously
(Top) Fe(hydr)3 ; (Bottom) Fe(Nmhydr)3
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For Fe(hydr)3, the DOMMIMOE energy differences of these trigonally distorted
complexes from the minimal geometry closely matched those from DFT calculation,
with the difference between optimal and trigonal prismatic geometry (ligand rotation
0.55 radians; trigonal twist 2°) for both DOMMIMOE and DFT being 31 kJ mol-1
(7.3 kcal mol-1). The offset between the maximum of the DOMMIMOE and the
DFT curves comes from the fact that the optimal geometry of the DFT structure
(trigonal twist 43°) was more trigonally distorted than the DOMMIMOE structure
(trigonal twist 48°), hence less rotation of the ligands was required to achieve
greatest energy difference at trigonal twist close to zero.
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Figure 6-8: Diagram showing the adjustment of the hydroxamate ligands in the measuring of
the trigonal twist potentials.
The ligands were rotated about the Fe-centroid axes towards a trigonal prismatic geometry.
This was also the case for Fe(Nmhydr)3 up to a rotation of 0.3 radians. This
corresponded to a trigonal twist of 24.6°, lower than the trigonal twists observed in
the X-ray crystal structures. As the trigonal twist of Fe(Nmhydr)3 tended to zero, the
difference between DFT and the DOMMIMOE energies from optimal geometries
increased to 5.67 kJ mol-1 (1.4 kcal mol-1), hence the difference between the optimal
and trigonal prismatic geometry for DOMMIMOE and DFT was about 31.9 kJ mol-1
and 25.4 kJ mol-1 respectively (a difference of 6.5 kJ mol-1).
In consideration of using this model in molecular dynamics simulations, it is
important to note what energy barriers are needed to be overcome to form the twisted
structures of ferrioxamine B found bound to siderophore-binding proteins such as S.
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coelicolor DesE and E. coli FhuD. This difference between the energies of 6.5 kJ
mol-1 is relatively insignificant.
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Figure 6-9: The difference in absolute DFT/ DOMMIMOE energies from optimal geometry
when each hydroxamate ligand twisted simultaneously about their centroids towards a trigonal
prismatic geometry.
(Top) Fe(hydr)3; (Bottom) Fe(Nmhydr)3.
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6.8 : Comparison with other models
The Fe – O bond lengths and O – Fe – O bite angles obtained by this
parameterization for Fe(hydr)3 performed better than the study by Zinelabidine et
al.103 as demonstrated by Table 6-12. The forcefield produced was trained to
replicate the crystal structure of ferrioxamine E as there was no structure available
for Fe(hydr)3. For instance, the Fe – O carbonyl distance was on average 0.048 Å
less than those given in X-ray crystal structures compared to 0.011 Å in
DOMMIMOE. Also the bite angle O(N) – Fe – O(C) was 3.4° greater than the
reference X-ray crystal structure, where the same figure is 0.2° for DOMMIMOE.
The model constructed by Herrera et al.105 was even worse at reproducing the
geometries of Fe(hydr)3 and Fe(Nmhydr)3 (Table 6-13), with Fe – O(carbonyl) bonds
underestimated by 0.18 Å, and the bite angle overestimated by 7.8° and 11° in the
case of Fe(hydr)3 and Fe(Nmhydr)3 respectively, implying that the oxygen atoms
around the central Fe(III) ion were almost octahedral, which is not the case in the X-
ray crystal structures of Fe(hydr)3 or ferrioxamine E.
Table 6-12: Comparison of the Fe – O bond lengths and angles of the crystal structure of
Fe(hydr)3, ferrioxamine E, and Fe(hydr)3 optimised with DOMMIMOE and the method of
Zinelabidine et al103
X-ray
Fe(hydr)3
71
DOMMIMOE
Fe(hydr)3
X-ray
(Ferrioxa
mine E)104
Zinelabidine et
al. 103
Fe(hydr)3
Average Fe- O(C)
bond length (Å)
2.056 2.045 2.055 2.007
Average Fe-O(N)
bond length (Å)
1.970 1.984 1.952 1.941
Average O(C)–
Fe–O(N) angle (°)
79.7 79.5 78.9 82.3
Another test of the model of Herrera et al. was measuring the energy difference of
fac and mer isomers of Fe(Nmhydr)3. In DFT, the energy difference was 4.0 kcal
mol-1, with the mer isomer being higher in energy, whilst their model gave a value of
3.6 kcal mol-1, which was surprisingly close to the DFT value. The DOMMIMOE
model gave a value of 0.7 kcal mol-1, with the fac isomer being higher in energy, in
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contrast to the DFT results. In this respect the DOMMIMOE model performed less
well than the model of Herrera et al.
Table 6-13: Comparison of the Fe – O bond lengths and angles of the crystal structure of
Fe(hydr)3, DFT structure of Fe(Nmhydr)3, and Fe(hydr)3 optimised with DOMMIMOE and the
method of Herrera et al.
Fe(hydr)3
X-ray 71 DOMMIMOE Herrera et al.105
Average Fe-O(C)
bond length (Å)
2.056 2.045 1.880
Average Fe-O(N)
bond length (Å)
1.970 1.984 1.874
Average O(C)-Fe-
O(N) angle (°)
79.7 79.5 87.5
Fe(Nmhydr)3
DFT DOMMIMOE Herrera et al.105
Average Fe-O(C)
bond length (Å)
2.10 2.042 1.875
Average Fe-O(N)
bond length (Å)
2.00 1.977 1.841
Average O(C)-Fe-
O(N) angle (°)
77.6 79.2 88.5
6.9 : Future work
The molecular model parameterization found would be ideal to predict the structure
of novel siderophores. A similar parameterization for Ga(III)-hydroxamates was
used to solve the structure of the novel siderophore coelichelin in complex with
Ga(III)52. This was achieved by the construction of isomers of the tetrapeptide
coelichelin with Ga(III) in DOMMIMOE, and their interatomic distances were
compared with those calculated by two-dimensional NMR data of gallium-
coelichelin.
The molecular dynamics function developed recently would be ideal to model the
interaction of the S. coelicolor protein DesE with different ferri-siderophores, with
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the recently solved structure of the DesE-ferrioxamine B complex could be used as a
starting point. Ferrioxamine B was found in a “twisted” conformation in complex
with DesE and also with E. coli FhuD (although this protein is not a strong binder to
this siderophore) unlike that found in ferrioxamine B crystallized without proteins72.
The flexibility of siderophores has successfully been taken into account by
consideration of the trigonal twist.
The DOMMIMOE model could be used to predict the binding of this protein with
other ferri-siderophores. The ferrioxamine B in the crystal structure could be
replaced by models of ferri-siderophores tested by the fluorescence quenching assay
to determine if important electrostatic and hydrogen bonding networks between the
amino acid residues and siderophore could be identified, plus whether the
dissociation constant of the receptor-siderophore complex could be estimated
computationally using molecular dynamics in DOMMIMOE.
The other two proteins implicated in siderophore binding in S. coelicolor, CchF and
CdtB, are sufficiently similar to other crystallized siderophore periplasmic binding
proteins to produce homology models. CchF and CdtB have an amino acid identity
of 27%, with 44% positive alignments with S. coelicolor DesE and Bacillus subtilis
FeuA34 respectively. These models could be used as suggested with DesE to find the
main factors that lead to their selective binding of ferric-siderophores.
6.10 : Conclusions
A molecular model of ferric-tris-hydroxamates has been constructed in
DOMMIMOE, which accurately reproduced bond lengths and angles of X-ray
crystal structures around the Fe(III) centre, but slightly overestimated the trigonal
distortion in these complexes. A range of techniques have been used to find the best
parameterization, such as the utilization of structural and energetic information from
DFT calculations, SVL programming, simulated annealing and Nelder-Mead
simplex optimization. The stretching and twisting of ferric hydroxamate ligands in
model complexes have shown this model may be able to model the flexibility of
these complexes, and would be more than adequate to use in molecular dynamics
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simulations, in particular to model the binding of ferric hydroxamate siderophores to
siderophore binding proteins.
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Chapter 7: Summary, conclusions and future work
7.1 : Summary and Conclusions
7.1.1 : Purification and characterization of three siderophore-binding receptor
proteins of Streptomyces coelicolor A3(2)
The main aims of this study were to overproduce and purify the three siderophore-
binding receptor proteins DesE, CchF and CdtB of Streptomyces coelicolor A3(2) in
Escherichia coli, and to assess their ability to bind to cognate ferri-siderophores by
monitoring the decrease of the fluorescence of the proteins upon ligand binding.
Initially, the full-length DesE, CchF and CdtB proteins were overproduced in E. coli
with a hexahistidine tag appended to their native N-termini. All three proteins were
overproduced in a soluble form, and two were purified by immobilized metal-affinity
chromatography (IMAC). CchF, whose His-tag was most probably cleaved by the
TAT translocase machinery of E. coli, could not be purified by this method. The
other proteins, DesE and CdtB, dimerized very strongly, as indicated by denaturing
SDS-PAGE and size-exclusion chromatography (gel filtration).
New plasmids were constructed for the expression of 5’-truncated desE, cchF and
cdtB genes in E. coli. These encoded the recombinant proteins DesE, CchF and
CdtB without the hydrophobic N-terminal signal sequences and lipidation sites. All
three proteins were overproduced in soluble form and purified by Ni-IMAC. DesE
and CdtB were monomeric, whereas CchF was found to dimerize (using gel
filtration). This CchF dimer was dissociated by incubation at 37 °C. The N-terminal
His-tags were removed from the proteins using tobacco etch virus (TEV) protease.
The identity of the purified proteins was confirmed by peptide mass fingerprinting
and ESI-MS analysis.
Circular dichroism analysis of the three proteins showed that two of them, DesE and
CchF, were fully folded, whilst CdtB was up to 25% unfolded. This may explain the
larger apparent molecular weight (corresponding to a larger hydrodynamic radius) of
this protein indicated by gel filtration than the more massive proteins DesE and
CchF.
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7.1.2 : Intrinsic fluorescence quenching of proteins by ferri-siderophore
binding
Solutions of ferri-siderophores were prepared and their concentrations were
determined by inductively coupled plasma optical emission spectroscopy (ICP-
OES). Ferri-coelichelin was purified from iron-deficient cultures from Streptomyces
coelicolor using reverse-phase HPLC, utilising a modification of the method of
Lautru et al52, to produce gallium-coelichelin, whose purity was examined by 1H
NMR spectroscopy. Ferri-coelichelin was made by adding an excess of FeCl3 to
gallium-coelichelin.
Solutions of the proteins DesE, CchF and CdtB showed significant decreases in their
intrinsic fluorescence upon addition of low concentrations of certain ferric
siderophores. Dissociation constants were calculated from the fluorescence
quenching data by fitting to a one-site binding curve using the equations of
Ahnstrom et al85 in the software package ORIGIN86.
DesE was found to bind the cognate siderophores ferrioxamine B and ferrioxamine E
with dissociation constants in the nanomolar range, but did not bind ferri-coelichelin
with nanomolar affinity. DesE also bound the hydroxamate xenosiderophore
ferrichrome with nanomolar affinity, but ferri-albomycin bound more weakly. CchF
bound ferri-coelichelin only, whilst CdtB was found to bind ferrioxamine B and
ferri-coelichelin with nanomolar affinity. None of the proteins studied bound the E.
coli siderophore ferri-enterobactin, nor did the desferri-siderophores enterobactin,
desferri-ferrichrome, and desferrioxamines E and B.
When CdtB was left to stand at room temperature in solution, the fluorescence
decreased steadily, likely to be due to its instability. Despite this, the dissociation
constants of ferrioxamine B and ferri-coelichelin from CdtB were in the nanomolar
range even when it was assumed that only 75% of the protein was folded.
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7.1.3 : X-ray crystal structures of DesE and DesE-ferrioxamine B
The X-ray crystal structures of apo-DesE and DesE-ferrioxamine B were determined
by our collaborators, at the University of St. Andrews. The co-complex crystal
structure confirmed the specific nature of the binding of ferrioxamine B to DesE, as
suggested by the fluorescence quenching data. Also, little conformational change
was observed in DesE on substrate binding, which was also seen in other
siderophore binding proteins.
Analysis of the DesE-ferrioxamine B structure found several aromatic residues
around the ferri-siderophore binding site, explaining the large quenching of the
intrinsic fluorescence of DesE upon ferrioxamine B binding. An important
hydrogen-bonding interaction of an arginine residue with the hydroxamate groups
surrounding the ferric iron centre of ferrioxamine B was identified. Also,
ferrioxamine B adopted an unusual configuration never observed before in X-ray
crystal structures of this ferri-siderophore.
7.1.4 : Construction of a molecular model of ferric-tris-hydroxamates
Another aim of the project was to construct a molecular model for ferric-tris-
hydroxamate complexes (including ferric-tris-hydroxamate siderophores) using the
molecular mechanics program DOMMIMOE. This involved parameterization of the
program such that it reproduced the geometries observed in X-ray crystallographic
structures of ferric-tris-hydroxamates, with energetic information from quantum
mechanical calculations on simple ferric-tris-hydroxamates to incorporate the
trigonal twist, the main distortion of these complexes seen in the crystal structures.
A suitable parameterization was found by applying the techniques simulated
annealing and Nelder-Mead simplex optimization to a cost function whose value was
minimal if the geometries and energies produced by the program were close to the
desired values.
The bond lengths around the metal centre observed in the X-ray crystal structures
were accurately reproduced, as well as the ligand bite angle. The estimation of
trigonal twist in X-ray crystallographic structures was less successful, with the
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molecular model overestimating this by on average 5.4°. The model was more
successful in predicting the quantum mechanical energies required to deform simple
ferric-tris-hydroxamates by stretching and rotation of the ligands – the latter to
imitate trigonal distortion of the complexes.
7.2 : Conclusions and future work
7.2.1 : Revised model for cognate siderophore uptake in Streptomyces coelicolor
A3(2)
From the results of this study and the results of Barona-Gómez et al.53, a revised
model of ferri-siderophore uptake in S. coelicolor is proposed in Figure 7-1.
? CdtA CdtA CchC CchD
? CdtC CchE
DesE
?
CdtB CchF
Ferrioxamine E Ferrioxamine B Ferri-coelichelin
Ferrichrome
Albomycin?
Ferrioxamine E
Ferrioxamine B
Ferrichrome
Ferrioxamine B
only Ferri-coelichelin
Key
ATPase
permease
lipoprotein
receptor
Figure 7-1: Proposed uptake pathways for ferri-siderophores in S. coelicolor.
Ferrioxamine E is transported into S. coelicolor cells via the lipoprotein receptor
DesE, through an as yet unidentified permease component of an ABC transporter
system. Most probably, ferrioxamine B can also use this route due to the ability of
DesE to bind this siderophore, the structural similarity of ferrioxamine B to
ferrioxamine E and the fact that S. coelicolor mutants lacking the cdt gene cluster
appear to be able to uptake ferrioxamine B59.
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The CchF lipoprotein can only bind ferri-coelichelin. Hence the ABC transporter
consisting of CchF, the permeases CchC and CchD, and ATPase CchE, can only
transport ferri-coelichelin. This suggests that the cch cluster, which is also found in
S. ambofaciens, encodes a complete siderophore biosynthetic-export-uptake
pathway, that can uptake iron via coelichelin independently of other siderophore
biosynthesis-export-uptake systems.
The specificity of CdtB for ferrioxamine B suggests the cdt cluster is involved in the
uptake of this ferri-siderophore. CdtB had surprisingly relatively little affinity for the
structurally very similar ferrioxamine E, demonstrating remarkable substrate
discrimination by this protein. This may indicate different modes of binding of
ferrioxamine B to CdtB and DesE. The role of the cdt gene cluster in ferrioxamine B
uptake warrants further investigation by deletion of the cdt and des clusters in the
same strain of S. coelicolor, and conducting uptake experiments with radiolabelled
ferrioxamine B, as well a growth promotion experiments in iron-deficient media
supplemented by desferrioxamine B.
The nanomolar dissociation constant of ferri-coelichelin-CdtB complex was
surprising, because the cchCDEF genes were found to be necessary for growth of
coelichelin non-producing mutants supplemented by ferri-coelichelin53, and not the
cdt cluster. Hence at least some of these genes were required for efficient ferri-
coelichelin uptake. The fate of CdtB-ferri-coelichelin could be investigated by
growth or uptake assays with ferri-coelichelin involving non-siderophore producing
mutants of S. coelicolor with the cdtB and cchCDE genes present to see whether the
permease-ATPase genes in the cch cluster can release and transport ferri-coelichelin
from CdtB (Figure 7-2).
It is possible that actually CdtB does not bind to ferri-coelichelin at all, and the
observed binding was due to the instability of the protein. For instance, the protein
may unfold slightly and ferri-coelichelin would be able to bind to the modified
binding pocket, whilst the stable protein in S. coelicolor is unable to unfold to
accommodate ferri-coelichelin. This could be investigated by comparing the kinetics
of the formation of the CdtB-ferri-coelichelin to CdtB-ferrioxamine B complexes to
see whether there are several steps involved in ferri-coelichelin binding than for
PhD. Thesis: Prakash Patel Chapter 7: Summary, conclusions and future work
153
ferrioxamine B binding, or by solving the structure of CdtB-ferri-coelichelin by X-
ray crystallography.
CdtA CdtA CchC CchD
CdtC CchE
CdtB CdtB
Ferri-coelichelin
Figure 7-2: Possible fate of CdtB-ferri-coelichelin?
CdtB was found to bind ferri-coelichelin strongly, but the cch cluster was found to be necessary
for growth of siderophore non-producing mutants supplemented with ferri-coelichelin. CdtB
may substitute for CchF in uptake of this siderophore.
7.2.2 : Xenosiderophore uptake in S. coelicolor
The tight binding of the fungal siderophore ferrichrome to DesE and the evidence of
Barona-Gómez et al. that the des cluster was necessary for efficient growth with this
ferri-siderophore suggests the same transporter is used for uptake of ferrichrome and
ferrioxamine E.
The antibiotic albomycin (a ferrichrome analogue) binds to the DesE protein with
two orders of magnitude less affinity than ferrichrome. However, the bacterium is
not sensitive to this antibiotic. This may indicate two things: (1) the binding of
albomycin to DesE is not strong enough to allow efficient uptake, or (2) albomycin
can be taken up but is deactivated or exported. To answer this question, one needs to
determine whether albomycin can be taken up by S. coelicolor (uptake experiments
with radiolabelled albomycin) or whether it can be used as an iron source in wild-
type S. coelicolor and des cluster mutants.
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The double des and cch cluster mutant of S. coelicolor was found to grow well when
supplemented with the siderophore desferrioxamine G (an intermediate in the
biosynthesis of ferrioxamine E in S. coelicolor55) as with ferric coprogen and the E.
coli siderophore ferri-aerobactin. These are likely to be taken up by the cdt system
as is ferrioxamine B (ferrioxamine G has a very similar structure), but it would be
necessary to construct a siderophore non-producing mutant lacking the des and cdt
clusters and carry out further growth promotion experiments. One could estimate
dissociation constants for ferrioxamine G, ferric coprogen and ferri-aerobactin from
DesE, CchF and CdtB to determine if these lipoproteins can bind these ferri-
siderophores, but tight binding may not be indicative of siderophore transport as
appears to be the case with CdtB-ferri-coelichelin.
Other putative lipoprotein receptors may be involved in xenosiderophore uptake in S.
coelicolor; in particular SCO0996, SCO2272 and SCO7218 are strong candidates.
Recombinant expression and purification of these proteins could be accomplished in
a similar manner to those of DesE, CchF and CdtB. The main problem is that the
roles of these proteins in iron metabolism in S. coelicolor is unknown, and they have
not been observed in the membrane-bound proteome of S. coelicolor62,63.
7.2.3 : Modelling Fe-siderophore – siderophore-binding-protein binding
The X-ray crystal structures of apo-DesE and the DesE-ferrioxamine B complex
demonstrates that the conformation of DesE does not change on substrate binding
but the configuration of the substrate does. This highlights an important
consideration for modelling the binding of ferri-siderophores to siderophore-binding
proteins of bacteria – the dynamics of ferri-siderophore complexes have to be
modelled effectively.
In this study, a forcefield in the program DOMMIMOE73 that handles ferric-tris-
hydroxamates was constructed where trigonal distortion was sufficiently
implemented. Hence the energy needed to affect configurational change of
ferrioxamine B, for example, to allow binding to a siderophore-binding protein such
as DesE could be calculated. This model could be used with the molecular dynamics
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features of DOMMIMOE to calculate values such as dissociation constants and
absolute binding energies, to assist in trying to understand the molecular basis of
siderophore-SBP binding.
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Chapter 8: Experimental methods
8.1 : Buffers and General solutions
8.1.1 : Chemicals and Reagents
All chemicals which were used in this study were of AnalR or molecular biology
grade and were purchased from Sigma, Difco, Fisher or VWR unless otherwise
stated.
Molecular biology reagents were used as in the manufacturers’ guidelines. Distilled
water was used for all solutions and media unless stated otherwise. Sterilization was
achieved by autoclaving (121 °C, 20 min; Priorclave). Solutions unable to be
autoclaved were passed through disposable 0.2μm pore size cellulose acetate sterile
filters (Millipore).
8.1.2 : Instruments and Equipment
Electroporations were performed using a BIORAD Genepulser II electroporator.
Centrifugation was performed using Eppendorf centrifuge 5415D, Avanti J-555.
PCR reactions were performed on an Eppendorf Mastercycler personal thermocycler.
Other instruments used: Priorclave autoclave, Gen lab incubator, New Brunswick
Scientific C24KC refrigerated incubator shaker. Lyophilization was performed
using a VirTis Benchtop K freeze-dryer.
ESI-MS was performed on a Bruker micrOTOF machine and LC-MS performed
using an Agilent 1100 machine connected via a splitter to a Bruker Esquire HCTplus
ESI-MS-MS. Preparative HPLC was performed on a quad-pump Agilent 1100
series machine run by Bruker HyStar software.
8.1.3 : Agarose Gel Electrophoresis buffers
2x TBE stock solution buffer was prepared using a standard protocol80. 10x gel
loading buffer was prepared with glycerol (30% in H2O), bromophenol blue (0.25%),
xylene cyanol FF (0.25%) using a standard protocol80.
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Agarose electrophoresis gels between 1% and 1.25% (w/v) were prepared from
electrophoresis grade LE agarose (SeaKem) and mixed with 1x TBE buffer. The
solution was heated by microwave until all the agarose had dissolved and ethidium
bromide (final concentration 2 μg/mL) was added and poured into the gel mould
with the appropriate gel comb and left to cool.
8.1.4 : Protein purification buffers
The protein buffers were prepared using distilled water and filtered in 0.22 μm
cellulose acetate filters before use and stored at 4 °C.
Washing buffer
10 mM Tris-HCl (pH 8.0), 100 mM NaCl, 20 mM imidazole, 10% v/v glycerol
Elution buffer
10mM Tris-HCl (pH 8.0), 100 mM NaCl, 300 mM imidazole,10% v/v glycerol
Gel Filtration buffer
10 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10% v/v glycerol
8.1.5 : Fluorescence buffers
All buffers for fluorescence measurements were prepared in HPLC grade water
filtered in 0.2 μm pore cellulose acetate filters (Millipore) before use to remove
small particles which may affect fluorescence.
Sodium Phosphate buffer (pH 7.0)
10 mM Na2(PO4)3 buffered with 0.1 M NaOH and 25% H3PO4 (v/v) .
Phosphate Buffered Saline (PBS) (pH 7.0)
10 mM Na2(PO4)3 buffered with 0.1 M NaOH and 25% H3PO4 (v/v) plus 100 mM
NaCl.
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8.1.6 : Chemical Stock Solutions
Stock solutions were prepared using the methods of Sambrook and Russell (Table
8-1)80
Table 8-1: Chemical stock solutions
Chemical Stock solution Solvent
Ethidium Bromide 10 mg/mL water
10% glycerol 10% v/v water
50% glycerol 50% v/v water
NaOH 10 M water
Ammonium persulfate 10% w/v water
IPTG (iso-pyrano thio-β-
galactosidase) (Melford)
1 mM water
8.1.7 : Antibiotic stock solutions
All antibiotic stock solutions were prepared using distilled water and filter-sterilised
by filtration (0.2μm filters, Millipore) before use (Table 8-2).
Table 8-2: Antibiotic stock solutions
Antibiotic Manufacturer Stock solution Working concentration
Ampicillin Melford 50 mg/mL 100 μg/mL (for 5 mL
overnight cultures and
LB Agar)
50 μg/mL (for protein
overproduction)
Kanamycin DUCHEFA 50 mg/mL 100μg/mL
Apramycin DUCHEFA 50 mg/mL 100μg/mL
Chlorophenamicol DUCHEFA 30 mg/mL 30μg/mL
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8.1.8 : Microbial strains and vectors
8.1.8.1 : Streptomyces strains
S. coelicolor M145, lacking the SCP1 and SCP2 plasmids present in S. coelicolor
A3(2), and S. coelicolor W2, a non-desferrioxamine B and desferrioxamine E
producing mutant of S. coelicolor M145, were used to produce coelichelin (Table
8-3).
Table 8-3: Streptomyces strains used in this study
Strain Genotype Description
Streptomyces
coelicolor M145
(wild-type)
SCP1-
SCP2-
Streptomyces coelicolor A3(2)
strain without plasmids SCP1
and SCP2
Streptomyces
coelicolor W253
SCP1-
SCP2-
desD::aac(3)IV
S. coelicolor M145 non-
desferrioxamine producing
mutant. Apramycin resistant.
Streptomyces
ambofaciens
ATCC23877
Streptomyces
longisporus ruber
8.1.8.2 : Escherichia coli strains
E. coli MC1061 (obtained from Professor G. Challis) and TOP10 (Invitrogen) were
used for general storage of plasmids. E. coli BL21star (DE3) (Invitrogen) was used
for the overproduction of proteins (Table 8-4).
Table 8-4: E. coli strains
Strain Genotype Description
Escherichia
coli MC1061
araD139 Δ(araA-leu)7697
ΔlacX74 galK16 galE15 e14-
mcrA0 relA1 rpsL spoT1
mcrB1 hsdR2 λ-
Plasmid-holding strain
E. coli
TOP10
F- araD139 Δ(ara-leu)7697
mcrA ΔlacX74 galK, Δ(mrr-
hsdRMS-mcrBC) deoR
recA1 rpsL endA1 nupG
galE15 galK16 λ-
Plasmid-holding strain supplied
by Invitrogen in TOPO kit
E. coli
BL21star
(DE3)
F- ompT hsdSB (rB
-mB-) gal dcm rne131 λ(DE3)
Overproducing strain supplied
by Invitrogen in TOPO kit.
Contains T7 polymerase.
E. coli F ompT hsdS + (rB Tobacco etch virus (TEV)
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BL21(DE3)-
RIL /
pRK793
-mB-)Terr gal λ(DE3) endA
Hte (argU ileY leuW Camr)
protease overproducing strain
of E. coli transformed with
plasmid pRK793. Kanamycin
and chloramphenicol resistant.
8.1.8.3 : Plasmids
Table 8-5: Commercially available plasmids
Plasmid Supplier Host Features
SCC105 John Innes Centre,
Norwich, UK
E. coli MC1061 Contains S.
coelicolor genes
sco2759 – sco2793
SCF34 John Innes Centre,
Norwich, UK
E. coli DH5α Contains S.
coelicolor genes
sco0482 – sco00505
8.1.9 : Growth media and culture conditions
Inoculation of media with Streptomyces sp. and Escherichia coli were done under
aseptic technique. For E. coli inoculation was performed under a Bunsen burner
flame whilst for Streptomyces inoculation was performed under a flame in a laminar
flow hood. All sterile solutions and media were prepared under laminar flow hood
conditions.
Luria-Bertani (LB) Medium80
Tryptone (10g/L), yeast extract (5g/L) and NaCl (10g/L) or Luria-Bertani Broth
powder (Lennox) (25g/L) was dissolved in distilled water and sterilized. 15g/L
Bacto agar was added to make LB agar.
Soya Flour Mannitol Medium (SFM)60
Soya flour obtained from a health food shop (20g/L), D-mannitol (20g/L) and Bacto
agar (15g/L) were dissolved in tap water and sterilized.
Iron Deficient Medium (for coelichelin production)52
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Iron deficient medium was made on a recipe based on the medium of Müller and
Raymond12. Salts were dissolved in distilled water (Table 8-6) and Chelex-100 resin
(Sigma-Aldrich, 50g/L) was added and stirred overnight in plastic containers.
Table 8-6: Salt concentrations in iron-deficient medium
Ingredient Concentration
K2SO4 2g/L
K2HPO4 3g/L
NaCl 1g/L
NH4Cl 5g/L
The resin was filtered by gravity in a plastic funnel with Whatman No.1 filter paper
and then trace nutrients were added to final concentrations given in Table 8-7 and
autoclaved. To start the cultures, 10 mL per litre of sterile CaCl2 (10g/L), sterile
glucose (250g/L) and sterile yeast extract (0.5%) was added with the Streptomyces
spores.
Table 8-7: Trace nutrient concentrations used in iron-deficient medium
Ingredient Concentration
Thiamine 2 mg/L
ZnSO4.7H2O 2 mg/L
CuSO4 5μg/L
MnSO4.H2O 35μg/L
MgSO4.H2O 80 mg/L
8.2 : Purification of ferri-coelichelin
8.2.1 : Preparation of spore stocks
Streptomyces coelicolor M145, S. coelicolor W2, Streptomyces ambofaciens
ATCC23877 and Streptomyces longisporus ruber spore stocks were made by adding
5-10μL of spore to 1 mL of sterile water on SFM plate (in the case of S. coelicolor
W2 supplemented with 60μg/mL apramycin) with incubating at 30 °C for 8-10 days
until complete sporulation had occurred. The spores were harvested by applying 4-5
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mL sterile water to the plate and scraping the hydrophobic surface to release spores
into the water. The spore suspension was filtered through sterile glass wool to
remove mycelial fragments. The filtrate was centrifuged (4000 rpm, 5 min, 4 °C)
and the sediment was resuspended in sterile 50% glycerol to a final total
concentration of 25% glycerol. The spore stocks were stored at -20 °C.
8.2.2 : Small-scale growth of Streptomyces in iron-deficient medium (50 mL)
50μL of Streptomyces spores were added to 50 mL of iron-deficient medium and the
culture was incubated in a rotary shaker (30 °C, 180 rpm) for 4-5 days.
8.2.3 : Large-scale growth of Streptomyces coelicolor in iron-deficient medium
(up to 2 L)
500μL of Streptomyces spores were added to 500 mL of iron-deficient medium and
the culture was incubated in a rotary shaker (30 °C, 180 rpm) for 4-5 days. After this
period, the culture developed a dark violet colour.
8.2.4 : Processing of culture supernatant
The supernatant was filtered through Whatman No.1 filter paper under partial
vacuum and FeCl3 was added to final concentration of 1 mM. The supernatant
developed a reddish-violet colour and became cloudy. The sample was evaporated
under vacuum (35 °C, 1-2 hours) until dry and the residue was dissolved in 5 mL
H2O. The concentrated supernatant was filtered through 0.2 μm cellulose HPLC
filters (Millipore) prior to HPLC or LC-MS analysis.
8.2.5 : LC-MS analysis of culture supernatants53
An Agilent 1100 instrument equipped with a binary pump and a diode array detector
was used for HPLC analyses. Samples were analysed on a Supelco Discovery HSF5
column (150 x 4.6 mm, 5 μm pore size, column temperature 20 °C) using the
gradient solvent profile given in (Table 8-8):
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The HPLC outflow was connected via a splitter (90% flow to waste; 10% flow to
MS) to a Bruker HCT+ ESI mass spectrometer (Bruker Daltonics, Coventry). The
spectrometer was operated in positive ion mode with parameters as follows:
nebulizer flow 40 p.s.i., dry gas flow 10 L / min, dry temperature 300 °C, capillary –
4 kV, skimmer 40 V, capillary exit 121 V, and ion charge control target (ICC)
100000, spectrum averages 3. The retention time of ferri-coelichelin was 3.2
minutes.
Table 8-8: HPLC eluent profile in LC-MS of culture supernatants
Time (min) 10 mM ammonium carbonate
buffer (pH 7.0)
Methanol Flow Rate
(mL/min)
0 90% 10% 1
10 90% 10% 1
18 0% 100% 1
28 0% 100% 1
36 90% 10% 1
40 90% 10% 1
8.2.6 : RP-HPLC purification of ferri-coelichelin
The processed culture supernatant of large cultures of S. coelicolor M145 or W2 was
separated by reversed-phase HPLC (Agilent Zorbax C-18 column, 21.2 x 10.0 mm, 5
μm particle size, temperature 20 °C) using an Agilent 1100 series instrument with a
UV detector monitoring absorbance at 435 nm. The solvent elution profile is given
in Table 8-9.
Table 8-9: HPLC eluent profile for purification of ferri-coelichelin
Time (min) Water (0.1% TFA) Acetonitrile (0.1% TFA) Flow Rate
(mL/min)
0 100% 0% 4.2
15 90% 10% 4.2
20 0% 100% 4.2
30 0% 100% 4.2
35 100% 0% 4.2
45 100% 0% 4.2
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Fractions were collected and analysed to see if they contained ferri-coelichelin by
direct injection into a Bruker micrOTOF ESI-MS operating in positive ion mode.
The retention time of ferri-coelichelin was 7 - 9 minutes. The fractions containing
ferri-coelichelin were snap-frozen in liquid N2 and lyophilized.
8.2.7 : Removal of iron from ferri-coelichelin
Using the established protocol75 partially purified ferri-coelichelin was dissolved in
25 mL of ultrapure water and 145 mg (1 mmole) of 8-hydroxyquinoline dissolved in
25 mL HPLC grade methanol and the two solutions were mixed together for 30
minutes, during which time the solution turned from light orange-yellow to green.
All glassware used from this step onwards was rinsed in 6 M HNO3 and deionised
H2O to remove traces of iron. The dark green ferri-8-hydroxyquinoline was
removed by extraction with 20 mL dichloromethane (five times). The aqueous phase
was retained, and excess organic solvents were evaporated under vacuum. The
remaining aqueous solution was snap-frozen in liquid N2 and lyophilized in iron-free
glassware.
8.2.8 : Purification of desferri-coelichelin by RP-HPLC
Due to the instability of desferri-coelichelin, this step was carried out without delay.
A published protocol was followed for this step52. After dissolving in 4 mL of 10
mM ammonium hydrogen carbonate buffer (pH 7.0) and filtering through 0.2 μm
cellulose acetate filters, desferri-coelichelin was purified by reversed-phase HPLC
(Phenomenex Synergi Fusion RP40 column, 250 x 10 mm, 4μm particle size) using
an Agilent 1100 series instrument with a UV detector monitoring absorbance at 210
nm. The solvent elution profile is given in Table 8-10.
Fractions were collected and analysed to see if they contained desferri-coelichelin by
direct injection into a Bruker micrOTOF ESI-MS operating in positive ion mode.
Fractions containing desferri-coelichelin were stored on ice, then combined and
frozen in liquid N2 and lyophilized.
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Table 8-10: HPLC eluent profile for purification of desferri-coelichelin
Time (min) 10 mM ammonium hydrogen
carbonate buffer (pH 7.0)
Acetonitrile Flow Rate
(mL/min)
0 100% 0% 3
25 100% 0% 3
30 0% 100% 3
40 0% 100% 3
45 100% 0% 3
55 100% 0% 3
8.2.9 : Addition of gallium to desferri-coelichelin
Using an established protocol75, 151 mg Ga2(SO4)3 was dissolved in 5 mL of 0.05 M
H2SO4 and added to a 5 mL solution of desferri-coelichelin. After 30 min, the
solution was neutralized with 0.5 M NaOH, frozen in liquid N2 and lyophilized in
plastic centrifuge tubes to prevent the loss of the light and fluffy gallium-coelichelin
powder.
8.2.10 : Purification of gallium-coelichelin by RP-HPLC
The gallium-coelichelin was dissolved in 4 mL of 10 mM ammonium carbonate
buffer (pH 7.0) and filtered through 0.2 μm cellulose filters. Gallium-coelichelin
was purified to homogeneity by reversed-phase HPLC (Agilent Zorbax C-18
column, 21.2 x 10.0 mm, 5μm particle size) using an Agilent 1100 series instrument
with a UV detector monitoring absorbance at 210 nm. The solvent elution profile is
given in Table 8-11.
Table 8-11: HPLC eluent profile for purification of gallium-coelichelin
Time (min) 10 mM ammonium hydrogen
carbonate buffer (pH 7.0)
Acetonitrile Flow Rate
(mL/min)
0 100% 0% 5
15 100% 0% 5
20 0% 100% 5
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30 0% 100% 5
35 100% 0% 5
45 100% 0% 5
Fractions were collected and analysed to see if they contained gallium-coelichelin by
direct injection into a Bruker micrOTOF ESI-MS operating in positive ion mode.
Fractions containing gallium-coelichelin (7-8 minutes retention time) were collected
and lyophilized in 15 mL plastic centrifuge tubes to prevent the loss of the light and
fluffy powder.
8.2.11 : 1H NMR of gallium-coelichelin
Gallium-coelichelin was dissolved in 750 μL DMSO-d6 (Cambridge Isotope
Laboratories) and a 1H NMR spectrum was measured at 400 MHz (Bruker Biospin,
Coventry). Assignments of the signals observed are given in Chapter 2.
8.2.12 : COSY and 13C -1H HSQC of gallium-coelichelin
COSY and HSQC spectra were measured on a 700 MHz machine (Bruker Daltonics,
Coventry) equipped with a TCI cryoprobe.
8.2.13 : Estimation of gallium-coelichelin concentration
60 μg CH2Br2 (Supelco) dissolved in 15μL DMSO-d6 was added to the NMR tube
containing the gallium-coelichelin. Comparison of the integrals for the signal due to
CH2Br2 (5.35 ppm) an the signal due to the proton on theαcarbon of the L-threonine
residue of gallium-coelichelin (4.38 ppm) gave the molar ratio of dibromomethane to
gallium-coelichelin, allowing the concentration of gallium-coelichelin to be
calculated from the known amount of CH2Br2 added.
8.2.14 : Conversion of gallium-coelichelin to ferri-coelichelin
1200 μL of a 1 mM FeCl3 solution was added to a gallium-coelichelin solution and
left to react for 15 h at 4 °C. The conversion of the gallium complex (m/z 632) to
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the ferric complex (m/z 619) was monitored by direct injection into a Bruker
micrOTOF ESI mass-spectrometer in positive ion mode.
8.2.15 : LC-MS analysis of pure ferri-coelichelin
The method used was as described previously53, with 10 μL of a 100μM solution of
ferri-coelichelin injected onto the HPLC column.
8.2.16 : ESI-MS-MS analysis of ferri-coelichelin in positive ion mode
A dilute sample of ferri-coelichelin was injected into a Bruker HCT+ ESI mass
spectrometer (Bruker Daltonics, Coventry) operating in positive ion mode with
parameters as follows: nebulizer flow 40 p.s.i., dry gas flow 10 L / min, dry
temperature 300 °C, capillary – 4 kV, skimmer 40 V, capillary exit 121 V, ion
charge control target (ICC) 100000, spectra averages 3.
8.3 : Overproduction, isolation and characterization of recombinant
proteins DesE, CchF and CdtB
8.3.1 : Miniprep extraction of plasmids/cosmids from E. coli
The standard miniprep procedure as described by Sambrook and Russell was used to
isolate plasmid and cosmid DNA80. Alkaline Lysis solutions I, II and III were made
as described by Sambrook and Russell80. To obtain DNA of sufficient quality for
sequencing reactions, the QIAGEN miniprep kit was used. In both miniprep
procedures, the isolated DNA was resuspended in EB buffer (10 mM Tris-Cl, pH
8.5).
8.3.2 : Preparation of primers
Primers were ordered from Sigma Genosys, dissolved in sterile water to a final
concentration of 1μg/mL and stored at -20 °C. The sequences of the primers used in
this study are listed in Table 8-12.
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8.3.3 : PCR (polymerase chain reaction) amplification of genes.
The template DNA used to amplify the gene desE was the S. coelicolor cosmid
SCC103 (from Prof. G. L. Challis). The S. coelicolor cosmid SCF34 (from Prof. G.
L. Challis) was used to amplify the gene cchF, and genomic S. coelicolor M145
DNA (from Dr. C. Corre) was used to amplify the cdtB gene. Minipreps of plasmids
pPP001 (pET151/D-TOPO + desE), pPP002 (pET151/D-TOPO + cchF) and pPP003
(pET151/D-TOPO + cdtB) were used to amplify the genes 5’-truncated desE, 5’-
truncated cchF and 5’-truncated cdtB respectively.
Table 8-12: PCR primers used in this study. Bases in bold were required to facilitate TOPO
cloning (CACC) or mutate Cys to Met (ATG).
Primer Sequence
desE forward CACCATGTCCCACGCCAGC
truncated_desE forward CACCATGGGCGACGGCGACGGCAAG
desE reverse TCAGCCGACCTTCTTGGCGT
cchF forward CACCATGCTCCTCAGAACAA
truncated_cchF forward CACCATGGGATCCGACTCGGACGA
cchF reverse CTACCCGGCCGACTTGACGA
cdtB forward CACCATGAGACGCCTCCTGC
truncated_cdtB forward CACCATGGGCACCACCGAACCCG
cdtB reverse CTACTTCGTCAGCGCGCCGACGAC
T7 forward TAATACGACTCACTATAGGG
T7 reverse TAGTTATTGCTCAGCGGTGG
The primers desE forward and desE reverse were used to amplify desE; the primers
cchF forward and cchF reverse were used to amplify cchF; the primers cdtB forward
and cdtB reverse were used to amplify cdtB. The primers truncated_desE forward
and desE reverse were used to amplify 5’-truncated desE; the primers
truncated_cchF forward and cchF reverse were used to amplify 5’-truncated cchF;
the primers truncated_cdtB forward and cdtB reverse were used to amplify 5’-
truncated cdtB. PCR was performed using a high fidelity polymerase was used with
the addition of 5% dimethyl sulfoxide (DMSO) due to the high GC content of the
template DNA. PCR reactions contained the reagents listed in Table 8-13. The PCR
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reactions were performed in an Eppendorf Mastercycler at annealing and elongation
temperatures of 55 °C and 72 °C respectively, using the program given in Table
8-14.
Table 8-13: Reagents in PCR reactions
Reagent μL
Sterile water 37.5
DMSO 2.5
Template DNA (~10 ng/μL) 1
dNTP mix (dATP, dTTP, dGTP, dCTP) (5 mM) 1
Forward primer (50 pmol) 1
Reverse primer (50 pmol) 1
10x PCR buffer (+ MgCl2) 5
Expand High Fidelity polymerase (Roche) 1
Table 8-14: PCR program used for all PCR reactions
Step number Temperature Duration of step (seconds)
1 94 °C 120
2 94 °C 45
3 55 °C 45
4 72 °C 90
5 GOTO 2 REPEAT x30
6 72 °C 900
7 4C store
8.3.4 : Analysis and purification of PCR products
6 μL of PCR products were mixed with 1 μL gel loading buffer (6x MassRuler
loading dye, Fermentas) and analysed on a 1 – 1.2% agarose gel by electrophoresis
using 6 μL of GeneRuler™ 1 kb DNA ladder (Fermentas) as a molecular size
standard. The gel was visualized on a gel documentation system (UV
transilluminator, UVP) after ethidium bromide staining, and the concentration of the
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desired amplimer was estimated by comparing the fluorescence intensity against
bands in the DNA ladder. A larger sample of the PCR products (20 μL) was
separated on an agarose gel and the DNA of the appropriate size was excised to
separate the product from the template and unreacted nucleotides. The QIAGEN gel
extraction kit was used to extract the DNA from the excised agarose plug, eluting
with the buffer provided.
8.3.5 : Insertion of amplimers into pET151-D/TOPO
The manufacturers’ protocol was used as described in the booklet provided with the
kit “Champion™ pET Directional TOPO® Expression Kits”: The reagents for the
TOPO® cloning reaction are given in Table 8-15.
Table 8-15: Reagents used in the ligation of the pET151/D-TOPO plasmid to the amplimers
Reagent Volume
Purified PCR product (approx. amount) 1μL – 3μL
Salt solution (kit) 1μL
TOPO® vector (pET151-D/TOPO) 1μL
Sterile water to a final volume of 6μL
The volume of purified PCR product used in the reaction depended on the estimated
concentration of the product. The total amount of insert DNA used in the TOPO
reaction was around 1 – 5 ng. The reaction was carried out at room temperature in a
200 μL sterile centrifuge tube and 3 μL of product was used to transform E. coli
MC1061 and TOP10 competent cells.
8.3.6 : Transformation of E. coli BL21star and MC1061 strains with plasmids
by electroporation
5 mL of LB medium was inoculated with E. coli BL21star or MC1061 cells, and the
culture was grown overnight in a rotary shaker (37 °C, 180 rpm). 50 mL of LB
medium was inoculated with 250 μL of the overnight culture, and the culture was
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incubated at 37 °C and 180 rpm until it grew to OD600 ~ 0.4. The culture was
centrifuged (10 min, 4 °C, 2700 rpm). The supernatant was decanted and the pellet
was resuspended gently in 25 mL of 10% ice-cold glycerol. The cells were
centrifuged again (10 min, 4 °C, 2700 rpm), the supernatant was decanted and the
pellet resuspended again in 25 mL 10% ice-cold glycerol. The cells were
centrifuged again (10 min, 4 °C, 2700 rpm), the supernatant was decanted and the
pellet was resuspended in 500μL of 10% ice-cold glycerol solution.
50μL of cell suspension was mixed with 1μL of plasmid DNA or TOPO® reaction
DNA in an ice-cold electroporation cuvette. Electroporation was carried out using a
BioRad Gene Pulser II instrument set to 200 Ω, 25 uF and 1.9 kV. 1 mL of ice-cold
LB was immediately added to the cells which were incubated (45 min, 180 rpm, 37
°C) before spreading onto LB agar containing 100 μg/mL ampicillin and incubating
overnight at 37 °C.
8.3.7 : Transformation of E. coli One-Shot BL21star and TOP10 chemically
competent cells
50 μL aliquots of chemically competent E. coli cells (Invitrogen) stored at -80 °C
were thawed on ice, and mixed with 2μL plasmid DNA (or 3μL TOPO® reaction)
and incubated on ice for 25-30 minutes. The cells were heat shocked at 42 °C for 30
seconds, incubated on ice for 2 minutes and resuspended in 200 μL of LB medium.
This suspension was incubated (45 min, 180 rpm, 37 °C) before being spread onto
LB agar supplemented with 100μg/mL ampicillin and incubated overnight at 37 °C.
8.3.8 : PCR analysis of cloning reactions
Single colonies of E. coli were inoculated into 5 mL LB (100μg/mL ampicillin) and
grown overnight (37 °C, 180 rpm). The plasmids from the cultures were extracted by
the standard miniprep protocol and the PCR reaction was performed on the plasmid
DNA with the original primers used for coding sequence amplification using Taq
polymerase. The PCR reactions were analysed by 1.2% agarose gel electrophoresis
and clones containing the correct inserts (about 1 kbps) were selected for analysis of
protein overproduction.
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8.3.9 : Expression analysis of clones
Plasmid DNA was used to transform E. coli BL21star. A single colony was picked
and grown overnight (5 mL LB, 50μg/mL ampicillin, 37 °C, 180 rpm) and 250μL
of the culture was used to inoculate 50 mL LB (50μg/mL ampicillin). The culture
was grown for approximately 3-4 hours (37 °C, 180 rpm) until it reached OD600 ~
0.6 and then it was stored on ice. A sterile solution of isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to a final concentration 0.5 mM for protein
overproduction, and the culture was incubated in a rotary shaker overnight (15 °C,
180 rpm).
8.3.10 : Preparation of total protein fraction
1 mL of the 50 mL culture was centrifuged (14,000 rpm, 10 min) and the supernatant
decanted. The pellet was resuspended in 100 μL cell lysis buffer80 and boiled for
100 °C for 10 minutes.
8.3.11 : Preparation of soluble protein fraction (cell-free extract)
35 mL of overproduction culture was centrifuged (20 min, 14,000 rpm, 4 °C) and
resuspended in 4 mL of washing buffer and 40 μL of a 1 mM
phenylmethylsulfonylfluoride (PMSF) solution was added to inhibit proteases. The
cells were lysed by pulsed sonication on ice (Sonics Vibracell, 2 min, 40 dB, 1 sec
pulse on, 1 sec pulse off) and centrifuged (20 min, 14,000 rpm, 4 °C) to pellet cell
debris and unlysed cells. The cell-free extract was decanted and stored at 4 °C.
8.3.12 : Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) analysis of protein fractions
The total and soluble protein fractions were mixed with 5x SDS-PAGE loading
buffer 80 and were analysed on an 8% SDS-PAGE gel using a Mini-Protean II gel
electrophoresis system (BioRad). Either a bovine serum albumin (BSA)/ovalbumin
(OVA) marker or PageRuler™ Plus Prestained Protein ladder (Fermentas) was used
as molecular weight standards. The gel was stained using Coomassie Blue80 and
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destained by heating in the microwave for 10 min at 700 W in distilled water. The
gel was visualized on a gel documentation system (UV transilluminator, UVP).
8.3.13 : Sequencing of the gene inserts of plasmids
Plasmid DNA prepared from holding strains of E. coli using the standard
procedure80. The forward and reverse primers used were T7 forward primer and T7
reverse primer, which flank the inserted gene region. The DNA sequencing was
carried out by the Biological Sciences Sequencing Service (University of Warwick)
and GATC Biotech (Germany) and chromatograms analysed by Chromas 1.45 for
mutations.
8.3.14 : Large-scale protein overproduction
2 mL of an overnight E. coli BL21star culture (containing the expression clone of
interest) was inoculated in 600 mL LB (50 μg/mL ampicillin). The culture was
grown at 37 °C for 3-4 hours until and OD600 ~ 0.6 was reached. IPTG was added to
a final concentration of 0.5 mM and the culture was incubated in a rotary shaker
overnight (15 °C, 180 rpm).
The overnight culture was centrifuged (20 min, 10000 rpm, 4 °C) and the pellet was
recovered and stored at -80 °C overnight (in the case of protein CdtB to facilitate
lysis). The pellet was resuspended in 20 mL washing buffer containing 10 μM
PMSF and the cells were lysed using a French Pressure Cell Press (Thermo
Scientific) at 4 °C using the 40K Standard Cell (Thermo Scientific) and a pressure of
20,000 psi.
The cell-free extract was separated from the cell debris by centrifugation (20 min,
10,000 rpm, 4 °C) and stored on ice.
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8.3.15 : Purification of proteins by Immobilized Metal Affinity
Chromatography (IMAC)
Ni-IMAC of the cell free extract was performed on an ÄKTA purifier (Amersham
Biosciences, GE Healthcare). The cell-free extract was injected via a 50 mL
superloop (Pharmacia Biotech) at 0.35 mL/min onto a 1 mL HisTrap Ni-NTA
sepharose column (GE Healthcare) at 4 °C. Non-specifically binding proteins were
washed off the column with 15 mL 98% washing buffer/2% elution buffer. The His-
tagged recombinant protein was eluted with 50 – 100 % elution buffer at 0.35
mL/min and collected in 5 mL glass tubes. Absorbance was monitored at 280 nm.
Combined fractions containing the recombinant protein were filtered through a
30,000 MW cutoff 15 mL Amicon Ultra centrifugal filter (Millipore), diluting with
gel filtration buffer by centrifuging for approximately 25 minutes (3000 rpm, 4 °C).
The purity of the protein was assessed by SDS-PAGE (8% gel) and the protein was
aliquoted into 200μL clean thin-walled centrifuge tubes and stored at -80 °C.
8.3.16 : Bradford assay for protein concentration determination
The Bradford reagent required for the assay was prepared according to a standard
procedure80. Dilutions of the protein were prepared (0, 10%, 20%, 40%, 60% 80%,
90%, 100%) in parallel with dilutions of a 0.78 mg/mL BSA solution (determined by
absorbance using the extinction coefficient ofε280 = 0.667 (mg/mL)-1cm-1) in a total
volume of 100 μL. 1 mL of Bradford reagent was added to the protein solutions,
which caused a colour change from brown to peacock blue on increasing
concentration of protein. The colour change was monitored by absorbance at 595
nm in a 1 cm path length cuvette using a BioMate UV-Vis spectrophotometer
(Thermo Scientific). The concentrations of the protein solutions were determined by
comparison with the absorbances of the standard BSA curve (plotted in Microsoft
Excel).
8.3.17 : Purification of tobacco etch virus (TEV) protease
E. coli BL21(DE3)-RIL transformed with pRK793 overproduced a autoinactivation-
resistant S219V mutant recombinant TEV protease catalytic domain with an N-
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terminal His-tag and a C-terminal polyarginine tag, and was the
(http://mcl1.nclfcrf/gov/waugh.html). This strain was inoculated into 5 mL LB (100
μg/mL ampicillin, 30μg/mL chloramphenicol) and incubated overnight at 37 °C.
2 mL of overnight culture was inoculated into 600 mL of LB (50μg/mL ampicillin,
15 μg/mL chloramphenicol) and incubated in a rotary shaker (3 h, 37 °C, 180 rpm)
until an OD600 ~ 0.6 was reached. IPTG was added to a final concentration of 0.5
mM and incubated overnight (3 h, 37 °C, 180 rpm). The protein was extracted and
purified using the protocol described in sections 8.3.14 : and 8.3.15 :, and 50 μL
aliquots stored at -80 °C.
8.3.18 : Digestion of proteins with TEV protease
Approximately 50μL of TEV protease was added to 300 – 400 μL of purified His-
tagged protein (approximately 1:50 ratio TEV protease: His-tagged protein) and the
mixture was incubated for 12 -15 h at 4 °C.
8.3.19 : Purification of TEV protease digested protein
0.5 – 1 mL of digestion product was injected via a 2 mL injection loop onto a 1 mL
HisTrap column at 0.15 mL/min with washing buffer as the mobile phase and the
flow-through was collected and concentrated. Undigested protein and TEV protease
were assumed to bind to the column. The undigested and digested products were
analysed by SDS-PAGE.
8.3.20 : Peptide mass fingerprinting of proteins
Electrospray ionization mass spectrometry (ESI-MS) of tryptic digests of proteins
excised from SDS-PAGE gels was performed by The Biological Mass Spectrometry
and Proteomics Facility in the Department of Biological Sciences, University of
Warwick.
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8.3.21 : ESI-MS analysis of proteins
Proteins were dialysed five times in 10 mM ammonium acetate (pH 7.0) using a
10,000 MW spin filter (Vivaspin, Millipore Inc.) to give a final concentration of
approximately 25 μM. The concentration of the protein solutions were determined
by the Bradford assay. The solution was acidified by a small amount of 50% MeCN
(0.1% TFA). A total volume of 60μL of protein solution was injected continuously
a Bruker micrOTOF ESI-MS (Bruker Daltonics, Coventry, UK) using the following
settings: positive ion mode, scan range m/z 800– 5000, capillary exit voltage 250.0
V, skimmer voltage 90.1 V, hexapole 24.8 V, hexapole RF voltage 750.0 V,
corrector fill 48 V, pulsar pull 369 V, pulsar push 369 V, reflector 1300 V, flight
tube 9000 V, detector TOF 2140 V. The spectra were analysed and deconvoluted to
identify multiply-charged species using Bruker Daltonics DataAnalysis 3.3 software
(Bruker Daltonics, Coventry, UK).
8.3.22 : Gel filtration (size exclusion chromatography) of proteins
500μL of a solution of protein was loaded onto a size exclusion column (HiLoad™
75 Superdex™ 12 prep grade serin, column volume 110 mL, Amersham
Biosciences) equilibrated with gel filtration buffer at 0.8 mL/min on an ÄKTA
purifier (Amersham Biosciences, GE Healthcare). The column was eluted with
isocratic gel filtration buffer. 5 mL fractions were collected in the case of preparative
gel filtration. Absorbance was monitored at 280 nm. The column was calibrated
with the Kit for Molecular Weights 12,000-200,000 Da (Sigma), consisting of
Cytochrome c (12,400 Da), Carbonic Anhydrase (29,000 Da), Bovine Serum
Albumin (66,000 Da), Alcohol Dehydrogenase (150,000 Da), β-Amylase (200,000
Da), and Blue dextran (2,000,000 Da), which eluted at volumes 89.2 mL, 71.5 mL,
59.6 mL, 56.1 mL, 52.9 mL and 40.1 mL, respectively.
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8.4 : Binding of siderophores to siderophore binding proteins
8.4.1 : Preparation of ferri- and desferri-siderophore solutions (except ferri-
coelichelin and ferrioxamine B)
The ferri-siderophores ferrioxamine E, ferrichrome, ferri-enterobactin and ferri-
albomycin (mixture of δ1, δ2 and ε forms) and the desferri-siderophores
desferrioxamine E, desferri-ferrichrome and enterobactin were purchased in 1 mg
amounts from EMC Microcollections (Tübingen, Germany). 1 mg of each
compound was dissolved in 100μL ultrapure water and stored at -20 °C.
8.4.2 : Preparation of ferrioxamine B solution
56 mg deferoxamine B mesylate (Sigma) was dissolved in distilled water and an
excess of 100 mM FeCl3 was added. The solution changed colour from colourless to
bright red due to the formation of ferrioxamine B. The water was removed by
evaporation under a partial vacuum, and the residue was dissolved in 1 mL HPLC
grade H2O and filtered.
The conditions for purification of ferrioxamine B by HPLC were the same as
previously described for ferri-coelichelin (see section 8.2.6 :). An orange fraction
was collected and was verified to contain ferrioxamine B by ESI-MS in positive ion
mode (m/z 614; ferrioxamine B + H+). The fraction was evaporated to remove
organic solvents, snap-frozen in liquid N2 and lyophilized. The resulting dark red
powder was redissolved in 1 mL of ultrapure water and stored at -20 °C.
8.4.3 : Concentration estimation of ferri-siderophores by UV-Visible
spectroscopy
The concentration of ferri-siderophore solution was estimated by UV-Visible
spectrometry in a 1 mm path length quartz cuvette (Starna Scientific UK) using a
Jasco V550 spectrophotometer. The extinction coefficients used are displayed in
Table 8-16.
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Table 8-16: Ferri-siderophore extinction coefficients.
Siderophore Wavelength
(nm)
Extinction coefficient
(M-1cm-1)
Reference
Ferrioxamine B 428 2800 11
Ferrioxamine E 430 2750 11
Ferrichrome 425 2895 11
Albomycin 425 2895 EMC Microcollections
Ferri-enterobactin 495 5600 11
8.4.4 : Inductively coupled plasma optical emission spectroscopy (ICP-OES) of
ferri-coelichelin and other ferri-siderophores
A Perkin Elmer Optima 5300 DV Optical Emission Spectrometer was used in
analyses to calculate the concentration of Fe in 1/1000 dilutions of siderophore
solutions. 40 μL of stock solutions of ferrioxamine E, ferrioxamine B, albomycin
and ferrichrome of approximately 500 μM and 100 μM and ferri-coelichelin of
approximate concentration 300 μM were diluted in 3.96 mL of ultrapure water prior
to analysis. The Fe standards were prepared from dilutions of an Iron for AAS
standard solution (1001 ± 3 mg/L) in ultrapure water and prepared in 15 mL plastic
centrifuge tubes. The iron standards prepared were 0 ppm, 0.05 ppm, 0.1 ppm, 0.5
ppm, 1 ppm, 5 ppm, 10 ppm and 50 ppm. The emission wavelengths analysed were
238.204, 239.562 and 259.939 nm and the plasma temperature was 8000 °C. The
emission intensities recorded were entered into Microsoft Excel and its linear
regression function was used to analyse the relationship between the concentrations
of standard solutions against emission intensity, with the intercept of the line set at
zero. The relationship formulae were used to determine the concentration of Fe in
the siderophore solutions and hence the concentration of siderophore (as the Fe-
siderophore complex is one-to-one) in the stock solutions from their emission
intensities.
8.4.5 : Fluorescence measurements
Proteins were dissolved in PBS to a final concentration of 0.78 mg/mL. In the case
of CchF it was incubated at 37 °C for 45 minutes prior to dissolving in PBS.
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Fluorescence of the proteins was measured using a Perkin Elmer LS 50B
luminescence spectrometer with an excitation wavelength of 280 nm. The xenon
flash lamp was the source of radiation, which illuminated at a frequency of 50 Hz.
No cutoff filters were used in the course of the experiments. The fluorescence
spectrum was recorded from 310 nm to 380 nm, with a scan speed of 50 nm/min.
The data was recorded in increments of 0.5 nm, with each data point being an
average of 12 measurements. The excitation and emission slit lengths were 5.0 nm
and 8.0 nm respectively, except in the case of CchF where they were 5.0 nm and
10.0 nm respectively. The measurements were taken using a 3 mm path length
quartz cuvette (Starna Scientific) with the total volume ranging from 90 – 100 μL.
Siderophore solutions were titrated into the protein solutions, mixed by agitation of a
micropipette tip and left to incubate in the cuvette for 4 minutes at 21±1 °C before
recording the spectra. The titrations were repeated at least three times.
8.4.6 : Processing of fluorescence data
The fluorescence data was transferred into Microsoft Excel from their format, and
collated into one worksheet. The fluorescence at 335 nm was used to monitor the
relative proportion of binding of different concentrations of ferri-siderophore ligand
to DesE and CdtB. In the case of CchF, the fluorescence was monitored at 325 nm.
The data was linearly transformed into proportion bound by the relation
min0
0
FF
FF


in
Microsoft Excel, where F0 is the fluorescence of unbound protein, F is the
fluorescence of the current protein-ligand solution and Fmin is the fluorescence of the
bound protein. The transformed data was copied into Origin 6.0 Professional86 and
the nonlinear curve fitting function was used to fit the data using the function
Onesitebind2 with the free parameter KD and fixed parameter [PT] the protein
concentration in nM.
If Fmin had to be estimated, as in the case of ferri-siderophore binding to CchF and
CdtB, a value of Fmin was used provisionally as CchF bound to high concentrations
of ferri-coelichelin and CdtB bound to high concentrations of ferrioxamine B. The
data was linearly transformed into “relative fluorescence decrease compared to
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Fmin(siderophore)” by the relation
min0
0
FF
FF


in Microsoft Excel. The transformed
data was copied into Origin 6.0 Professional86 and the nonlinear curve fitting
function was used to fit the data using the function Onesitebind_lipid with the free
parameters KD and Q =
)(min0
0
esiderophorFF
FF


, and the fixed parameter [PT] (the
protein concentration in nM).
Origin 6.0 Professional was also used to graph the relative binding curves of ferri-
siderophores to DesE, CchF and CdtB (relative binding versus total ligand
concentration in μM), with each data point being the mean of at least three separate
measurements, with y-error bars indicating ±1 standard deviation. A curve of best fit
was also drawn, which represents the curves of best fit of KD (and Q) to the models
Onesitebind2 and Onesitebind_lipid.
8.4.7 : Circular dichroism spectroscopy of proteins with siderophores
Proteins were dissolved in sodium phosphate buffer (pH 7.0) to a final concentration
80 μg/mL three hours prior to analysis. Ferri-siderophores were added to a final
concentration of 5 μM and incubated for 5 minutes at 21 °C prior to analysis. The
instrument used was a Jasco J715 spectropolarimeter with excitation slit length of 1
nm. A 1 mm path length quartz cuvette was used to hold the sample. The spectra
were recorded from 190 – 250 nm and eight scans were accumulated, with the
spectrum of the solvent subtracted upon processing.
8.5 : Molecular modelling of ferric hydroxamates
8.5.1 : Hardware
All DFT calculations were performed on a dual Intel Pentium Xeon workstation 3.0
GHz running Mandriva Linux using the Centre for Scientific Computing delivered
desktop (University of Warwick). All other calculations were performed on a Viglen
Intel Pentium 4 workstation 3.0 GHz running Mandriva Linux using the Centre for
Scientific Computing delivered desktop (University of Warwick).
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8.5.2 : DFT
DFT calculations were carried out using Amsterdam Density Functional 2005
program114. All calculations were run spin unrestricted, using triple zeta basis sets.
The 2p core was frozen on Fe and the 1s orbital frozen on C, N and O. All
calculations used COSMO (conductor-like screening model) solvation corresponding
to water (probe radius 1.4 Å, dielectric constant 78.4), with solvation radii of Fe, O,
N, C and H being 2.20, 1.30, 1.40, 2.40 and 1.16 respectively.
Most of the ferric tris-hydroxamate geometry optimizations and single point
calculations were performed with no symmetry except for trigonal prismatic
calculations which were performed with symmetry C3v. All geometry optimizations
were carried out using the generalized gradient approximation Perdew-Wang 91115
(PW91) with default geometry and SCF convergence criteria.
8.5.3 : Molecular Mechanics
Molecular mechanics was performed using the DOMMIMOE program73
implemented in the Molecular Operating Environment (MOE)74, which uses
traditional molecular mechanics for atoms not based around the metal centre, and a
computational treatment of the angular overlap model (AOM) on the transition metal
centre and the immediate coordination environment.
The MMFF94 forcefield98 was used for calculations, with additional terms added to
remove angles, torsions and stretch-bends and adjust the charge at the Fe(III) metal
centre. Out-of-plane terms were added to keep the hydroxamate ligands planar. All
other forcefield terms were left unchanged.
Parameter optimization and molecule modification were implemented in programs in
scientific vector language (SVL), MOE’s internal programming language.
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APPENDICES
A.1. The estimation of Fmin by previous studies
A.1.1 Simulated quenching data
To test the different methods used to estimate the value of Fmin, two “perfect”
datasets were created such that their fluorescence maximum and minimum (F0 and
Fmin) were set to 400 and 300 respectively, with different dissociation constants, (KD
= 0.2, 2.0μM) using the one site binding model:
]2
])]])]((-]] 2
T
TTTTDTTD
P
LPLPKLPK
FF
FF
[
[[4[[[[
min0
0 

…(1)
where F is the fluorescence of the hypothetical solution in the presence of [LT]
concentration of ligand. The protein concentration was fixed at [PT] = 2.257μM and
[LT] varied from 0 – 30 μM. The datasets (F versus [LT]) are illustrated in Figure
0-1.
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Figure 0-1: Graphs of simulated datasets of a ligand L binding to a fluorophore P where
F0=400, Fmin=300, [P] = 2.257 μM, with (left) KD = 200 nM, (right) KD = 2.0μM
A.1.2 Method of Rohrbach et al.
In Rohrbach et al.30 the maximal quenching of the fluorescence of the E. coli protein
FhuD was determined “from the intercept of the straight line obtained by double-
reciprocal plotting of the substrate concentration versus the fluorescence quenching”,
with the x-axis being the reciprocal of the fluorescence quenching. There was no
explanation or reference to the derivation of this method.
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Using this method on the two datasets of known Fmin (Figure 0-2), these gave
estimations of the intercept as 3.0876 and 3.3348 for the simulated data with KD =
0.2μM and KD = 2 μM respectively. To convert the intercept into estimates of Fmin,
the unknown F was found in the expression (3.0876 = F0/(F0 – F)) which
corresponded to Fmin values of 270 and 280 respectively, which were not close to the
true value of 300.
Rohrbach et al. Fmin calc.
y = 7702.2x + 3.0876
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Figure 0-2: The estimation of Fmin from the simulated data using the method of Rohrbach et al.30
The intercept of these lines are supposed to give the value of Fmin after linear transformation
(the value of 4 would correspond to Fmin = 300) but from the calculated intercepts of the lines
from the equations on the top-right corner they are far out. (left) KD = 200 nM, (right) KD =
2000nM.
A.1.3 Method of Sebulsky et al.
Sebulsky et al.38 have suggested the equation to estimate the value of Fmin:



 
 0
0
min
1
][
][
F
FF
FcL
L
T
T …(2)
[LT] is the total concentration of ligand and c is a constant. Again, there was no
explanation or reference to the derivation of this relation. To estimate Fmin from this
relation, one assumes one has to plot [LT]/([LT]+c) against (F0-F)/F0 with an arbitrary
c, and the resulting gradient of the line will be 1/Fmin, but the transformation of the
simulated datasets did not give a straight line and the gradient of this curve varied
greatly (Figure 0-3).
PhD Thesis: Prakash Patel Appendices
190
Sebulsky et al. Fmin calc. c=1000
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Figure 0-3: The estimation of Fmin from the simulated data using the method of Sebulsky et al.
The left hand side of Equation 2 was plotted against the right hand side, and c was chosen such
that the curve was roughly linear. The gradient 4 would give the desired value of Fmin after
linear transformation. (left) KD = 0.2 μM (right) KD = 2μM
Double reciprocal plotting of these curves does give an almost linear curve (Figure
0-4), but this time the gradient gives a value of Fmin (after transformation) and the
value of c was adjusted to give a relationship which was nearly of the form y = mx (a
line with intercept zero), where the relationship is analogous to






FF
F
F
L
cL
T
T
0
0
min][
][
. The gradients of these graphs correspond to Fmin values of
193 and 258 for the simulated data with KD = 0.2 μM and KD = 2μM respectively,
which were inaccurate estimates of the true value of 300.
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Figure 0-4: The estimation of Fmin from the simulated data using the method of Sebulsky et al. -
double-reciprocal plots.
The reciprocal of the left hand side of Equation 2 was plotted against the reciprocal of the right
hand side, and c was chosen such that the curve had an intercept of nearly zero, such that the
gradient corresponded directly to Fmin after linear transformation. A gradient of 0.25 would
correspond to Fmin = 300, which both do not (left) KD = 0.2 μM, (right) KD = 2μM.
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A.2. Derivation of one site binding equation
Assume the binding of protein to the substrate is one-to-one, i.e.:
PSSP  …(1)
The dissociation constant KD is given by the formula:
[PS]
[P][S]DK …(2)
But both the free concentrations of protein and substrates, [P] and [S] respectively,
can be expressed as the sum of the total concentration [PT] and [ST] minus the
concentration of bound species [PS]:
[PS]-][S[S]
[PS]-][P[P]
T
T


…(3)
Substituting into (2) and rearranging:
[PS]
[PS])-][PS])([S-]([P
[PS]
[P][S] TTDK
2
TTTT [PS]])[PS][S]([P-]][S[P[PS] DK
0]][S[P])[PS][S][P(-[PS] TTTT
2 DK …(4)
Equation (3) is now a quadratic equation in [PS], which can be easily solved by the
quadratic formula:
2
])][S[P4])[S][P((][S][P
[PS] TT
2
TTTT  DD KK …(5)
But [PS]/[PT] is precisely the proportion of protein bound to the substrate, which can
be monitored by techniques such as fluorescence quenching if the fluorescence of the
non-bound F0 and fully bound protein Fmin is known:
Hence:
]2[P
])][S[P4])[S][P((-][S][P
][P
[PS]
T
TT
2
TTTT
min0
0
T

 DD KK
FF
FF
…(6)
where F is the fluorescence of the protein at a given total protein [PT] and total
substrate [ST] concentration.
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A.3. Origin function files
A.3.1 Onesitebind2 method
[GENERAL INFORMATION]
Function Name=Onesitebind2
Brief Description=user4
Function Source=N/A
Function Type=User-Defined
Function Form=Y-Script
Number Of Parameters=2
Number Of Independent Variables=1
Number Of Dependent Variables=1
[FITTING PARAMETERS]
Naming Method=User-Defined
Names=Kd, P
Meanings=Dissociation Constant, Protein concentration
Initial Values=500(V), 2000(V)
Lower Bounds=0(X, On),0(X, On)
Upper Bounds=--(X, Off),--(X, Off)
Number Of Significant Digits=
[FORMULA]
q = Kd+x+P;
y = ( q - ( q^2 - (4*x*P) ) ^ 0.5 ) / (2*P)
[CONSTRAINTS]
/*Enter general linear constraints here*/
[CONSTANTS]
[INITIALIZATIONS]
/*Scripts to be executed before fitting, a good place for
complicated initialization.*/
[AFTER FITTING]
/*Scripts to be executed after fitting, a good place for generating
results.*/
[INDEPENDENT VARIABLES]
x=
[DEPENDENT VARIABLES]
y=
[CONTROLS]
General Linear Constraints=Off
Initialization Scripts=Off
Scripts After Fitting=Off
Number Of Duplicates=N/A
Duplicate Offset=N/A
Duplicate Unit=N/A
Generate Curves After Fitting=Yes
Curve Point Spacing=Same X as Fitting Data
Generate Peaks After Fitting=Yes
Generate Peaks During Fitting=Yes
Generate Peaks with Baseline=Yes
Paste Parameters to Plot After Fitting=Yes
Paste Parameters to Notes Window After Fitting=Yes
Generate Residue After Fitting=No
Keep Parameters=No
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A.3.2 Onesitebind_lipid
[GENERAL INFORMATION]
Function Name=Onesidebind_lipid
Brief Description=user5
Function Source=N/A
Function Type=User-Defined
Function Form=Y-Script
Number Of Parameters=3
Number Of Independent Variables=1
Number Of Dependent Variables=1
[FITTING PARAMETERS]
Naming Method=User-Defined
Names=Kd, P, IPL
Meanings=?
Initial Values=500(V),2000(V),1(V)
Lower Bounds=--(X,OFF)
Upper Bounds=--(X,OFF)
Number Of Significant Digits=
[FORMULA]
q = (x - Kd - P)/2;
Lf = q + (q^2 + Kd * x )^0.5;
qq = Lf / (Lf + Kd);
y = IPL * qq
[CONSTRAINTS]
/*Enter general linear constraints here*/
[CONSTANTS]
[INITIALIZATIONS]
/*Scripts to be executed before fitting, a good place for
complicated initialization.*/
[AFTER FITTING]
/*Scripts to be executed after fitting, a good place for generating
results.*/
[INDEPENDENT VARIABLES]
x=
[DEPENDENT VARIABLES]
y=
[CONTROLS]
General Linear Constraints=Off
Initialization Scripts=Off
Scripts After Fitting=Off
Number Of Duplicates=N/A
Duplicate Offset=N/A
Duplicate Unit=N/A
Generate Curves After Fitting=Yes
Curve Point Spacing=Same X as Fitting Data
Generate Peaks After Fitting=Yes
Generate Peaks During Fitting=Yes
Generate Peaks with Baseline=Yes
Paste Parameters to Plot After Fitting=Yes
Paste Parameters to Notes Window After Fitting=Yes
Generate Residue After Fitting=No
Keep Parameters=No
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A.4. Dissociation constant calculation graphs
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Figure 0-5: The relative fluorescence of ferrichrome decrease compared to Fmin of ferrioxamine
B bound to CdtB to a 78μg/mL CdtB solution at 21 °C.
The model was fitted to the Onesitebind_lipid method, and the non-linear curve fitting function
was used to find a suitable KD and Q given [P] = 2.380 μM. The best fit to the data was
obtained with KD = 77μM.
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Figure 0-6: The relative binding of ferri-coelichelin to a 78 μg/mL CdtB solution at 21 °C on
assumption that 75% of the protein participates in binding.
The model was fitted to the Onesitebind2 method, and the non-linear curve fitting function was
used to find a suitable KD given [P] = 1.790μM. The best fit to the data was obtained with KD =
172 nM.
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Figure 0-7: The relative binding of ferrioxamine B to a 78 mg/mL CdtB solution at 21 °C on
assumption that 75% of the protein participates in binding.
The model was fitted to the Onesitebind2 method, and the non-linear curve fitting function was
used to find a suitable KD given [P] = 1.790μM. The fit to the data was obtained with KD = 100
nM.
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Figure 0-8: The relative fluorescence decrease on addition of ferri-siderophores of a 78 μg/mL
CdtB solution at 21 °C compared to Fmin of ferrioxamine B bound to CdtB, on assumption 75%
of the protein can participate in binding.
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The model was fitted to the Onesitebind_lipid method, and the non-linear curve fitting function
was used to find a suitable KD and Q given [P] = 1.793 μM. (Top) ferrioxamine E; (middle)
ferrichrome; (bottom) ferri-albomycin.
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A.5. Modelling of ferric hydroxamates
Table 0-1: Summary of the 27 X-ray crystal structures of ferric-tris-hydroxamates used in the
survey of bond lengths and angles of ferric-tris-hydroxamates.
The CDS reference code is the code used by the Cambridge Crystallographic Database at
Daresbury to refer to the crystal structure, with the common name or chemical name and the
original reference also given. Only one ferric iron centre was included in the multinuclear
complexes IRADEK and TEQKUV.
CDS Reference
code
Common name Reference
BOPMUO01 Asperchrome A M.B.Hossain, D.van der Helm, M.Alam,
R.Sanduja (1983) ACA,Ser.2 ,11,29
BUHQUQ (tris((3-(N-Acetyl-N-
hydroxy)glycylamino)
propyl)ammonium)-iron(iii)
K.Matsumoto, N.Suzuki, T.Ozawa, K.Jitsukawa,
H.Masuda (2001) Eur.J.Inorg.Chem. ,2481
CETWIH Ferric neurosporin D.L.Eng-Wilmot, A.Rahman, J.V.Mendenhall,
S.L.Grayson, D.van der Helm (1984)
J.Am.Chem.Soc. ,106,1285
COFDIK10 Neocoprogen I M.B.Hossain, M.A.F.Jalal, B.A.Benson,
C.L.Barnes, D.van der Helm (1987)
J.Am.Chem.Soc. ,109,4948
CUJHIY Ferrirubin hydrate C.L Barnes, M. B. Hossain, M.A.F.Jalal,
B.A.Benson, D.L. Eng-Wilmot, S.L Grayson,
S.K.Agarwal, R.Mocheria, D.van der Helm (1985)
Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.
41 , 341
DEWNAU tris(μ2-1.5-bis((1,2-Dihydro-1-
hydroxy-2-oxopyridin-6-yl)carbonyl)
-5-diazapentane-di-iron
R.C.Scarrow, D.L.White, K.N.Raymond (1985)
J.Am.Chem.Soc. 107, 6540
DUPJON Ferrioxamine D1 M.B.Hossain, M.A.F.Jalal, D.van der Helm (1986)
Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.
,42 ,1305
FEBOAH02 tris(Benzohydroxamato-O,O')-
iron(iii)
T.W.Failes, T.W.Hambley (2000) Aust.J.Chem.
,53 ,879
FERCRN10 Ferricrocin C.L.Barnes, D.L.Eng-Wilmot, D.van der Helm
(1984) Acta Crystallogr.,
Sect.C:Cryst.Struct.Commun. ,40,922
FERMAH11 Ferrichrome-A D.van der Helm, J.R.Baker, R.A.Loghry,
J.D.Ekstrand (1981) Acta
Crystallogr.,Sect.B:Struct.Crystallogr.Cryst.Chem.
,37,323
FEROXE10 Ferrioxamine E D.van der Helm, M.Poling (1976)
J.Am.Chem.Soc. ,98,82
FERRID10 Ferrichrome D.van der Helm, J.R.Baker, D.L.Eng-Wilmot,
M.B.Hossain, R.A.Loghry (1980)
J.Am.Chem.Soc. ,102,4224
FTAFUS10 N,N',N''-Triacetylfusarinine-iron(iii) M.B.Hossain, D.L.Eng-Wilmot, R.A.Loghry,
D.van der Helm (1980) J.Am.Chem.Soc.
,102,5766
IRADEK (μ2-1,3-Benzodihydroxamato-O-O’)-
tetra-iron
Y.Bai, D.Guo, C-y Duan, D-b Dang, K-L Pang, Q-
J Meng (2004) Chem. Commun. 186
JEPRAX Ferrirhodin K.Fidelis, M.B.Hossain, M.A.F.Jajal, D.van der
Helm (1990) Acta Crystallogr.,
Sect.C:Cryst.Struct.Commun. ,46,1612
OCELOX (tris[2-(((N-acetyl-N-oxy)glycylamino
)ethyl)amine])-iron(iii)
K.Matsumoto, T.Ozawa, K.Jitsukawa, H.Einaga,
H.Masuda (2001) Inorg.Chem. ,40,190
OFUYET Ferrioxamine B S.Dhungana, P.S.White, A.L.Crumbliss (2001)
J.Biol.Inorg.Chem.(JBIC) ,6,810
QOZDUE -(((R,R,R)-tris(2-((N-Acetyl-N-
hydroxy) -D-alanylamino) ethyl)
amine)- iron(iii))
K.Matsumoto, T.Ozawa, K.Jitsukawa, H.Einaga,
H.Masuda (2001) Chem.Commun. ,978
SIPMEJ Retro-ferrioxamine E M.B.Hossain, M.A.F.Jalal, D.van der Helm,
K.Shimizu, M.Akiyama (1998) J.Chem.Cryst.
,28,53
SISSAO tris(N-(p-Tolyl) acetohydroxamato- A.Dietrich, K.A.Fidelis, D.R.Powell, D.van der
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O,O')-iron(iii) acetone solvate Helm, D.L.Eng-Wilmot (1991)
J.Chem.Soc.,Dalton Trans.,231
SISSES tris(N-Methyl-4-
methylbenzohydroxamato-O,O')-
iron(iii)
A.Dietrich, K.A.Fidelis, D.R.Powell, D.van der
Helm, D.L.Eng-Wilmot (1991)
J.Chem.Soc.,Dalton Trans. ,231
SUXREI (fac) fac-tris(Hydroxamato-O,O')-iron(iii) T.W.Failes, T.W.Hambley (2000) Aust.J.Chem.
,53,879
SUXREI (mer) mer-tris(Hydroxamato-O,O')-iron(iii) T.W.Failes, T.W.Hambley (2000) Aust.J.Chem.
,53,879
TEQKUV (μ2-Alcaligin)-bis(alcaligin)-di-iron Hou, Z.; Sunderland, C. J.; Nishio, T.; Raymond,
K. N., J.Am. Chem. Soc. 1996, 118, 5148.
UNEVUE bis(Ferrioxamine B)
bis (benzo-18-crown-6)
S.Dhungana, P.S.White, A.L.Crumbliss (2003)
J.Am.Chem.Soc. ,125,14760
UNEWAL bis(Ferrioxamine B)
bis (cis-syn-cis-dicyclohexano-18-
crown-6)
S.Dhungana, P.S.White, A.L.Crumbliss (2003)
J.Am.Chem.Soc. ,125,14760
UNEWEP bis(Ferrioxamine B)
18-crown-6 ether
S.Dhungana, P.S.White, A.L.Crumbliss (2003)
J.Am.Chem.Soc. ,125,14760
Table 0-2: Summary of the 23 X-ray crystal structures of ferric-tris-hydroxamates used in the
DOMMIMOE parameter refinement.
CDS Reference
code
Common name Reference
BOPMUO01 Asperchrome A M.B.Hossain, D.van der Helm, M.Alam,
R.Sanduja (1983) ACA,Ser.2 ,11,29
BUHQUQ (tris((3-(N-Acetyl-N-
hydroxy)glycylamino)
propyl)ammonium)-iron(iii)
K.Matsumoto, N.Suzuki, T.Ozawa, K.Jitsukawa,
H.Masuda (2001) Eur.J.Inorg.Chem. ,2481
CETWIH Ferric neurosporin D.L.Eng-Wilmot, A.Rahman, J.V.Mendenhall,
S.L.Grayson, D.van der Helm (1984)
J.Am.Chem.Soc. ,106,1285
COFDIK10 Neocoprogen I M.B.Hossain, M.A.F.Jalal, B.A.Benson,
C.L.Barnes, D.van der Helm (1987)
J.Am.Chem.Soc. ,109,4948
DUPJON Ferrioxamine D1 M.B.Hossain, M.A.F.Jalal, D.van der Helm (1986)
Acta Crystallogr.,Sect.C:Cryst.Struct.Commun.
,42,1305
FEBOAH02 tris(Benzohydroxamato-O,O')-
iron(iii)
T.W.Failes, T.W.Hambley (2000) Aust.J.Chem.
,53,879
FERCRN10 Ferricrocin C.L.Barnes, D.L.Eng-Wilmot, D.van der Helm
(1984) Acta Crystallogr.,
Sect.C:Cryst.Struct.Commun. ,40,922
FERMAH11 Ferrichrome-A D.van der Helm, J.R.Baker, R.A.Loghry,
J.D.Ekstrand (1981) Acta
Crystallogr.,Sect.B:Struct.Crystallogr.Cryst.Chem.
,37,323
FEROXE10 Ferrioxamine E D.van der Helm, M.Poling (1976)
J.Am.Chem.Soc. ,98,82
FERRID10 Ferrichrome D.van der Helm, J.R.Baker, D.L.Eng-Wilmot,
M.B.Hossain, R.A.Loghry (1980)
J.Am.Chem.Soc. ,102,4224
FTAFUS10 N,N',N''-Triacetylfusarinine-iron(iii) M.B.Hossain, D.L.Eng-Wilmot, R.A.Loghry,
D.van der Helm (1980) J.Am.Chem.Soc.
,102,5766
JEPRAX Ferrirhodin K.Fidelis, M.B.Hossain, M.A.F.Jajal, D.van der
Helm (1990) Acta Crystallogr.,
Sect.C:Cryst.Struct.Commun. ,46,1612
OCELOX (tris[2-(((N-acetyl-N-
oxy)glycylamino )ethyl)amine])-
iron(iii)
K.Matsumoto, T.Ozawa, K.Jitsukawa, H.Einaga,
H.Masuda (2001) Inorg.Chem. ,40,190
OFUYET Ferrioxamine B S.Dhungana, P.S.White, A.L.Crumbliss (2001)
J.Biol.Inorg.Chem.(JBIC) ,6,810
QOZDUE -(((R,R,R)-tris(2-((N-Acetyl-N-
hydroxy) -D-alanylamino) ethyl)
amine)- iron(iii))
K.Matsumoto, T.Ozawa, K.Jitsukawa, H.Einaga,
H.Masuda (2001) Chem.Commun. ,978
SIPMEJ Retro-ferrioxamine E M.B.Hossain, M.A.F.Jalal, D.van der Helm,
K.Shimizu, M.Akiyama (1998) J.Chem.Cryst.
,28,53
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SISSAO tris(N-(p-Tolyl) acetohydroxamato-
O,O')-iron(iii) acetone solvate
A.Dietrich, K.A.Fidelis, D.R.Powell, D.van der
Helm, D.L.Eng-Wilmot (1991)
J.Chem.Soc.,Dalton Trans. ,231
SISSES tris(N-Methyl-4-
methylbenzohydroxamato-O,O')-
iron(iii)
A.Dietrich, K.A.Fidelis, D.R.Powell, D.van der
Helm, D.L.Eng-Wilmot (1991)
J.Chem.Soc.,Dalton Trans. ,231
SUXREI (fac) fac-tris(Hydroxamato-O,O')-iron(iii) T.W.Failes, T.W.Hambley (2000) Aust.J.Chem.
,53,879
SUXREI (mer) mer-tris(Hydroxamato-O,O')-
iron(iii)
T.W.Failes, T.W.Hambley (2000) Aust.J.Chem.
,53,879
UNEVUE bis(Ferrioxamine B)
bis (benzo-18-crown-6)
S.Dhungana, P.S.White, A.L.Crumbliss (2003)
J.Am.Chem.Soc. ,125,14760
UNEWAL bis(Ferrioxamine B)
bis (cis-syn-cis-dicyclohexano-18-
crown-6)
S.Dhungana, P.S.White, A.L.Crumbliss (2003)
J.Am.Chem.Soc. ,125,14760
UNEWEP bis(Ferrioxamine B)
18-crown-6 ether
S.Dhungana, P.S.White, A.L.Crumbliss (2003)
J.Am.Chem.Soc. ,125,14760
Table 0-3: Performance of DOMMIMOE on X-ray crystallographic structures after parameter
refinement.
The first column denotes the six-letter reference code of the structure in the Cambridge
Crystallographic Database. Fe-O(C) and Fe-O(N) denote the Fe-oxygen bond lengths between
carbonyl and oxime oxygens in the hydroxamate groups respectively. The RMSD The bite angle
denotes the angle between the oxime oxygen–iron–carbonyl oxygen in a hydroxamate group in
degrees. The calculated trigonal twist difference from the DOMMIMOE to the X-ray
structures are given in the fifth column, and were calculated by the “eclipsing triangles”
method.
CDS
reference
code
Fe-O(C) RMSD
(Å)
Fe-O(N) RMSD
(Å)
bite angle
RMSD (°)
Trigonal twist
difference
(DOMMIMOE – X-
ray) (°)
BOPMUO01 0.017 0.020 0.3 3.6
BUHQUQ 0.023 0.015 0.7 7.3
CETWIH 0.010 0.017 1.0 0.1
COFDIK10 0.022 0.029 1.5 0.8
DUPJON 0.007 0.018 0.4 5.3
FEBOAH02 0.015 0.005 0.7 12.2
FERCRN10 0.004 0.011 0.7 7.9
FERMAH11 0.025 0.014 1.0 8.3
FEROXE10 0.030 0.047 0.4 2.9
FERRID10 0.013 0.016 0.5 5.7
FTAFUS10 0.026 0.016 1.2 2.4
JEPRAX 0.017 0.020 1.0 1.7
OCELOX 0.016 0.020 0.6 6.6
OFUYET 0.014 0.011 0.3 8.6
QOZDUE 0.006 0.014 0.2 3.7
SIPMEJ 0.006 0.011 0.7 -4.2
SISSAO 0.024 0.007 1.3 12.5
SISSES 0.004 0.011 0.6 6.1
SUXREI (fac) 0.019 0.023 0.9 3.7
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SUXREI (mer) 0.012 0.008 0.9 9.3
UNEVUE 0.021 0.010 0.7 7.2
UNEWAL 0.010 0.015 0.6 5.6
UNEWEP 0.020 0.009 0.7 7.2
